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Zusammenfassung  
In dieser Arbeit wurde das Konzept der Synthetischen Biologie umgesetzt, um minimalistische 
künstliche Zellen zu konstruieren, welche strukturell und funktionell einer lebenden Zelle 
ähneln.  
In diesem Sinne wurden mittels mikrofluidischer Lab-on-a-Chip Technologie zellgroße 
Wasser-in-Öl Tröpfchen in hohem Durchsatz hergestellt und mit isolierten Zellbausteinen, wie 
Membranlipiden, Zellskelett- und Rezeptor-Proteinen, ausgestattet. Die Wasser-in-Öl 
Tröpfchen wurden über geladene oder ungeladene Tenside stabilisiert. Dadurch konnten 
Interaktionen zwischen der Tröpfchenwand und dem Tröpfcheninhalt veranlasst oder 
verhindert werden. Durch das Einkapseln von Membranlipiden konnten so Strukturen in den 
Tröpfchen aufgebaut werden, welche den Lipidmembranen einer lebendenden eukaryotischen 
Zelle ähnlich sind: eine äußere Lipidmembran und interne kleinere Kompartimente. 
Im Weiteren konnten künstliche Zellen entwickelt werden, die einer lebenden Zelle nicht nur 
strukturell, sondern auch funktionell ähneln. Hierfür wurden die Zellkompartimente mit 
Hauptbausteinen des zellulären Bewegungsapparates ausgestattet: ein dynamisches Aktin 
Zellskelett, Motorproteine und Membranrezeptoren, welche die Zellen auf dem Untergrund 
adhärieren lassen. Hierbei ist hervorzuheben, dass so erstmals eine multifunktionale künstliche 
Zelle hergestellt wurde, die sowohl Adhäsions- als auch Zellskelett-Bausteine enthält.  
Darüber hinaus wurden autonome Bewegungen der Zellkompartimente gezeigt und dieses 
Phänomen über einen chemisch-physikalischen Effekt erklärt.  
Der hier beschriebene Ansatz ist eine vielseitige Methode, um komplizierte Funktionen einer 
Zelle in minimalistischen und kontrollierbaren Kompartimenten zu untersuchen. Darüber 
könnten Mechanismen des frühen evolutionären Lebens – wahrscheinlich ähnlich 
minimalistisch – erklärt werden. 
 
 
 
 
 
 
 
 
 
 
 
  II 
Abstract 
The investigation into how life evolved and cellular complexity developed is an ongoing and 
highly researched pursuit in science. The central goal of my thesis was to develop a bio-inspired 
synthetic cell model in order to address this important topic. Towards this end, polymer-
stabilized water-in-oil droplets were used as cell-sized compartments for the assembly and 
testing of specific sets of bioactive components. Moreover, an automated, droplet-based 
microfluidic technology was implemented for high throughput production of these cell-like 
compartments and their subsequent manipulation.  
To resemble the eukaryotic cell architecture, I established a highly-tunable method for the on-
demand creation of synthetic cell systems in the form of 3D-supported lipid bilayers, 
multicompartment systems or free-standing giant unilamellar vesicles (GUVs). To accomplish 
this, small unilamellar vesicles were encapsulated into polymer-stabilized water-in-oil droplets. 
By tuning the charge of the inner droplet interface, adsorption of lipids can either be inhibited, 
leading to multicompartment systems, or induced, leading to the formation of droplet-
stabilized giant unilamellar vesicles (dsGUVs) or a combination of multicompartment systems 
and dsGUVs. Following assembly, the successful release of free-standing GUVs from the 
polymer shell and the oil phase into physiological conditions was demonstrated. This paves the 
way towards future applications in which synthetic cell interactions with a physiological 
environment are crucial. 
Another significant achievement in this thesis was the assembly of a cellular motility module 
by the reconstitution of actin cytoskeletal networks and adhesion membrane receptors within 
droplet-based synthetic cells. These disparate cytoskeletal and adhesive elements were united 
in the lipid membrane structure of dsGUVs. I showed that this module was able to recapitulate 
key mechanisms in cell migration – namely cytoskeletal pushing and contractile forces. To date, 
such synthetic cells containing both cytoskeletal and adhesion-associated functional modules 
capable of self-propulsion has never been demonstrated.  
Remarkably, this minimal but functional set of building blocks allowed for the generation of 
autonomous motion in synthetic cells, and led to the analysis of the mechanism behind this 
self-propulsion.   
The powerful microfluidic technology and synthetic cell-like compartments presented in this 
thesis have the potential for widespread and diverse employment in synthetic biology as they 
allow for the use of varied sets of both synthetic and natural building blocks. I believe that the 
scientific achievements presented in this thesis will be of great interest to researchers in 
fundamental biology, bioengineering and biochemistry.  
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1. Introduction 
 
1.1. Origin of Life 
 
The questions when and how life first appeared on Earth are amongst the most fundamental 
questions – prompted by the mesmerizing complexity of each and every organism that are now 
present on Earth.  
It appears that already 3.8 billion years ago, first forms of life had emerged on Earth. This could 
be evidenced by fossilized mats of stromatolites, formed by the growth of many layers of single-
celled microbes.1 While there are some ideas about when life appeared on Earth, how it appeared 
is the more difficult question.  
To investigate this question from a scientific point of view, we first of all have to define what 
life and living matter actually is. One recent definition, which in my opinion suits the best, is 
phrased by Ruiz-Miarazo et al.: “Life is based on the idea of an autonomous system with open-
ended evolutionary capacities”.2 Autonomy refers to boundaries between the living entity and 
its environment as well as to its capacity to use energy and matter for their metabolism and for 
the synthesis of its own components in order to self-sustain and to replicate. Open-ended 
evolution refers to the capability to gain new functions and to adapt to distinct situations in an 
almost unlimited way in order to survive.2 
With regard to the question of how life evolved, most scientists agree, based on experimental 
evidence, that the creation of life – meaning the creation of first organic building blocks – 
required very specific environmental conditions.3 There are two competing theories. In the 
more conventional one, the primordial soup theory, life has evolved close to the surface due to 
the oxygen-poor and thus, reactive atmosphere of the early Earth. Hence, simple inorganic 
molecules could have emerged, fueled by the energy from lightning or from UV rays to form 
organic building blocks.4 With the accumulation of these building blocks in the primordial 
soup, further reactions might have happened leading to the formation of nucleotides or amino 
acids. These building blocks then formed polymers, like nucleic acids and proteins, that in turn 
assembled further into units or structures capable of sustaining and replicating themselves.1 In 
1952, Stanley Miller and Harold Urey simulated the early Earth’s inorganic conditions in a 
chemical experiment and ended up with amino acids, supporting the described theory of 
evolution of life.5  
However, the fact that today’s living organism gaining their energy via a proton gradient across 
the membrane, favors an alternative theory, where life arose in the deep sea within warm and 
porous geological structures, so-called hydrothermal vents.6 Fluids from the Earth’s primitive 
oceanic crust and the more acidic ocean water could have led to a proton gradient in the 
hydrothermal vent and thus, allowed for chemical reactions driven by a similar energy supply 
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as seen in the living cells today.7 Later, cells learned how to produce their own gradients and 
could eventually escape the vents.6 
Even though these theories are close to bridge the gap between non-living molecules and living 
cells, synthesis of living matter has not been achieved in the laboratory until now. Approaches 
towards the creation of an entire cell from scratch are still in their infancy – even though much 
afford has been made to achieve this major milestone in understanding life in greater detail in 
the last decades. To recreate what evolution shaped for billions of years in few hours or days in 
a test tube goes far beyond the grasp of contemporary science. Nevertheless, great results have 
been achieved towards the creation of functional cellular modules in cell mimetics.8 The idea 
here is to start with a minimal system and step-by-step increase its complexity, similarly as it is 
imagined in the evolution, when cells went from primitive to the complexity they reached now. 
The use of a minimal set of building blocks, helps to find key players of cellular functions and 
allows for a better understanding of cellular function and life in general. 
In the following, I will introduce relevant functional modules of a eukaryotic cell that have been 
dissected and studied in the less complex environment of a synthetic cell in my Ph.D. thesis. 
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1.2. The Complexity of a Living Cell 
 
In this thesis, I will present the eukaryotic membrane architecture and cellular motility based 
on an in vitro synthetic cell approach. Towards this aim, a minimal set of natural building blocks 
were assembled into cellular mimetic modules within a defined and synthetic environment. To 
determine the right building blocks to start with, complex cellular functions need to be dissected 
and fundamental building blocks need to be identified. Thus, before presenting synthetic cell 
approaches, I will briefly outline the relevant structural and functional modules in a living cell. 
First, I will introduce eukaryotic lipid membrane structures. Then, I will focus on cellular 
motility and its major constituents. 
 
1.2.1. Compartments  
 
Compartments are the most basic feature in every cell to maintain the essential difference 
between cytosol and extracellular environment and to guarantee special reactions to take place. 
Besides a semipermeable barrier function, the demands on cellular membranes go far beyond.9 
Thus, cellular membranes can be enormously diverse among cells of different species as well as 
among cells within a multicellular organism, depending on their habitat and their tasks.10 One 
thing, however, that all cellular membranes have in common is the 5 nm thick lipid double 
layer.11 The most fundamental building block of these membranes are phospholipids. Since the 
chemical structure of phospholipids and the lipid composition of a membrane can significantly 
affect crucial biological functions,9 I will explain the structure and assembly of these building 
blocks in the following sections.  
 
1.2.1.1. Phospholipids 
 
All lipids of the cell membrane are amphiphilic molecules that possess a polar (hydrophilic) 
head and a nonpolar (hydrophobic) tail. Among these, most abundant membrane lipids are 
phospholipids, in animal cells especially phosphoglycerides.11 As illustrated in Figure 1, these 
are made from a glycerol backbone that is linked through ester bonds to two fatty acids and to 
one phosphogroup.10,12 Typically, one of the fatty acids is unsaturated and thus kinked, and the 
other one is saturated and straight.11 The phosphogroup can be linked to several types of head 
groups e.g. phosphatidyl – ethanolamine (PE), serine (PS) or choline (PC).11  
Another common lipid is sphingomyelin that have instead of the glycerol backbone a 
sphingosine and an extra hydroxyl group that increases the polar properties of the head.13  
Other constituents that play important roles in the cellular membrane in terms of membrane 
mechanical properties and signaling, are cholesterol and phosphatidylinositol, respectively.9,14  
The Complexity of a Living Cell          
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Figure 1: Chemical structure of the major phospholipids in the lipid membrane. Reproduced 
and modified from 1 1.  Copyright © 2002, Bruce Alberts, Alexander Johnson, Julian Lewis, 
Martin Raff, Keith Roberts, and Peter Walter; Copyright © 1983, 1989, 1994, Bruce Alberts, 
Dennis Bray, Julian Lewis, Martin Raff, Keith Roberts, and James D. Watson. 
 
For studying lipid membranes in vitro, natural lipids (e.g. isolated from egg or soy)15 or 
synthetically derived lipids16 can be used. In my thesis, I will use lipid compositions made of 
synthetically derived phospholipids, among these mainly phosphatidylcholine and a varying 
amount of negatively charged phospholipids, as well as 15% cholesterol; a lipid composition 
similarly seen in living eukaryotic cells.12 
 
1.2.1.2. Lipid Bilayers 
 
Due to the amphiphilic nature of phospholipids, lipids can spontaneously assemble into highly 
ordered structures, depending on their shape: e.g. bilayers or micelles in the case of cylindrical 
or cone shaped lipids, respectively.17 Since thereby the least number of water molecules are 
exposed to the hydrophobic lipid tails of the lipids, the free energy is minimized. However, one 
could imagine, that at the edges of planar lipid bilayers the hydrophobic tails are exposed to the 
water. This would be energetically unfavorable. Thus, lipid bilayers exist in a living cell only as 
sealed compartments, which is a fundamental principle in the creation of life.11  
 
The lipid membranes of a eukaryotic cell can be seen as a two-dimensional fluid at room 
temperature.12 This fluidity depends mainly on the composition of the membrane and on the 
temperature. Whereas straight and long fatty acid tails decrease fluidity, unsaturated and kinky 
fatty acid tails increase the fluidity.11 Further cholesterol molecules influence the membrane 
                                                   Introduction  
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fluidity in a temperature-dependent manner. Moreover, cholesterol incorporation decreases 
permeability of the membrane, as it leads to a dense packing of the bilayer.12 
 
 
 
Figure 2: Lipid bilayer of the cellular membrane. Asymmetric lipid composition of the two 
leaflets. Extracellular leaflet: phosphatidylcholine (PC), sphingomyelin (SM), glycolipids. 
Intracellular leaflet: phosphatidylserine (PS), phosphatidylethanolamine (PE), 
phosphatidylinositol (PI). Reproduced and modified from 1 1 Copyright © 2002, Bruce 
Alberts, Alexander Johnson, Julian Lewis, Martin Raff, Keith Roberts, and Peter Walter; 
Copyright © 1983, 1989, 1994, Bruce Alberts, Dennis Bray, Julian Lewis, Martin Raff, Keith 
Roberts, and James D. Watson. 
 
Besides the diverse lipid compositions and thus varying properties from one membrane type to 
the other,10 also the lipid composition in the two leaflets of the bilayer is strikingly distinct 
(Figure 2). In the inner leaflet, this is especially important for mediating signaling pathways. 
E.g. the arrangement of functional lipid domains, so-called lipid rafts, are involved in the 
recruitment and activation of proteins.17 Further, the negatively charged phosphatidylinositol 
at the inner leaflet can be modified by an activated lipid kinase to initiate signaling pathways; 
and another specific phospholipids can be cleaved to generate fragments that subsequently 
function as signaling molecules.11 In contrast, the extracellular leaflet contains a lot of 
glycolipids that are involved in cell-cell or cell-extracellular matrix (ECM) interactions and help 
to protect the membrane against harsh conditions.18  
 
The lipid bilayer membranes are not only found as an outer cell membrane, but also form 
intracellular smaller compartments, which are a hallmark of the eukaryotic architecture. Since 
I aim to resemble these eukaryotic structures in my thesis (multicompartment system, see 
Section 5.1.2), I will explain briefly some of the major intracellular compartments in a living 
cell in the next section. 
 
1.2.1.3. Intracellular Compartments 
 
In or on lipid membranes many essential biochemical processes take place. The precursors of 
first eukaryotic cells were simple organisms without internal membranes, however, much 
smaller, comprising thereby a large surface-to-volume ratio and enough area for all membrane 
The Complexity of a Living Cell          
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dependent vital functions in the cell.11 In eukaryotic cells, membrane-enclosed compartments 
occupy in average around half of the cell volume.11 This provides additional membrane surface, 
and allows for specialized separated aqueous space with an own set of enzymes and specialized 
molecules.19  
The basic structure of a eukaryotic cell is shown in Figure 3. 
 
 
Figure 3: Representative schematic image of a eukaryotic cell.  The outer lipid membrane 
surrounds the internal cytosol, which contains a highly structured internal architecture e.g. 
nucleus, mitochondria, endoplasmatic reticulum (ER), Golgi apparatus, cytoskeleton etc. 
Reproduced and modified from 1 1  Copyright © 2002, Bruce Alberts, Alexander Johnson, 
Julian Lewis, Martin Raff, Keith Roberts, and Peter Walter; Copyright © 1983, 1989, 1994, 
Bruce Alberts, Dennis Bray, Julian Lewis, Martin Raff, Keith Roberts, and James D. 
Watson. 
 
The name Eukaryote is derived from the Greek words “eu” meaning “well” or “true”, and 
“karyon” meaning “nut” or “kernel”. Thus, the most fundamental internal eukaryotic 
compartment is the nucleus, which houses the genetic material and mediates the protein 
synthesis.20 Similar like other internal compartments, the nucleus probably has been evolved 
from invagination and pinching off specialized membrane structures from the plasma 
membrane (like Golgi apparatus, endoplasmatic reticulum (ER)) or through the engulfment of 
bacteria (like in case of mitochondria).21,20  
Another prominent intracellular structure is the ER, which makes up about half of the total 
membrane area in a cell.11 The “rough ER” comprises ribosomes bound to the cytosolic part, 
here, cytosolic and membrane-bound proteins as well as lipids are synthesized.22 The “smooth 
ER” is lacking ribosomes and is mainly involved in sending off the produced lipids and proteins 
to the Golgi apparatus, where they are covalently modified and further translocated to different 
destinations in the cell.22 
Another essential internal compartment – especially concerning the cellular energy supply – 
are mitochondria.11 These possess an inner, highly convoluted, and an outer membrane and 
thereby two separated compartments: the internal matrix and the intermembrane space. Each 
compartment is equipped with a unique set of proteins that e.g. mediates selective transport or 
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governs the signaling cascade of the respiratory chain, essential to generate ATP.23 This process 
is membrane-dependent as it is based on a proton gradient across the membrane. Thus, the 
highly folded inner membrane is key for large surface-to-volume rations and for an efficient 
ATP production.19 These lipid membrane folds are an interesting phenomenon in a living cell. 
In this regard, membrane folds have been also studied in artificial membrane systems in the 
past24–26 and will be further investigated in my thesis in Section 5.1.4.4.4. 
 
I demonstrated in the last section that lipid membranes provide barrier function as well as that 
they actively participate in cell signaling pathways. Besides this, lipid membranes serve as 
scaffolds for membrane proteins, which are key to equip the membranes and compartments 
with complex and sophisticated function as for example the mentioned respiratory chain in the 
mitochondria. The structure of membrane proteins and how they are assembled at the 
membrane, will be presented in the following section. 
 
1.2.1.4. Transmembrane Proteins 
 
Around 30% of the encoded proteins in an animal cell are membrane proteins and make up 
half of the membrane’s mass.27 Membrane proteins promote important membrane functions 
including, but not limited to, specific transport, catalysis of membrane associated reactions 
(ATP synthesis) or transduction of signals from the extracellular environment.19 Proteins 
interact with the membrane mainly due to amphiphilic properties.11  
 
 
Figure 4: Representative image of membrane proteins in the cellular membrane. (1) 
transmembrane protein, (2) integral membrane protein with a hydrophobic terminal 
domain, (3) membrane protein covalently linked to lipid, (4) peripheral membrane protein. 
Reproduced and modified from 1 1  Copyright © 2002, Bruce Alberts, Alexander Johnson, 
Julian Lewis, Martin Raff, Keith Roberts, and Peter Walter; Copyright © 1983, 1989, 1994, 
Bruce Alberts, Dennis Bray, Julian Lewis, Martin Raff, Keith Roberts, and James D. 
Watson. 
 
In this regard, Figure 4 shows that depending on the arrangement of their hydrophobic and 
hydrophilic protein domains, they can either span across the lipid bilayer (transmembrane 
proteins (1)); or appear only at one side of the membrane (integral membrane proteins (2)) by 
having one hydrophobic terminal domain; or by being covalently connected to a lipid in one 
The Complexity of a Living Cell          
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leaflet of the membrane (3). Some other membrane proteins are non-covalently associated to 
the membrane via interactions to other membrane proteins. These are called peripheral 
membrane proteins (4).11 
 
In my thesis, a transmembrane protein, the so-called integrin-transmembrane receptor, was 
reconstituted within the lipid membranes of synthetic cells. Thereby, the membrane was 
equipped with an important building block of the cellular adhesion module that allow the cell 
to attach onto an extracellular substrate. Moreover, peripheral membrane proteins are 
addressed in my thesis, which connect the integrin receptors to the cytoskeleton, and thereby 
coordinate multiple aspects in cell locomotion. However, before these proteins are discussed in 
more detail in Section 5.3, I will first outline cellular motility more generally in the next section. 
 
1.2.1. Cellular Motility 
 
The phenomenon of cell migration is seen in many animal cells. For example cells of the 
immune system migrate to the site of infection, osteoclasts crawl over bone, or fibroblasts 
migrate through connective tissues, rebuilding damaged structures.28  
 
 
 
Figure 5: Schematic illustration of major steps of a cell migration on a 2D substrate. 
Locomotion is mediated by: 1. cellular protrusions at the leading edge, 2. formation of new 
adhesions to the substrate, 3. contraction of the cell body and 4. the forward translocation 
of the cell.  Reprinted with permission from 2 8.  
 
The migration process is highly complex, as it has to integrate the dynamic interplay between 
cytoskeletal filaments, filament regulators, motor proteins and membrane flows.11  
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Nevertheless, it can be condensed into few major activities presented in Figure 5: protrusion at 
the front of the cell; attachment onto the substrate; and traction, in which the rear of the cell is 
drawn forward.29 
Major constituents that mediate this migration are actin cytoskeletal filaments together with 
contractile motor proteins, like the myosin motor II, as well as for the attachment of the cell 
body the already mentioned integrin transmembrane receptors. These building blocks will be 
outlined in the following sections, starting with cytoskeletal building blocks. 
 
1.2.1.1. The Cytoskeleton  
 
In a eukaryotic cell, the cytoskeleton governs many cellular processes. It mediates the cell’s 
shape, its mechanical robustness and its internal structure.30 Moreover, the cytoskeleton is 
crucial for chromosome segregation during mitosis, it splits the cell in two during division, 
guides the intracellular transport of organelles and allows the cell to crawl across surfaces.19  
 
 
Figure 6: Primary constituents of the cytoskeleton: (A) actin filaments, (B) microtubules, 
(C) intermediate filaments with their persistence lengths. Reprinted with permission from 
3 1  © Copyright 2009 ANNUAL REVIEWS, INC. 
 
There are three kinds of cytoskeletal filaments depicted in Figure 6: actin filaments that shape 
dynamically the cell surface, build the contractile ring to round up the cells before division and 
that are further responsible for cell locomotion (A);32 microtubules that direct intracellular 
transport and location of membrane enclosed organelles (B); and intermediate filaments that 
provide mechanical strength and align around the inner part of the nuclear envelope (C).11 
These three cytoskeletal constituents comprise a polymer-like structure made of subunits that 
assemble based on different intermolecular attractive forces. Intermediate filaments, for 
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example, form strong lateral contacts between their fibrous subunits, thus, possessing strong 
rope-like properties that can tolerate stretching and bending.33 Microtubules are built from 
globular subunits, the α and β tubulin, each of them bound to a GTP. These subunits form 
dimers before being assembled into a protofilament by hydrolyzing the GTP, which is bound 
to the β tubulin. 13 of these protofilaments are then used to build a hollow cylindrical structure. 
This structure makes the microtubule stiff and difficult to bend, possessing a persistence length 
(length before filament bends due to random thermal fluctuations) of several millimeters.34 
Filamentous actin (“F-actin”) is made of only one kind of ATP or ADP-bound globular 
monomer (“G-actin”) and only two of the protofilaments twist around each other in a right-
handed helix. This makes the filaments relatively flexible and easy to bend, thus, actin filaments 
possess a persistence length of around 17 µm.35 However, actin-binding proteins as crosslinkers 
and bundling proteins ( 
Table 1) can combine individual actin filaments to filament structures with adaptable 
properties.36  
 
Table 1: actin-binding proteins and the effect on actin filaments. 
Actin-binding protein Effect on actin 
Arp2/3, WASP Branch formation 
Fascin, α-actinin Filament bundling  
Filamin, spectrin Filament crosslinking 
Cortactin Sidebinders 
Gelsolin, villin Severing and Capping 
ADF/cofilin Depolymerisation 
WASP  Nuclelators 
Profiling, profilin Monomer delivery and   polymerization 
 
In my thesis, I will reconstitute actin cytoskeleton networks in a synthetic cell. Thus, I will 
address next solely actin-related cytoskeletal features, especially regarding pushing and 
contractile forces during cell migration. 
 
Pushing Forces generated by Actin Treadmilling 
 
The protrusion of the leading edge during cellular locomotion relies primarily on forces of 
elongated filaments that push during actin polymerization against the plasma membrane.37 This 
can result in different shapes of protrusive structures, including filopodia (spiky structures), 
lamellipodia (sheet-like structures) or pseudopodia (stubby 3D- projections).11 
 
Polymerization of actin is basically initiated by a local monomer concentration above a critical 
value. This critical concentration depends critically on the presence of ATP or ADP. In this 
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regard, the monomer concentration needs to be significantly higher when the monomers are 
bound to the diphosphate state (ADP). Thus, actin polymerization happens mainly when the 
monomers are bound to ATP.11 After the incorporation of actin monomers into the filament, 
the ATP is hydrolyzed to ADP in a time-dependent manner (Figure 7). Thus, the longer the 
subunits have been in the polymer lattice the more likely they hold the ADP.38  
Much of the free energy from the ATP-hydrolysation reaction is stored within the polymer 
lattice. This drives the dissociation of monomers when bound to ADP and the incorporation 
when bound to ATP.39 Thus, the ends of the actin filaments are often described as a “plus” and 
a “minus end” with distinct kinetic rate constants for association and dissociation. This can lead 
to a simultaneous shrinkage and elongation of the filament at the according sides, so-called 
treadmilling.40  
 
 
Figure 7: Illustration of actin treadmilling. ATP-bound (orange stroke) actin monomers 
polymerize at the “plus end”. ATP will be hydrolyzed to ADP (blue stroke) and actin 
monomers again depolymerize at the “minus end”. Reproduced and modified from 1 1  
Copyright © 2002, Bruce Alberts, Alexander Johnson, Julian Lewis, Martin Raff, Keith 
Roberts, and Peter Walter; Copyright © 1983, 1989, 1994, Bruce Alberts, Dennis Bray, 
Julian Lewis, Martin Raff, Keith Roberts, and James D. Watson. 
 
Besides the critical monomer concentration and the binding of ATP / ADP, the polymerization 
and depolymerization of actin filaments is further regulated by many accessory proteins that 
are in turn controlled by extracellular or intracellular signal. The ARP complex, for example, is 
a nucleation regulator associated to the leading edge of migrating cells and forms a treelike 
filament web at the cell cortex, thus assist the actin cytoskeleton to regulate cell shape and 
movement.41,29 Other proteins, e.g. cross linkers or bundling proteins lead to parallel bundles of 
actin filaments. A list of actin-binding proteins and their function is listed in  
Table 1.29 The recruitment of these proteins and its complex interplay with actin filaments allow 
for rapid and coordinated network transformation during cell cycle or locomotion.19,29 
 
Contraction Forces through Molecular Motors 
 
The most remarkable cytoskeleton-binding proteins are motor proteins. These proteins bind 
with one part to a cargo (e.g. organelles or other filaments) and with another part to the filament 
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track. While changing their conformation under ATP hydrolysis, the cargo is then translocated 
along a filament.42 The motor proteins in a cell differ depending on the type of filament they 
bind to, which direction they move in and which cargo they carry.11  
The motor protein, myosin II, is the most relevant motor for cell motility, as it leads to the 
contractile force that retracts the cell rear during cell migration.28  
Myosin II is a homodimer (Figure 8), with each monomer consists of a light and a heavy chain 
that builds a long α-helix tail and a globular head region.43 The two long tails form a coiled-coil 
that further interact tail-to-tail with other dimers, resulting in thick bundles exposing several 
hundred heads.44 The heads bind to a filament and under ATP hydrolysis each head undergoes 
a conformational change. Cycles of filament binding, conformational change, filament release, 
conformational relaxation and filament rebinding lead then to a pushing or pulling force.45  
 
 
Figure 8: Schematic illustration of myosin II motor as a dimer and as a myosin bundle 
interacting with actin filaments. Reprinted from 4 3.  
 
The contraction of the actin networks upon myosin II activity is based on the symmetry 
breaking of actin filaments severing: actin filament buckling is much more prone under 
compression (already at 3-4 pN) than actin rupture under tension (round 400 pN).46 This allows 
the cell to contract its rear and to move forward.  
 
Besides the cytoskeleton pushing and contractile forces, the third crucial element in cell 
locomotion is the cell adhesion to the substrate. When moving forward, the cell has to create 
new attachment sites that serve as anchor points. This only allows the cell to apply the traction 
force to the substrate and to pull the cell body forward.28 The crosstalk between the dynamic 
cell adhesion machinery and cytoskeletal assembly is thereby particularly important and makes 
the whole locomotion process considerably complex.47 
The adhesion of the cell to the extracellular matrix (ECM) via integrin transmembrane 
receptors and its important linkage to the cytoskeleton will be addressed in the following 
section. 
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1.2.1.2. Cell-Extracellular Matrix (ECM) Interactions 
 
The extracellular matrix (ECM) consists of a variety of protein fibers in a hydrated gel of 
glycosaminoglycan chains.11 It does not only provide a mechanical support for cells but also 
influences their behavior in multiple ways.48  
 
 
Figure 9: Schematic representation of integrins that are bound to the extracellular matrix 
and linked to the actin cytoskeleton through multiple peripheral anchoring proteins, 
including, but not limited to, talin, vinculin and α-actinin. Other proteins, like focal 
adhesion kinase are also recruited and trigger the downstream activation of signaling 
pathways that influence e.g. myosin II motor activity. Adapted from 4 9.  
 
The protein fibers e.g. collagen, fibronectin and fibrinogen provide binding sites on the ECM 
substrate that allow cells to attach via integrin transmembrane receptors.50  The integrin family 
includes at least 24 different integrins, composed of two non-covalently associated α and β 
subunits that both span across the cell membrane.51 Their extracellular tail specifically 
recognizes certain ligands of extracellular matrix proteins. These ligands are small peptide 
sequences within the ECM proteins e.g. the tripeptide RGD found in fibrinogen or fibronectin, 
or more complex ones, as the GFOGER peptide that is found within collagen.52 With the 
intracellular part integrins are connected to actin filaments via a set of intracellular anchoring 
proteins (Figure 9).53 During migration, the cell rapidly creates and breaks adhesion 
interactions with the ECM accompanied by the prompt assembly and disassembly of actin 
filaments.28 This interplay is governed by an activated or inactivated conformation state of 
integrin, which can be triggered by the mentioned anchoring proteins or by extracellular cues.54 
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This in turn influences major signaling pathways regulating for example cell proliferation, 
differentiation, survival or cell death (Figure 9).55  
The assembled protein complexes can be quite heterogeneous, either small and transient or 
large and durable.47 Very strong attachments are for example focal adhesions.43 Characteristic 
proteins involved in this complex include for example vinculin, talin, paxillin or tyrosine-
phosphorylated proteins, as the focal adhesion kinase (FAK).43,53  
Since talin and FAK will be addressed in my thesis, I will explain only these two adhesion-
associated proteins in more detail:  
 
Talin is a 270 kDa protein that links, beside others, the actin cytoskeleton to the integrin β 
subunits and triggers the affinity of integrin to ECM proteins.56  
 
 
Figure 10: Domain structure of talin with binding sites for e.g. integrin, actin, vinculin. 
Reprinted from 5 6.  
 
It comprises a globular head (talin head domain (THD)) and a flexible rod domain as depicted 
in Figure 10.54 The FERM-domain (F for 4.1 protein, E for ezrin, R for radixin and M for 
moesin), which is a wide spread domain in adhesion-associated proteins, at the globular head 
includes binding sites to the cytoplasmic domain of β-integrins as well as for actin.57 The talin 
rod contains additional binding sites for – among others –integrin and at least two more for 
actin.56,58  
 
FAK is a signaling protein that is one of the major and initial proteins recruited to the adhesion 
sites at the intracellular integrin domain.52,59 Further due to its tyrosine kinase activity it can 
phosphorylate other proteins and thus, regulates adhesion dynamics.60 It is supposed to have a 
talin binding site as well as a FERM-domain for integrin binding.59 
 
This is only a very brief description of the cell-ECM interaction and its regulation during cell 
migration. In fact, many aspects of the regulatory mechanism of cell adhesion and migration is 
not yet elucidated as it is incredibly complex. In this regard, a review of Zaidel-Bar and 
colleagues describes the “integrin adhesome” as a network comprising up to 156 linked 
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components modified by up to 690 interactions.53 This emphasizes the advantages of the 
bottom-up approach presented in my thesis, where cellular function is first dissected into its 
basic structure before moving to more complex systems.  
 
1.2.1.3. Membrane Flow in Cell Migration 
 
Besides cytoskeletal pushing and contractile forces, the adhesion to the substrate and its ECM-
cell crosstalk many more minor elements contribute to cell locomotion e.g. the cell membrane 
flow. Clearly, by extruding the cell body in the front of the cell, the membrane needs to be 
enlarged.61 Towards this aim, the additional membrane surface can be provided for example by 
exocytosis of internal vesicles at the front of the cell body and the according endocytosis at the 
rear of the cell.62 This generates a lateral flow of the lipids in the membrane from the front to 
the rear (see Figure 11).61 
 
 
Figure 11: Schematic representation of membrane flow through exocytosis of internal 
vesicles at the front of the cell body and the according endocytosis at the rear of the cell.  
Reprinted from 6 1.  
 
Moreover, in the amoebae Dictyostelium discoideum, this membrane flow is speculated to be 
directly linked to locomotion.63 This assumption is based on the observation that peripheral 
cytoplasmic vacuoles as well as externally bound particles flow in the same velocity as the 
forward movement of the amoebae.64 It was further shown that migration was impaired in 
mutants lacking an exocytosis-relevant protein.65 Nevertheless, if the membrane flow is indeed 
a key driving force in the locomotion of this primitive eukaryotic cell, is still controversially 
discussed in literature.62,63 
A possible route towards understanding and elucidating cellular function in greater detail is by 
means of synthetic biology. In this regard, I investigated in my thesis the influence of such 
tangential membrane flows on self-propulsion of synthetic cells (see Section 5.2.6). 
 
The Complexity of a Living Cell          
 16 
 Primarily, in the following section, I will explain the concept of synthetic biology and will 
present in detail the state of art regarding the reconstitution of eukaryotic architecture and 
cellular motility in synthetic cells. 
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1.3. Bottom-up Synthetic biology 
 
Synthetic biology is an interdisciplinary field of biology and engineering. Research in this field 
is dealing with the fundamental question how life has evolved in order to understand it in 
greater detail. The question is addressed in two ways: Through a bottom-up and a top-down 
approach. In the top-down strategy, living organisms are compared in order to find similarities 
and a universal ancestor. Furthermore, living organisms are used for engineering and 
modification approaches, e.g. integrating modules with designed properties or modifying 
genomes by deleting or inserting genes encoding for proteins of interest.66 The effects of these 
approaches might then be microscopically visible through a gain or loss of function or an altered 
response to an incoming signal.67,68  
However, today’s living organisms are the result of billions of years of evolution, hence, even 
the simplest cell has achieved a high degree of complexity that limits the understanding of all 
the processes and its synergistic interactions. This is very challenging for the top-down 
approach.  
In contrast, the philosophy behind the bottom-up approach is often summarized with a quote 
from the physicist Richard Feynman “What I cannot create, I do not understand” – meaning 
we can only fully understand a living cell when we build it from scratch.69 Hence, to circumvent 
the complexity of living cells, the bottom-up approach relies entirely on new building blocks 
and functional modules that are created and used to construct a minimal artificial cell (Figure 
12). These simplified systems provide well-understood starting points to elucidate complicated 
cellular functions and life in general.70 
 
 
Figure 12: Schematic representation of a bottom-up synthetic cell approach. The dissection 
of a living cell into building blocks and the reconstruction of functional modules within an 
artificial compartment.   
 
One of the most basic features of life are the boundaries between the environment and the 
internal space, where metabolic reactions take place. In this regard, many compartment-based 
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model systems have been developed in synthetic biology.71 In the following, I will give an 
overview of different compartment systems used in synthetic biology, including water-in-oil 
droplets and lipid-based compartment systems, which I used in my thesis.  
 
1.3.1. Compartmentalization 
 
Base of all life is formed by compartments, which create an enclosed space for controlled 
biochemical reactions. In particular, eukaryotic life is characterized by the coexistence of a 
larger outer compartment and internal smaller ones. It provides segregated internal reaction 
volumes that enable spatial and temporal assembly of biological processes.11 
An adequate compartment system is thus indispensable for the bottom-up construction of 
synthetic cells. One of the current challenges in synthetic biology is the creation of cellular 
membrane mimetics, providing chemical and physical stability while allowing for further 
functionalization with biological components. Moreover, the manufacturing process should be 
bio-compatible and the system should be transferable into physiological conditions.72 
Even though they may not yet fulfill all these prerequisites, various compartment systems have 
been developed and used as model systems in the past decades. These include natural 
membrane-based lipid vesicles,73 but also capsules of other amphiphilic molecules like 
coacervates,74 polymersomes,75 proteinosomes,76 and water-in-oil droplets.16,77  
 
1.3.2. Cell-sized Compartments 
 
The advantage of synthetic membranes is the possibility to employ a nearly unlimited toolbox 
of building blocks, with properties designed by means of chemical synthesis. Moreover, bio- 
and synthetic molecules can be combined merging the potency of chemical as well as biological 
systems.78,79 In this regard, the first concept of an artificial cell was developed already in 1960’s 
by Thomas Chang. His artificial cells were based on semipermeable nylon microcapsules 
containing lysate from red blood cells.80 Remarkably, these artificial red blood cells were capable 
of oxygen81 and carbon dioxide transport,82 and had antioxidant functions.83 This is not only 
one of the oldest examples of artificial cells, but simultaneously also one of the most successful 
ones, as a blood substitute based on this nanotechnological assembly of red blood cell 
constitutes has been approved in 2009 for routine use.84 This proves the valuable potential of 
synthetic cells, not only in helping us to understand evolution of life but also for medical 
applications.  
Nowadays, the widely used water-in-oil emulsion droplets are considered to be one of the 
simplest cell-sized compartments. They can be produced with high yield by manually mixing 
of an aqueous phase comprising the biological material and an oil phase,85 or – with more 
precise control - by means of microfluidic technology.77 To prevent coalescence, the water-in-
oil droplets are stabilized by amphiphilic molecules, that can be either synthetic block 
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copolymers86 or phospholipids87 forming a monolayer around droplets. Due to their chemical 
and physical stability and their high throughput production, these droplets are used widely in 
studies concerning cell-free gene expression or PCR applications88 as well as in synthetic cell 
studies.16,77,89 Therefore, in my thesis, I will make use of the advantages of surfactant-stabilized 
water-in-oil droplets. I implement them as compartments for the assembly of artificial cells.  
A drawback of water-in-oil droplets in implementation as a synthetic cell is the continuous oil 
phase that lacks the physiological relevance and biocompatibility.  
Water-in-water polymersome-based compartments, comprising a bilayer of amphiphilic 
block copolymers, are promising candidates for the assembly of artificial cells in physiological 
conditions.75 Moreover, polymer chemistry provides the ability to tailor the properties of the 
polymersome’s building blocks depending on the application the vesicles are produced for. 
Hence, their properties are diverse, resulting in stable compartments with capabilities such as 
drug encapsulation, targetability, stimuli-responsive release, and biodegradability.90,91 Towards 
this end, Langowska et al. for example created permeable polymersomes by the insertion of a 
bacterial pore-forming protein into the membranes, for the in-situ production and release of 
antibiotics by an encapsulated antibiotics-producing enzyme.92 A similar polymersome 
approach has been shown to act as an artificial organelle – an artificial peroxisomes – 
demonstrating activity in cells by the uptake and conversion of superoxide radicals and H2O2.93 
Besides the usage of synthetic polymers, natural polymers as Deoxyribonucleic acid (DNA) and 
proteins can be found as building blocks for synthetic cell compartments.94 In this regard, there 
are polymersomes that consist of protein building blocks, thus, are called proteinosomes. In 
order to achieve their self-assembly into compartment structures, proteins can be rendered 
amphiphilic by being chemically linked to synthetic hydrophobic segments.80 Similarly, like in 
case of synthetic polymersomes, the proteinosome function can be tailored by encapsulating a 
variety of enzymes and active compounds. In this regard, Huang et al. designed a proteinosome 
based on amphiphilic BSA-polymer hybrid molecules, featuring controlled membrane 
disassembly and release of entrapped material.95 
Further, also DNA has been used to construct compartments.96 However, the field of synthetic 
biology benefits in a much broader way from DNA nanotechnology, as it can be used to create 
robust building blocks with new functions and features97 e.g. membrane ion channels,98 or 
molecular motors.99 Even though natural building blocks as proteins and DNA are intrinsically 
biologically relevant, the best way to mimic cellular compartments is by means of 
phospholipids, since they also make up the cellular membranes in living cells.
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1.3.3. Lipid-based Model Systems 
 
In my thesis, I will combine polymer-stabilized water-in-oil droplets with lipid-based vesicles. 
Thereby, the mechanical and chemical stability of polymersomes and the physiological 
relevance of phospholipid bilayers is exploited. Lipid membranes have been studied intensively 
in the last decades, as they are considered as the best mimetics of the cellular membranes.100,101 
Important parts in this research are planar lipid membranes. These include so-called black lipid 
membranes, lipid bilayers spanned over a hollow device, and solid supported lipid bilayers 
(SLB, see Figure 13A). Both are valuable models for studying membrane physics,100 cell-cell 
interface interactions,102 or lateral mobility of adsorbed macromolecules.103  
In addition to adaptation of SLB for various light microscopy techniques, SLBs allow analysis 
by means of very sensitive surface techniques, such as surface plasmon resonance, Quartz 
crystal microbalance (QCM, for more details see Section 4.8.1) or atomic force microscopy 
(AFM).104 The most common way to create such lipid bilayers are the Langmuir Blodgett 
technique or the direct fusion technique, that was pioneered by McConnell et al. in the early 
80s.101 The fusion of lipid vesicles on hydrophilic supports is easy to implement, however, the 
process is not fully understood, yet. The driving force of the fusion process is suggested to be 
governed by van der Waals forces and electrostatic interactions with the substrate. The process 
begins with the adsorption of the vesicles, what can result then to the fusion of the vesicles with 
each other and to the support once a certain surface coverage is reached.100 Vesicle fusion 
depends on the gain in adhesion energy and the energy cost for the vesicles’ curvature,105,106 
however, can be influenced by many factors, e.g. vesicle properties (bending rigidity, lipid 
composition, size, surface charge, osmotic pressure), nature of the surface (charge, roughness, 
cleanliness), as well as buffer conditions (pH, ionic strength).100 
 
 
Figure 13: Illustration of lipid-based model systems. A) Supported lipid bilayer (SLB) 
formation, B) Small unilamellar vesicles (SUVs), C) Large unilamellar vesicles (LUVs) D) 
Giant unilamellar vesicles (GUVs)
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Despite the fact that valuable knowledge has been gained by studying planar lipid membranes, 
spherical lipid compartments are considered as favorable model system for cell mimetics. Lipid 
vesicles are classified into small (SUVs, <100 nm, see Figure 13B), large (LUVs, 100 to 1000 nm, 
Figure 13C) or giant unilamellar vesicles (GUVs, 1 µm – 100 µm, Figure 13D)107 and, depending 
on the number of bilayers, into uni-, oligo- and multi-lamellar. An additional important 
parameter is the phospholipid charge.108 
The production of SUVs and LUVs is a high yield and straight forward process. In the 
production process, the desired lipids are mixed in organic solvent in a glass vial. After the 
solvent is dried off, a lipid film remains. This film is then hydrated by the addition of an aqueous 
buffer and vigorous shaking. This results in multilamellar vesicles, that can be downsized and 
transformed into mainly unilamellar vesicles by a variety of techniques, such as sonication, or 
extrusion.109 In the extrusion technique, the vesicles are pressed through a bicarbonate filter 
with a pore size of 50 – 400 nm.86,110 Another way to create lipid vesicles is the detergent removal 
method. Here the dried lipid film is dissolved in an aqueous buffer, containing detergents above 
their critical micelles concentration. Upon removal of the detergent, the micelles enrich in 
phospholipids, and finally form lipid vesicles. The detergent can be removed e.g. by dialysis or 
by adsorption to porous hydrophobic beads. This method of detergent removal allows for 
reconstitution of membrane-associated proteins. It also allows for a good encapsulation 
efficiency of soluble material109,111,112 rendering the lipid vesicles a good model system to 
investigate cellular processes.4,113,114 
Even though they are too small to be observed with optical tools, SUVs can be analyzed in bulk 
by means of dynamic light scattering (DLS), AFM, quartz crystal microbalance with dissipation 
monitoring (QCM-D), or electron microscopy.115 Moreover, lipid vesicles play an important 
role as carriers for numerous molecules in drug delivery, cosmetics, and food industries.116 
 
1.3.4. GUVs 
 
Cell-sized GUVs possess significant advantages when used as synthetic cell compartments. This 
is due to cell-like membrane curvature and the possibility to be easily observed and manipulated 
under optical microscopes. Therefore, GUVs remain the gold standard in synthetic biology and 
are used widely to imitate cellular processes.117 Moreover, GUVs gained much attention as 
biochemical reactors for macromolecule synthesis.118  
For the preparation of GUVs several techniques have been developed (Figure 14). Currently, 
electroformation (Figure 14a)119 and gentle hydration120 are the most commonly used methods 
to create GUVs. Similar as for SUV or LUV preparation, the procedure starts with the formation 
of a dried lipid film on a substrate. For the gentle hydration method, a pre-swelling step in 
water-saturated atmosphere is followed by the introduction of aqueous buffer into the swelling 
chamber. The gentle hydration can take up to a couple of days until the process is completed 
and the GUVs can be harvested. For electroformation, the vesicle swelling is accelerated by 
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applying an AC field. For this purpose, the lipid film has to be deposited on conductive indium 
tin oxide (ITO) coated glass slides.121 The advantage of electroformation is that it is much faster 
(few hours) than the hydration method and the vesicles are usually larger, unilamellar and have 
fewer defects in the membrane. Nevertheless, it also brings along several drawbacks: Low yield 
in physiological buffer solutions, heterogeneity in lipid composition and size, the limitation that 
only small amounts of charged lipids can be used, as well as low efficiencies when encapsulating 
biomolecules.107,122,123 Other methods like microfluidic jetting (Figure 14d),124 or emulsion 
transfer (Figure 14b),72 overcome these limitations to some extent but compromise the GUV 
yield. 
 
 
Figure 14: Overview of most common GUV formation methods. (a) Electroformation or 
gentle swelling (without electrical field); (b) emulsion-transfer method; (c) microfluidic 
double emulsions; (d) microfluidic jetting. Reprinted from 1 2 5  - Published by The Royal 
Society of Chemistry.  
 
For the microfluidic jetting approach (Figure 14d), a black lipid membrane is formed in 
aqueous solution. By applying a microfluidic jet across the membrane, GUVs are blown from 
the planar lipid film.124 In the droplet transfer method126 aqueous buffer is dropwise introduced 
into an oil-solution containing lipids. These lipid-stabilized water-in-oil droplets are 
subsequently transferred by means of centrifugation through another lipid monolayer into an 
aqueous phase, thereby receiving a second lipid leaflet.127 Both processes allow for efficient 
encapsulation of macromolecules and ensure that the content is distinct from the continuous 
aqueous phase.  
In recent years, microfluidic technologies for the high throughput production of monodisperse 
GUVs have been developed (Figure 14c), most of them based on water-in-oil-in-water double 
emulsions. Here the critical point is the residues of organic solvents in the bilayer. This 
limitation could be solved by Deshpande et al. by generating double emulsion droplets with an 
organic phase, consisting of lipid-carrying octanol. The excess octanol in the bilayer is – within 
few seconds after production – dewetted from the droplet as a pocket, which is pinched off by 
outer fluid streams. This leaves a pure lipid bilayer-enclosed vesicle behind.128 Further, Elani et 
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al. optimized the droplet transfer method by incorporating the procedure within a microfluidic 
device.129  
A different microfluidic approach to generate GUVs in a high throughput manner was 
developed in our group.16 These GUVs are initially stabilized by a block copolymer layer in an 
oil phase, therefore named droplet-stabilized GUVs (dsGUVs). In this stabilized environment, 
the dsGUVs can be loaded sequentially with biomolecules via high throughput picoinjection 
technology.130 After loading, the dsGUVs can be released as free-standing GUVs from the 
surfactant shell and the oil phase into a physiological environment. This method will be 
discussed in more detail in Section 4.5.5 and 5.1.4 of this thesis.  
 
1.3.5. Multicompartment Systems  
 
To date most of the artificial cell research has been focused mainly on single-compartment 
structures with homogenously distributed internal content. However, the natural architecture 
of eukaryotic cells features smaller vesicular compartments inside the external lipid membrane. 
These smaller vesicular compartments – like organelles and transport vesicles – provide a 
physical boundary between specialized microenvironments, and allow for a multitude of vital 
processes e.g. energy production or material transport (see Sections 1.2.1.3). Thus, to achieve 
multiple distinct reactions in a single artificial cell, compartments that incorporate organelle-
like structures have to be designed.71,131,132  
The idea of a multicompartment system within water-in-oil droplets has been implemented in 
my thesis in Section 5.1.2. Thus, I want to give an overview how multicompartment systems 
have been realized in other groups, thereby addressing also multivesicular system, that mimic 
multicellularity. 
 
 
Figure 15: Synthetic multicompartment and multivesicular systems. (A) Confocal 
fluorescence images of GUVs with different numbers and ratios of internal liposomes. Scale 
bar 100 µm. Reprinted with permission from 1 3 3.  Copyright 2018 American Chemical 
Society. (B) Multivesicular structure allowing for multi-step enzyme reactions through α-
hemolysin pores. Scale bar 250 mm. Reprinted with permission from 7 2.   
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GUVs containing smaller lipid vesicles exhibit the required topological feature to mimic the 
basic organelle-like structure in eukaryotic cells. These structures can appear as a result of endo-
budding or during morphological changes of the GUVs under osmotic stress or temperature 
changes.134  
In a different approach, so-called vesosomes have been developed, comprising of aggregated 
vesicles with distinct content, that were encapsulated by unrolling bilayers from spirally twisted 
lipid cylinders.135 More advanced, monodisperse vesosome structures have been recently 
produced by the microfluidic approach of Deng et al., in which single or a defined number of 
liposomes have been encapsulated into larger double emulsion droplets (Figure 15A).133 
Thereby, multicompartment vesicles, capable of performing sophisticated reactions, including 
RNA synthesis and transport between the encapsulated liposomes, were realized.133  
Bolinger et al. trapped SUVs inside LUVs by hydrating a dried lipid film with an SUV solution. 
Based on different phase transition temperatures of the encapsulated SUVs, distinct chemical 
reactions could be performed in a controlled and successive way through the rupture of SUVs 
once a particular phase transition temperature is reached.136  
To achieve multivesicular structures, which mimic multicellular organisms, Villar and 
colleagues surrounded several water-in-oil emulsion droplets by a monolayer of 
phospholipids.137 Thereby a droplet network was created allowing for communication between 
the vesicles via membrane pores. Elani et al. constructed similar structures, with internal lipid 
bilayer divisions, to perform a multi-step enzymatic cascade by transferring the products from 
one to the adjacent compartment (Figure 15B).72 More recently, the same group achieved a 
multistep reaction cascade between living cells and co-encapsulated enzymes within 
microfluidic water-in-oil droplets.129 These results can relate to the evolutionary milestone of 
eukaryotic cells, originated – based on the endosymbiotic theory – through endocytosis of 
formerly free-living organisms.20  
These recent works show the importance of segregated space to allow for sophisticated reactions 
to happen. Moreover, internal compartments increase the cellular membrane area, a place 
where major cellular function takes place in eukaryotic cells (e.g. proton gradient for ATP 
synthesis, protein and lipid synthesis, transport etc.).11 A way to further increase surface-to-
volume ratio in eukaryotic structures is through membrane folds. This is for example seen in 
organelle structures as the mitochondria or the endoplasmic reticulum.  
 
In the next section, I will discuss how the surface-to-volume ratio can be increased in artificial 
compartments. I will focus thereby only on the membrane folds in GUVs as this will be part of 
my thesis in Section 5.1.4.4.4. 
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1.3.6. Organelle Structures with Increased Surface-to-Volume Ratio  
 
GUVs are normally spherical vesicles, but – due to the low bending rigidity – GUV’s lipid 
membrane can be adapted to various shapes with increased surface-to-volume ratio.121,138 These 
shape changes can be mediated e.g. by osmotic stress or by encapsulated macromolecules (like 
PEG) leading to a depletion effect between the membrane and the crowding polymers.134 Under 
such conditions the morphology of GUVs can deviate from the spherical shape and resemble 
eukaryotic organelles like the mitochondria, the Golgi apparatus, or the smooth endoplasmic 
reticulum with increased surface-to-volume ratio (Figure 16A).139  
In this regard, it has been achieved that GUVs display cristae-like morphology (Figure 16B), 
and thus, provide a good model system to mimic the inner membrane morphologies of 
mitochondria.24 This cristae structure evolved due to certain mitochondria-typical and 
cardiolipin-rich lipid composition and a local pH gradient created by exposing the outer lipid 
monolayer to an acidic buffer solution. It was assumed that the negatively charged cardiolipin 
functioned as a proton trap, leading to an area reduction of the exposed monolayer and thus, 
to an area mismatch between the inner and outer monolayers of the membrane. This created 
mechanical stress and induced tube-like membrane invaginations. 
In another work by Bilal et al. (Figure 16C), endoplasmic reticulum networks were mimicked, 
based on nanotube networks, that rolled up from of multilayered lipid films upon Ca2+ 
depletion.140 
 
 
Figure 16: Lipid-based systems with increased surface-to-volume ratio. (A) Confocal 
fluorescence images of different GUV shape categories, evolved through interactions with 
macromolecules and deflation. Scale bar 10 μm. Reprinted with permission from 1 3 9. 
Copyright 2018 American Chemical Society .  (B) Various bright-field time-lapse images of 
dynamic cristae-like membrane invaginations due to a local pH gradient at a cardiolipin-
containing membrane. Reprinted with permission from 2 4.  Copyright © 2008 The 
Biophysical Society. (C) Fluorescence images showing the formation of lipid nanotube 
networks by retraction of lipid bilayer membranes from the surface. Reproduced from 1 4 0  
with permission from The Royal Society of Chemistry.   
 
This shows that lipid membrane systems alone can create specialized cellular structures. 
Nevertheless, in a living cell, proteins are key to equip the cellular membranes with 
sophisticated and complex functions. Therefore, in the following sections I will discuss the 
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contributions of membrane proteins towards the creation of functional modules within a 
synthetic cell.  
 
1.3.7. Functional Modules 
 
A living cell constantly needs to fulfill different tasks including, but not limited to, protein 
expression, endo- and exocytosis, cell-cell or cell-matrix interaction, and locomotion. All these 
tasks are based on a specialized set of building blocks and regulatory molecules, which can be 
grouped into functional modules.  
To create cellular functional modules in a synthetic system, first, the complex machinery of a 
living cell has to be dissected. Major building blocks have to be identified and reconstituted 
within the artificial system. Towards this end, some approaches involve cell lysate extracts to 
ensure optimal conditions for the machinery of interest.89 However, the content of such cell 
extracts is poorly defined and limits experimental control. Thus, for bottom-up assembly of 
functional modules it is advantageous to use synthetic or purified building blocks, isolated or 
engineered proteins, or DNA constructs.  
In my thesis, I focused on reconstituting cellular motility, that can be subdivided into the 
functional modules of actin dynamics (elongation and contraction), and adhesion-associated 
membrane proteins. Thus, in the following sections, I will present an overview of different 
works that addressed the reconstitution of membrane proteins into cell-sized vesicles, followed 
by the state of art regarding cytoskeletal network reconstitution.  
 
1.3.8. Reconstitution of Membrane Proteins 
 
Nearly one third of the proteins in a living cell are embedded in cellular membranes and 
mediate important biological reactions, such as transport, adhesion, signal transduction, and 
the generation of energy.141,142 In this concern, it is crucial to include transmembrane proteins 
when constructing cell mimetics.  
In the following, I will discuss the most common methods for reconstituting membrane 
proteins into SUVs and GUVs.  
 
First studies of reconstituted membrane proteins in artificial cells have been done in liposomes 
and date back to the 70’s.143 Here ATPase activity and ATP exchange could be achieved in SUVs 
by isolating and reconstituting membrane fragments from mitochondria.143 Since then, many 
more membrane proteins have been reconstituted within SUVs, ranging from proteins for 
selective transport (e.g. ion channels144, H+/K+-ATPase145) to integrin adhesion receptors as 
presented in Figure 17.15,146 
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Figure 17: Cryoelectron micrographs of vesicles containing reconstituted integrin α I I bβ3 in 
high(A) and low (B) density. Scale bar 100 nm. (Reprinted with permission from 1 5.  Copy- 
right (1997) American Chemical Society.  
 
Towards this end, first, the active protein has to be isolated from a recombinant source, or in 
case of larger proteins, membrane fractions have to be obtained from cells of interest or from 
specific organelles. Then they need to be purified from other components of the natural 
membrane by means of differential centrifugation and detergent-mediated solubilization. 
For the reconstitution of the isolated membrane protein into an artificial membrane, it can be 
either directly embedded into the lipid membrane or, if the hydrophobic domain is too large, 
the transfer of the protein needs to be assisted by the presence of a detergent that is removed 
after reconstitution.109 
Whereas the reconstitution of transmembrane proteins into small lipid vesicles is straight 
forward, the reconstitution into GUVs comes along with challenges and thus is not as prevalent. 
Due to the GUV’s fragility and harsh preparation conditions, the reconstitution of 
transmembrane proteins is more complicated, however, not less important. GUVs resemble a 
eukaryotic cell in terms of size, and thus, a wider range of optical analysis methods can be used. 
In standard GUV preparation methods, a dehydration step is involved. This may lead when a 
protein is included to the loss of its activity. A gentler dehydration step, however, in the presence 
of e.g. agarose, can help to prevent complete dehydration.147 Doing so, the reconstitution of e.g. 
a functional voltage-gated ion channel has been achieved.148 Further, the droplet transfer 
method has been used for transmembrane protein reconstitution. The pitfall here is that most 
proteins do not assemble into a lipid monolayer, which limits its application.149  
To bypass the mentioned problems, some approaches involve a prior step of proteoliposome 
formation and subsequently their fusion with GUVs through the help of detergents,150 fusogenic 
peptides,151 DNA,152 or complementary charges.153 Nevertheless, while being favorable for 
protein activity, these methods come with their own challenges, due to GUV instabilities.117  
Thus, transmembrane proteins have been embedded as well into membranes of mechanically 
stable polymersomes, by means of detergent-mediated reconstitution. In this concern, however, 
the polymersomes need to meet certain criteria e.g. a membrane thickness and fluidity 
comparable to the ones of typical lipid bilayers. Fulfilling this, the reconstitution of e.g. quinol 
oxidase or bacteriorhodopsin and the F1FO ATP synthase into polymersomes, was 
achieved.154,155  
Nevertheless, all these methods for reconstituting membrane proteins into cell-sized 
compartments, come along with limitations. In this regard, a stable and fast method, to fuse 
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protein-containing SUVs into one big GUV, would be highly desirable. The first method, 
achieving this goal, was developed here and will be presented in Section 5.1.3 of this thesis. 
 
1.3.9. Towards Artificial Motility  
 
Many processes in the cell, including but not limited to, embryonic development, immune 
response, tissue formation and wound healing, are based on cellular motility. Eukaryotic cells 
move mostly by migration on a substrate. This movement is accomplished in - simply put - 
three major steps: 1) Extension of the leading edge. 2) New adhesions to the substrate at the 
front and 3) detachment of adhesion sites at the rear and the contraction of the cell body (see 
Section 1.2.1).28 
Thus, towards the reconstitution of cellular motility, an active cytoskeleton as well as cell 
adhesion receptors are key players. Therefore, reconstitution of these building blocks in 
synthetic cells was the major goal in my thesis. To date, no cell mimetics have been reported 
that include adhesion capability as well as cytoskeletal function. The state of art in this field will 
be presented in the following.  
 
1.3.9.1. Artificial Cytoskeleton  
 
The cytoskeleton consists of three major filament types (see Section 1.2.1.1). To date, the 
encapsulation of actin and microtubule networks is a similarly straight forward procedure.156,157 
However, the encapsulation of intermediate filaments into artificial cells is clearly absent as its 
reconstitution is relatively complex.8 Therefore, I will only introduce the reconstitution of 
microtubules and actin networks in the following sections. 
 
Microtubules 
The first studies that encapsulated microtubules into artificial cells were performed in the early 
90’s.156,157 Here, the impact of microtubules on cell shape could be resembled by the deformation 
of vesicles upon microtubule polymerization due to their intrinsic stiffness (persistence length 
1-2 mm158) and their capability to apply a significant pushing force onto the compartment 
boundaries.156,157  
More recently, Hayashi et al. showed the dynamic control of microtubule polymerization and 
depolymerization via compression force. It was demonstrated that while microtubule 
polymerization led to GUV protrusions at ambient pressure, the application of hydrostatic 
pressure led to the shrinkage of the protrusions, as a result of microtubule depolymerization 
(Figure 18A).159 This dynamic process resembled the organization of the cytoskeleton in a living 
cell, which is not static but permanently reassembles in response to internal and external 
environmental factors. In a living cell, this dynamic organization is mainly mediated by motor 
proteins like kinesin.11  
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Figure 18: Microtubules reconstituted in artificial cell systems (A) Phase contrast images 
of microtubules polymerized in liposomes. Reversible shrinkage of vesicle protrusions by 
applied pressure. Reprinted with permission from 1 5 9  Copyright © 2016 American Chemical 
Society. (B) Fluorescence image of active microtubule bundles in a water-in-oil droplet. 
Pushing microtubules induced streaming flows, indicated with blue arrows; red arrow 
indicates direction of droplet velocity. Scale bar 100 mm. Reprinted with permission from 
1 6 1  Copyright © 2012, Springer Nature (C) Confocal image of microtubule asters (labeled 
in red) in surfactant-stabilized water-in-oil droplets, organized by kinesin (labeled in 
green).7 7  - Published by The Royal Society of Chemistry. 
 
In 2012, it was demonstrated in a synthetic cell that upon kinesin activity microtubule bundles 
showed highly ordered collective network dynamics, orchestrated by a hydrodynamic 
connection between the bundles and a resulting directed fluid flow (Figure 18B).161 Most 
remarkably, an autonomous motion of water-in-oil droplets could be observed when the 
droplets comprised microtubules and kinesin networks.  
Recently, water-in-oil droplets were used by our group and others,77,85 to investigate the 
microtubule aster organization (Figure 18C) depending on kinesin motor concentration and 
confinement size. Whereas in smaller droplets, microtubules bent in bundles at the droplets 
boundary, in droplets larger than 100 µm microtubule aster formation appeared.77,85  
 
Actin 
The actin cytoskeleton is involved in the elongation force, contraction force and the connection 
to the membrane receptors. These are major features of cellular motility and will be 
implemented in the synthetic cell approach, presented in my thesis in Section 5.2. However, 
first I will introduce what have been done so far in the field of actin dynamics in synthetic cells. 
 Actin networks have been studied intensively in the past.162–164 First incorporation of actin 
networks within cell mimetics was achieved in the late 80’s by Cortese et al.,162 followed by a 
more sophisticated approach of Bärmann et al.163 Bärmann and colleagues used the hydration 
method to incorporate actin monomers in the GUV’s lumen and polymerized them by 
increasing ion concentrations through ionophores in the GUV membrane. Similar to 
encapsulated microtubules, a deformation of the flexible compartment upon filament 
polymerization was observed. However, this was dependent on the compartment size. Thus, 
deformation was observed only, when actin filaments were encapsulated in vesicles, that were 
smaller than the filament’s persistence length.163  
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Figure 19: Examples of actin and actomyosin networks within artificial cell systems. (A) 
Confocal fluorescence images of actin networks polymerized in liposomes. Presence of the 
crosslinker fascin (actin-to-fascin ratio 5:1) leads to long protrusions of vesicles. Scale bar 
5 µm. Reproduced from 1 6 5  with permission from The Royal Society of Chemistry. (B) Actin 
filaments encapsulated within water-in-oil droplets surrounded by a phospholipid 
monolayer. Actin forms thick and rigid bundles in the presence of methylcellulose.  
Filaments are forced to adapt to the spherical shape of the droplet and organize into cortical 
rings in order to minimize filament bending, Scale bar 20 µm. Reprinted with permission 
from 1 6 6  Copyright © 2015, Springer Nature (C) Fluorescent image of actomyosin cortex 
(labeled in magenta) assembly within water-in-oil droplets stabilized by an amphiphilic 
actin-binding protein (labeled in green). Through myosin’s contraction force, the network 
detaches from the droplets interface. Scale bar 10 µm. Reprinted with permission from 8 9  
Copyright © 2014, Abu Shah and Keren. (D): Confocal fluorescence image of actomyosin 
within water-in-oil droplets. Contraction leads to non-periodic oscillatory deformation of 
the lipid interface. Scale bar 50 μm. Reprinted with permission from 1 6 7  Copyright © 2016, 
Springer Nature. 
 
In similar studies, it was shown that the deformation of actin-containing vesicles can be 
triggered by changing the length and mechanical properties of the actin filaments through co-
encapsulation of capping proteins as gelsolin,162 or bundling proteins as fascin (see Figure 
19A).165 Further, membrane deformation could be suppressed by increasing the bending 
rigidity of the membrane. Hereby, actin bundles were forced to adapt to the spherical shape, 
and organize into cortical rings in order to minimize the elastic energy costs, associated with 
filament bending.165  
Similar effects could be seen in water-in-oil droplets by modelling the actin bundling through 
the presence of methylcellulose (see Figure 19B).166 The bundling is based on the depletion effect 
that leads to the exclusion of macromolecules from the surface of actin filaments. The total free 
energy is minimized, when the depletion volume is at its maximum.168  
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These works show that rigid actin filaments can generate a considerably amount of pushing 
force between the confinement and the network, depending on the filament bending elasticity 
and membrane curvature. 
In a living cell, the actin networks are constantly reassembled. Thereby, dynamic actin forces 
are generated based on directional polymerization and depolymerization of the actin filaments, 
the so-called treadmilling. A popular model system, showing the motor-free force generation 
of actin networks through polymerization, is the intracellular pathogen listeria, which uses the 
actin cytoskeleton of its host to be propelled throughout the cell body. Thereby, listeria recruits 
actin monomers to its rear and by inducing actin polymerization the bacterium is pushed 
forward.169 Towards recreation of this phenomenon in vitro, polystyrene beads, or small lipid 
vesicles, were coated with the listeria’s pathogenic protein ActA, that acts as nucleation sites for 
actin polymerization. 169 
In cell motility, the pushing forces at the front of the cell have to be orchestrated with the 
contraction of the rear. In this regard, myosin motor proteins, associated to the actin 
cytoskeleton, so-called actomyosin networks, play a critical role.170  
Actomyosin dynamics have been studied intensively on 2D substrates, investigating the effects 
of e.g. different actin-to-myosin ratios, the presence and critical concentrations of actin 
crosslinkers, ionic conditions, and ATP concentrations on network contraction.164,171 Further 
stability of actomyosin filaments were tested under compressive and tensile stresses,172 
explaining the break of symmetry between myosin-mediated forces, that leads finally to a net 
contractile force.46 
In order to create cytoskeletal dynamics within a cell-like confinement, several studies 
encapsulated actomyosin networks into lipid vesicles or water-in-oil droplets.87,171,173  
In a living cell, the actomyosin network forms a dynamic cortex, linked via several complex 
tethering proteins to the membrane.170 Hence, actomyosin linkage to the membrane was 
reconstituted artificially, e.g. via electrostatic interaction to positively charged lipids in the 
membrane,87,171 via biotin-streptavidin interactions,174 or via natural anchoring proteins.173  
In this regard, Shah et al. encapsulated cell extracts into water-in-oil droplets and linked the 
actomyosin cortex via an amphiphilic protein to the lipid monolayer at the oil-water interface. 
With this system, they could show spontaneous, myosin-driven symmetry breaking of the 
assembled actomyosin cortex, resulting either in an asymmetric organization of the cortex and 
a deformation of the droplet, or in a detachment of the cortex from the droplets interface (see 
Figure 19C).89 
In other studies, encapsulated and membrane-linked actomyosin contraction led to membrane 
oscillation (see Figure 19D),171 membrane blebbing,175 or even to a collapse171 of the 
compartment membrane, depending on the bending rigidity of the compartment’s membrane 
and the connection to it.  
 
Bottom-up Synthetic Biology                 
 32 
To balance the applied cytoskeletal forces, major steps in motility involve, besides the described 
cell shape changes, the adhesion to the substrate.170 How the functional module of adhesion can 
be implemented in an artificial cell will be described in the following section, and is further 
described in context of the droplet-stabilized GUV approach in my thesis in Section 5.3. 
 
1.3.9.2. Adhesion Receptors 
 
In a living cell, adhesion to certain proteins of the extracellular substrate is mediated by the 
transmembrane protein integrin. To study cellular adhesion in artificial systems, integrins have 
been reconstituted in SLB in 2D.176 By doing so, GUVs, comprising the RGD peptide on their 
surface, showed a specific binding to the integrin proteins embedded in the SLB.176 Even though, 
this shows the functionality of reconstituted integrin proteins, the fact that the integrin proteins 
are reconstituted in 2D has several drawbacks. First, it is lacking cell-like geometry and second, 
it does not provide the possibility to include a cytoskeletal connection.  
Towards adhesion studies in spherical liposomes, the reconstitution of αIIbβ3 integrin into SUVs 
(see Figure 20) has been shown together with their specific interaction to various ECM proteins 
by means of QCM-D.146,15 This proves the functionality of the reconstituted integrin proteins, 
however lacks cell-like dimensions.146  
 
 
Figure 20: Integrin reconstituted in GUVs. (A) Confocal image of a GUV containing 5% of 
the integrins fluorescently labeled. (B) Scheme of a GUV containing integrins interacting 
with a fibrinogen-coated surface. (C) Adhesion is detected with reflection interference 
contrast microscopy (black patch). Scale bar 10 µm. (Reprinted with permission from 1 7 7.  
Copyright (2009) Elsevier Ltd. 
 
In this regard, Streicher et al. showed the successful incorporation of functional integrin 
proteins into GUVs (Figure 20A), and further, their biological activity by specific adhesion of 
these GUVs to substrates comprising RGD motifs (Figure 20B, C).177  
Besides the work of Streicher et al. there is only one more study to my knowledge, showing the 
reconstitution of integrins into GUVs: it is the before mentioned droplet-stabilized GUV 
approach, that involves the fusion of proteoliposomes to a cell-sized vesicle, and the subsequent 
release of integrin-GUVs out of the stabilizing droplet and oil phase into an aqueous and 
physiological phase. Whereas the protocol of Streicher et al. involves a dehydration step, which 
can potentially affect protein activity, the dsGUV approach is performed in mild conditions 
and under high throughput performance, providing thereby the possibility to implement the 
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integrin-GUVs in versatile follow-up adhesion studies.16 This method will be implemented in 
this thesis in Section 5.3.3. 
As described above, previous synthetic cell studies have investigated the functional modules of 
adhesion and cytoskeleton separately, however to my knowledge, none have reported a 
combined approach. Thus, another milestone to achieve would be to combine adhesion and 
cytoskeletal proteins in one artificial cell and further introduce proteins to anchor the actin 
cytoskeleton to integrin receptors. Such an approach will be addressed in my thesis in Section 
5.3.4.  
 
Prior to this, I will characterize the compartment system that is implemented in my thesis: 
microfluidic block copolymer stabilized water-in-oil emulsion droplets. The according 
technical and theoretical background will be described in the following.
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1.4. Technical Background 
 
In my thesis, I will use a microfluidic approach to create water-in-oil emulsion droplets as 
compartments for the assembly of synthetic cells. In this regard, I will introduce in the following 
the general concept of emulsions and their stabilization through surface active molecules, 
namely emulsifiers or surfactants. In addition to the reduction of the interfacial tension at the 
water-oil interface, surfactants may induce the interactions of encapsulated molecules with the 
interface layer. These surfactant-based functions play a crucial role in the generation of droplet-
stabilized GUVs as well as in actin network dynamics (see Section 5.1 and 5.2.3.2, respectively). 
Further, I will describe adsorption models to give an idea about the dynamics at the droplets 
interface. Moreover, I will describe, how water-in-oil droplets are implemented through precise 
and high throughput microfluidic technology. 
 
1.4.1. Emulsions 
 
An emulsion is a colloidal mixture of substances that are insoluble in each other and thus, form 
a two-phase system with a continuous and a dispersed phase.178 In emulsions, both substances 
are liquids e.g. mayonnaise or homogenized milk are emulsions where, respectively, water is 
dispersed in oil, thus a water-in-oil emulsion, or vice versa. These two emulsions are called 
single emulsions. Double or multiple emulsions are also possible and include for example 
water-in-oil-in-water systems.179  
 
 
Figure 21: Schematic representation of mechanisms in emulsions. Adapted and reprinted 
with permission from 1 8 4.  Copyright (2017) Elsevier Ltd. 
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The fact that the phases are not soluble in each other is governed by distinct intermolecular 
interactions between molecules of each phase. This means that the energy costs of enthalpy and 
entropy of mixing counteract.180 In this sense, emulsions do not form spontaneously and are 
intrinsically unstable.181 Thus, to create an emulsion energy is required. Energy can be provided 
for example in the form of vigorously stirring, ultrasound sonication or by means of 
microfluidics. Eventually, the emulsion phases tend to separate again in the two primary 
phases.178 The instability or aging of an emulsion is described by the time how long it takes 
before the emulsion changes its properties due to e.g. phase inversion (1), flocculation (2), 
sedimentation or creaming (3), Ostwald ripening (4) or coalescence (fusion of two droplets) (5) 
(see Figure 21).182–184  
Ostwald ripening is a process based on differently sized droplets in the emulsion. As the Laplace 
pressure (see Section 1.4.3) is lower in large droplets than in small droplets, the large droplets 
grow in expense of smaller droplets.185 Flocculation describes the process when the droplets 
form grape-like structures due to attractive interactions between each other.178 Creaming is the 
effect when the dispersed phase rise up due to buoyancy. This happens for example when the 
two phases have a large difference in their density.186 The instability of an emulsion can be 
influenced by e.g. temperature or mechanical methods like centrifugation.187 
The stability of emulsion is of great importance in industry and particularly in biotechnological 
applications,188 when emulsion droplets are used as microreactors or – like in this thesis – as 
synthetic cells, where the components are required to maintain stably encapsulated to well-
controlled biochemical conditions.189–191 Thus, in the following I will explain how emulsifiers or 
surfactants counteract the aging effects of emulsions.  
 
1.4.2. Surfactants 
 
A surfactant is a compound word describing surface-active agents. As the name implies, 
surfactants adsorb at interfaces of two insoluble fluids (Figure 22), as they possess typically a 
hydrophobic tail and a hydrophilic head.  
Since emulsions are metastable systems, they require surfactants for stabilization.192 In this 
regard, surfactants can increase stability from minutes to weeks, which is suitable for the 
approach of water-in-oil droplets in synthetic cell assembly.193  
The mechanisms behind stabilization can be thermodynamically driven by decreasing the 
interfacial tension and thus, the free energy or by repulsive interaction or steric barrier 
(activation energy) between the surfactant layer of two adjacent droplets.194,195  
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Figure 22: Schematic representation of emulsion stabilization through surfactants in 
concentration above critical micellar concentration (CMC) and below CMC. 
 
1.4.2.1. Surfactant Adsorption 
 
The adsorption of the surfactants to the interface is mediated by the Gibbs free energy195 and 
can be described by the Gibbs Adsorption Equation.180  
 
 𝑑𝛾 = − Γ&	dµ&&  
 
with 𝛾 is the interfacial tension, µ the chemical potential of each compound 𝑖 (which is in case 
of surfactant adsorption to the interface the surfactants and the solvents), and the surface 
coverage Γ (Figure 23) (which is the concentration per area of the compound at the interface). 
The Gibbs convention says that Γ of the solvent is 0 and for surfactants Γ+ ≠0,180 resulting in  
 𝑑𝛾 = −Γ+	dµ+ 
 
The chemical potential of the surfactant 𝑑µ+ can be described as 
 𝑑µ+ = 𝑅𝑇𝑑𝑙𝑛𝐶1234 
 
with	𝐶1234 as the surfactant concentration in the bulk, R the ideal gas constant and T the 
absolute temperature.  
This leads in equilibrium condition to 
 Γ56 = − 1𝑅𝑇 𝑑𝛾56𝑑𝑙𝑛𝐶8234 
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Figure 23: Schematic representation of surfactant surface coverage 𝛤+ at a water-oil 
interface with the adsorption and desorption constant ka d s  and kd e s and the bulk 
concentration of the surfactant Cb u l k.  
 
We can derive that the surface tension γ is directly related to the surface coverage Γ56, meaning 
the more surfactant molecules are adsorbed at the interface the lower the surface tension. The 
surface coverage is in turn dependent on the chemical and physical properties of the surfactant, 
e.g. charge or size of the head group and tail and their interaction with the according phase. In 
this regard, surfactants with a charged head group cannot form a dense packing in pure water 
interfaces due to electrostatic repulsion.196 This can, however, be reversed by adding a 
counterion resulting in a possibly even denser packing as the charge of the head group is 
screened.197  
These considerations will be of great importance to understand the formation of lipid-based 
compartment systems inside our water-in-oil droplets that are stabilized by a mixture of 
charged and uncharged surfactants (see Section 5.1.3). 
 
1.4.2.2. Critical micellar concentration  
 
The Gibbs adsorption equation holds only for surfactant solutions below a critical 
concentration.198 This concentration is called the critical micellar concentration (CMC, see 
Figure 22). Above this CMC, the surfactant monomers assemble into micelles and thus, the 
linear relation between interfacial tensions and surfactant concentrations is no longer valid. The 
micelle formation of the surfactant is mediated by decreasing the contact area of the 
hydrophobic or hydrophilic part to the solvent, thus also depends on the properties of the 
solvents.199 A typical CMC for fluorosurfactants at water-oil-interfaces is 4 µM.181 
 
1.4.3. Interfacial tension 
  
Two immiscible liquids experience an unbalanced force of attraction at their interface, due to 
distinct interactions with the second phase. This leads to the accumulation of free energy, the 
surface free energy. To reduce surface free energy, the area of the interface is always 
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minimized.200 The force needed to increase the area is the interfacial tension; it has the 
dimension of an energy per area, in other words a force per length.201  
The surface tension of an interface between two liquids can be measured by different methods. 
One method is the pendant drop method (see Figure 24) that is based on the shape of a hanging 
drop. The drop is suspended from a needle into a bulk liquid and the contour of the drop is 
detected.202 
 
 
Figure 24: Droplet shapes of oil-in-water pendant drop measurements. Left: spherical 
droplet indicates high surface tension γ  at the water-oil interface. Right: An elongated 
droplet indicates lowered surface tension γ  at the water-oil interface. R1 and R2 are the 
principal radii of curvature at point S on the surface. Figure adapted from 2 0 5 , 2 0 6.  
 
The shape or the radii of the pendant drop is dependent on both, gravity and the surface tension. 
Whereas the surface tension seeks to get the drop into a spherical shape to minimize the surface 
area, gravity stretches the drop to the characteristic pear shape.203 Thus, how much the shape 
deviates from a sphere is dependent on the density difference of the two phases and the surface 
tension. This is described in the Bond number Bo 
 
 𝐵𝑜 = ∆=>?@A 	 
 
where ∆ρ is the density difference between the phases, g is the gravity constant, R the droplet’s 
radius and γ the surface tension. In pendant drop experiments the Bond number of a droplet is 
then used for the Young-Laplace fit.201,204  
The Young-Laplace equation describes the increased pressure ∆p within a drop as a result of 
the interfacial tension between the inner and the outer phase and relates the radii of the 
curvature of the surface to the interfacial tension183,207: 
 ∆𝑝 = 	𝑝&C − 𝑝D2E = 		𝛾 ∙ 1𝑅G +	 1𝑅I 	 
 
where R1 and R2 are the radii of curvature, ∆p the Laplace pressure and 𝛾 the interfacial tension. 
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As in this thesis, different kinds of surfactants in mixtures are used to stabilize the water-in-oil 
droplets, the measurement of interfacial tension helps to characterize the system and gives a 
hint, what kind of surfactant is most prevalent at the interface (see Section 5.1.1.4). To further 
understand molecular processes associated with the stabilization of water-in-oil droplets, I will 
introduce in the following the kinetics of surfactant assembly at water-in-oil interfaces.  
 
1.4.4. Adsorption Kinetics 
 
Adsorption kinetic models describe the coverage of an interface in a time dependent manner, 
starting at time 0, when the interfacial tension is given by the interface of the pure liquids, until 
the equilibrium coverage is reached.  
The kinetics of surfactants is governed by their properties (electrostatic repulsion or attraction, 
steric hindrance) in relation to the two phases. Further, adsorption kinetics depends critically 
on the length scales. In this regard, the models are either limited only by diffusion (Figure 25A, 
macro scale) or limited by adsorption due to an adsorption barrier (Figure 25B, micro 
scale).181,190 
 
 
Figure 25: Schematic representation of adsorption kinetics in (A) macro scale, where 
kinetics is limited by diffusion of surfactants from the bulk to the depletion area (with the 
depth h) and (B) microscale ( R*<50 µm), where kinetics is limited by adsorption. Here the 
diffusion is much faster than the adsorption process. 
 
(A) Macro scales: 
In larger scales (Figure 25A), the diffusion is generally slower than the adsorption process itself. 
This means that the time 𝜏IK	a surfactant molecule needs to adsorb on a flat interface is directly 
related to the Fickian diffusion laws.208 Thus, when a planar interface (2D) is considered 𝜏IK	is 
described as 
 𝜏IK = ℎI𝐷  
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with D the diffusion coefficient and h the depletion depth (Figure 25B) of the layer where all 
molecules adsorb to a planar interface  
 
 ℎIK = NOPQRST 
 
with ΓUthe maximal interfacial coverage and C8234 the concentration in the bulk. 208,209 For 
surfactant concentrations below CMC ℎIK is in the order of tens of centimeters and for 
concentrations above CMC in the order of mm or µm.203 
A time dependent surface coverage can be described at flat interfaces197,210 with  
 Γ 𝑡 = 2 𝐷𝑡C8234 
 
(B) Micro scales 
For small dimensions, as in the case of the water-in-oil droplets of my thesis, kinetics is usually 
limited by the adsorption mechanism. Here, the diffusion in a system is much faster than the 
adsorption of the molecule to the interface. This effect is referred to as an adsorption barrier, 
which could be e.g. electrostatic repulsion.203 
 
This counts for systems below the cutoff radius R* (Figure 25B), that is described by 
  𝑅∗ = 𝐷𝑘[\]ΓU 
 
with D the diffusion constant,	𝑘[\] the adsorption rate and ΓUthe maximal interfacial coverage. 
For surfactants at water-oil interfaces R* is in the range of 50 µm.203 
 
 
A model describing the adsorption of molecules to an interface is the Langmuir adsorption 
isotherm.180 This model includes the following assumptions: There is a fixed number of 
adsorption sites that are all similarly in favor. That means that when there are no interactions 
between surfactant molecules, adsorption is independent on the presence of already adsorbed 
surfactants. All adsorption sites can hold only a maximum of one surfactant molecule.180 This 
in turn means that in the Langmuir model the adsorption of molecules at an interface is only 
dependent on the concentration in the bulk 𝐶1234, the maximum number of adsorption sites ΓU	and the adsorption 𝑘[\].211 
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𝑑Γ𝑑𝑡 = 𝑘[\]𝐶1234ΓU 1 − ΓΓU  
 
When the coverage of the interface is in a steady state, this results in the Langmuir isotherm: 
 Γ56 = ΓU 𝜅𝐶1234	1 + 𝜅𝐶1234  
 
with 𝜅=𝑘[\]/𝑘\5].  
This is only valid for surfactant concentrations below the CMC.211 
Indeed, most of the microfluidic experiments are performed above the CMC, where Γ56 should 
be constant for all 𝐶1234.  
In this regard, significant deviations from this model have been observed by Riechers et al., 
when the model was applied on experimental data.181 Moreover, they observed a 𝐶1234 
dependency of interfacial processes, even though surfactant concentration was above the CMC. 
This was explained by the additional desorption and adsorption processes of surfactant at the 
interface in equilibrium, showing that water-in-oil droplets cannot be considered as a stable 
capsule but that the surfactants at the interface are dynamically exchanged.181 
 
This demonstrates that the interfacial processes in water-in-oil droplets may be considerably 
complex. Especially, in case of surfactant mixtures, like it is used in this thesis, more complex 
adsorption kinetics may happen due to competitive adsorption of the different surfactants or 
due to a synergistic adsorption behavior based on coupling or electrostatic repulsion.196  
Nevertheless, the discussed dynamical arrangement of molecules at the water-in-oil interface 
brings up a phenomenon that has to be considered when studying artificial motility. This 
phenomenon, the Marangoni effect, will be explained in the following and will be further 
investigated in Section 5.2.6 in my thesis.  
 
1.4.5. Marangoni effect 
 
The Marangoni effect appears at liquid-liquid interfaces, e.g. water-in-oil droplets, when the 
surface coverage is out of equilibrium and there are local variations in the surface tensions 
(Figure 26A).212,213 These differences in the surface tension, ∇γ, create a surface stress that needs 
to be balanced by viscous stresses. These in turn lead to a flow tangential to the surface, the 
Marangoni flow, towards the interfaces with higher surface tension. This can lead then to a 
propulsion of droplets towards lower surface tensions (Figure 26B).214 
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Figure 26: A schematic representation of Marangoni flow fields on water-in-oil droplets 
with a local heterogeneity of surface tension. (A) Two possibilities to generate Marangoni 
flow at the surface of the droplet: a concentration gradient of surfactants along the droplet 
interface or black/white surfactants have distinct surface tension and are not 
homogeneously distributed, e.g. through a local chemical reaction at the interface. Arrows 
indicate that Marangoni stresses point in direction of higher surface tension. (B) 
Marangoni stresses at the surface inside and outside of a droplets emerging due to surface 
tension differences (γ(A)> γ(B)). Large arrow to the right indicates motion of the droplet 
due to flow around the droplet. Reprinted with permission from 2 1 5  - Published by The Royal 
Society of Chemistry.  
 
In a glass of wine, the Marangoni effect can be observed by the naked eye. Here the “tears of 
wine” result from the fact that the alcohol evaporates faster than the water, especially, at the 
corners of the glass. This leads to a local decrease in alcohol concentration and thus, to an 
increase in surface tension, what results in stresses that can lift the liquid upwards against 
gravity.215  
Various other factors could be responsible for a non-uniform surface tension (Figure 26A). For 
example, the simplest scenario can be imagined at a surfactant-free water-in-oil droplet that is 
then exposed to a surfactant micelle that adsorbs asymmetrically somewhere at the interface.212 
Further variances in the surface tension could be achieved due to a surfactant mixture created 
by a chemical reaction216 at the interface e.g. through shining a laser on light-switchable 
surfactants.217  
Droplet propulsion continues until equilibrium conditions are reached. This can happen very 
fast in case of a surfactant micelle adsorbing to a surfactant-free interface, or when the 
movement is coupled to a chemical reaction, the movement continues until the precursors that 
sustained a heterogeneity of the interface (“stagnant cap”219) are used up.218  
This effect was used already in several studies to create so-called microswimmers that were 
capable of spontaneous motion.216,220 
Thus, the influence of this kind of surfactant kinetics and surfactant interactions with 
encapsulated components need to be considered, when working with water-in-oil droplets, 
especially, when investigating artificial motility modules, as presented in this thesis.  
 
So far, I introduced the physico-chemical characteristics of water-in-oil emulsions. Now, I 
would like to introduce the concept behind the production of the mentioned water-in-oil 
droplets. In this regard, microfluidic technology and its characteristic features will be discussed 
in the following sections.  
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1.4.6. Microfluidics   
 
Microfluidics is a technology to manipulate small amounts of fluid (nano- to atto-liters) in 
channels with micrometer dimensions.221,222  
Whereas first applications of microfluidics have evolved in chemical analysis e.g. gas-phase 
chromatography or high-pressure liquid chromatography,223 the most common and well-
developed field of microfluidics today are lab-on-a-chip devices that first appeared in the early 
90’s.224 This concept of microfluidic devices has benefitted from the photo- and soft-lithography 
technology225 that was originally developed by the semiconductor industry.226 Thus, the field of 
microfluidics could grow rapidly towards versatile and successful applications in research and 
economics. Moreover, lab-on-a-chip devices gained more and more importance concomitant 
to the progression in the field of genomics and molecular biology, where sensitive methods for 
high throughput analysis and synthesis are requisite for e.g. DNA sequencing approaches.227 
Further, in recent years, the microfluidic technology was exploited to develop sophisticated 
devices for biomedical applications222 e.g. a portable insulin delivery device.228 Moreover, 
microfluidics is also applied in research applications, as in my thesis, where I use microfluidic 
lab-on-chip devices to provide an automated assembly line for synthetic cells.  
 
Obvious advantages of microfluidic technology are the reduced costs and consumption 
volumes of expensive reagents and the possibility for analysis and fast diagnostics without 
specialized laboratory equipment. Further hallmarks of the microfluidic concept lay in physical 
characteristics that come along with small dimensions. This will be explained in the following 
sections.  
 
1.4.7. Macroscopic versus Microscopic Force  
 
The behavior of liquids at microscopic or macroscopic scale are quite distinct from each 
other. Whereas in macroscopic scale, gravity dominates fluid dynamics, in microfluidics 
these fundamental concepts change. As the volume decreases and the surface-to-volume ratio 
increases, surface tension or interfacial tension (see Section 1.4.3) plays a more dominant role 
than gravity.222,229 This results for example in the phenomenon of the capillary action, the 
movement of liquids through a narrow constriction. It can be explained by the fact that when 
an interface between a solid and a liquid is energetically more favorable (resulting in a lower 
surface energy) than the liquid-liquid interface, the interface between liquid and solid is 
increased e.g. water rises in a tube. At micro scales, this capillary force is more prevalent as 
gravitational forces have less impact.230,231 Thus, the effect can be exploited to manipulate fluids 
in microfluidic applications e.g. capillary electrophoresis232 or at-home pregnancy tests.205 
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In respect to flow or swimming of cells or objects in micrometer scale another aspect is crucial 
to keep in mind: Viscous forces are here much more prevalent than inertial forces.234 Thus, a 
swimming movement of a microorganism is very different to that of a swimmer in the macro-
world, where the mechanism of swimming forward is based on inertia. In contrast, 
microorganisms make use of the viscous drag of the surrounding fluid and mainly swim 
through a cyclic distortion of the cell body (e.g. through flagella), which does not retrace its path 
as reciprocal motion would not lead to forward movement.235  
The self-propulsion of non-living objects in micro scale will be further discussed in the results 
part of my thesis (Section 5.2.4). 
Connected to that another important feature concerning flow regimes in small constraints is 
the laminar flow that will be introduced next. 
 
1.4.8. Laminar Flow 
 
The flow of a fluid through channels can be characterized by the (dimensionless) Reynolds 
number Re, 
 𝑅𝑒 = 	𝜌𝑣𝑙𝜂  
 
with 𝜌 is the density, 𝑣 the velocity, 𝑙 the characteristic length and 𝜂 the dynamical viscosity. 
Fluids with high Re numbers (> 3000) possess flow profiles that are turbulent. In microfluidic 
length scales (𝑙 is small) the Re number is low (<< 2000) and thus, fluids normally exhibit 
laminar flow.231 This results for example in the phenomenon that co-flowing fluids do not 
necessarily mix (Figure 27).236 This is extremely useful in microfluidic devices when two 
liquids should not be mixed within the microfluidic channel, e.g. polymer precursor and 
activator can co-flow separately in one channel until mixing is desired. Mixing can be 
achieved through separating the continuous phase into segments by applying a vertical flow 
of a different immiscible fluid phase, e.g. production of water-in-oil droplets, (see Figure 28 
“T-junction” or “flow focusing junction”) or through curved geometries (see Figure 28 
“mixing”).233 Due to the resulting convective flow within the segments rapid mixing evolves.  
 
 
Figure 27: Colored bright-field image of a microfluidic channel showing laminar co-flow of 
three solutions. Scale bar 100 µm. 
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The concept of segmented flow is applied in microfluidic water-in-oil-droplets, which I will 
use as a basis for synthetic cell assembly. In this regard, I will address in the following section 
how microfluidic water-in-oil emulsions are implemented. 
 
 
1.4.9. Droplet-based Microfluidics  
 
In droplet-based microfluidics, the reactants, usually in the aqueous phase, are separated into 
individual segments or droplets by an immiscible phase, usually an oil solution (water-in-oil 
emulsion droplets).237 In that condition, the liquid within the droplets does not wet the channel 
walls and thus, prevents an axial dispersion of components between different droplets.233  
 
 
Figure 28: Droplet-based microfluidic modules. Adapted and reprinted with permission 
from 9 7.  Copyright © 2018 Göpfrich  et al. 
 
Droplet generation is typically achieved by certain geometries in the microfluidic device, either 
a T-junction238 or a flow focusing junction239 (see Figure 28), where the two immiscible liquid 
phases meet. Here, the continuous oil phase applies shear forces to the aqueous phase leading 
then to the formation of monodisperse droplets. Besides the diameter of the channels, droplet 
size can be controlled by adjusting the applied flow rates and the flow ratio between aqueous 
and continuous oil phase. By the addition of surfactants, droplets are stabilized and coalescence 
is prevented, allowing for storage of the droplets over several weeks.189  
Further, the droplets can be manipulated by implementation of various active microfluidic 
units. Figure 28 shows the summary of various microfluidic units that allow for example 
merging or splitting of droplets or picoinjection of aqueous components into the droplets.97  
As each droplet contains the same content and production happens at kilohertz rates, the 
technology is a great tool for high throughput analysis or for the generation of microreactors. 
This is for example exploited in the well-established emulsion polymerase chain reaction 
(ePCR).88 Here every droplet contains not more than one template and can be amplified within 
the droplet without any competition between other templates. The fact that systems for 
microfluidic ePCR technology are now commercially available240 shows that microfluidic water-
in-oil droplets have also great economic potential. Moreover, they bear great potential for 
assembly, manipulation and analysis of synthetic cells. This, I will demonstrate in my thesis, 
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and further I will show, how the here outlined lab-on-chip functions can be employed for the 
bottom-up construction of synthetic cells.  
 
 
In the introduction section I have described the complexity of a living cell especially regarding 
cellular membranes and motility. Further, I gave an overview about how synthetic biology 
dissects and simplifies functional modules of a living cell in artificial systems. Thereby, I 
especially focused on cell-like compartment systems based on lipid vesicles and water-in-oil 
droplets. In the case of water-in-oil droplets, I moreover gave an introduction into the 
mechanisms behind their stabilization and their microfluidic production. 
In the following section, I will address the aims of my research and further explain the methods, 
how I created biologically relevant membrane systems within water-in-oil droplets and how I 
assembled functional cellular motility modules. 
 
 
  
 
 
 
 
 
_______________________ 
 
 
 
Motivation 
 
 
 
________________________ 
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2. Motivation 
Even though Life Sciences provide fast and big steps towards elucidating life in its diversity and 
complexity, yet, we are lacking a detailed understanding. Thus, mankind still fails to beat 
functional deficits as e.g. cancer or autoimmune diseases. 
Towards learning about vital function and life in general, in my opinion, it is best to start from 
scratch and first understand the building blocks and the assembly of these building blocks into 
functional modules before investigating more complex and synergistic effects in living systems. 
This idea exactly describes what bottom-up synthetic biology is based on.68  
In my thesis, I will use this concept of synthetic biology to build an artificial cell that is 
comprised of a minimal set of building blocks. Towards this aim, I will implement emulsion-
based microfluidic technology, thereby creating a powerful approach to study the assembly of 
these building blocks into functional modules.  
 
 
Figure 29 :  Main elements addressed in my thesis: The membrane-based architecture of 
eukaryotic cell (Section 5.1) as well as the key features of cell motility (Section 5.2  and 
5.3).   
 
The most basic functional unit of a cell is the outer membrane, formed by an entropy-driven 
self-assembly of phospholipids to a bilayer vesicle in aqueous solution.11 The reconstitution of 
these membranes in an artificial system provides not solely a confined reaction space but can 
be also used to study fundamental membrane physics144 and to create further structures as 
membrane tethers and internal smaller compartments to conjecture how eukaryotic 
architectural structures may have evolved. This will be described in the first Part of my thesis 
(Section5.1), depicted in Figure 29.I. 
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The second functional module I want to address in my thesis is cellular motility (Section 5.2 
and 5.3). In this regard, I want to assemble most basic building blocks within the synthetic cell 
to create simple force generating modules that principally resembles the locomotion machinery 
in a living cell. The required building blocks are:28  
- Actin filaments that apply a pushing force onto the membrane in order to protrude the 
cell body (depicted in Figure 29.IIa).  
- Motor proteins that lead to a contraction of the cell body (depicted in Figure 29.IIb).  
- An attachment to the substrate to balance these two forces: an integrin adhesion 
receptors (depicted in Figure 29.III). 
 
After reconstituting and analyzing each building block separately it would be another great 
achievement to move one level up in complexity and combine multiple functional modules in 
one artificial cell to allow for a synergistic interplay of the building blocks. 
Clearly, the ultimate goal, when reconstituting building blocks of the cellular motility 
machinery, is the creation of locomotion. This may then elucidate mechanisms governing 
locomotion is its most basic form. 
 
 
 
 
 
 
 
  
 
 
 
 
 
_______________________ 
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3. Materials  
Having introduced the idea of reconstituting structural and functional modules in an artificial 
compartment system, I will explain now the materials and methods I used in my thesis. 
Experiments. I will start with the description of the materials I used and then I will continue 
describing the methods. 
 
3.1. Lipids 
 
Lipids used in this thesis: L-α-phosphatidylcholine (Egg, chicken, eggPC), L-α-
phosphatidylglycerol (Egg, chicken, eggPG), 1,2-dioleoyl-sn-glycero-3-phosphocholesteroline 
(DOPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholesteroline (POPC), 1,2-dioleoyl-sn-
glycero-3-phospho-(1'-rac-glycerol) (DOPG) and 1,2-dioleoyl-3-trimethylammonium-
propane (DOTAP) were purchased from Avanti (Avanti Polar Lipids, USA), ATTO 488 1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine (ATTO 488 DOPE) was purchased from ATTO 
TEC (Siegen, Germany). All lipids were stored in chloroform at -20 °C and used without further 
purification. Cholesterol C8667 were purchased from Sigma-Aldrich (Sigma-Aldrich, 
Germany).  
 
3.2. Surfactants 
 
To stabilize the water-in-oil droplets, non-ionic amphiphilic and ionic block copolymer 
surfactants were used. These diblock or triblock copolymer surfactants consisted of 
hydrophobic perfluorinated polyether (PFPE) blocks and Polyethylene glycol (PEG) 
hydrophilic blocks. The PFPE blocks, which were exposed to the oil phase provide stability by 
preventing coalescence of the droplets and the PEG blocks provide biological compatibility and 
inertness to the water encapsulated biomolecules.189 Dr. Jan-Willi Janiesch (postdoc, MPI, Prof. 
Spatz Department) synthesized the surfactants that I used at the beginning of my research. 
However, most of the experiments described in this thesis were based on a commercial 
fluorosurfactant from RANbiotechnologies, USA. In the following, I will describe the PFPE 
polymer that is by itself already interfacially active, then the synthesis of custom-made triblock 
surfactants and further I will introduce the commercial surfactants that I used in this research.  
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3.2.1. Krytox 
 
The perfluorinated acid, Krytox 157 FS(H), was purchased from DuPont, Netherlands and is 
basically an perfluoropolyether oil that comprises a carboxylic acid end group (Figure 30), thus 
can serve as an interfacially active surfactant in water-in-oil-systems. 189 Krytox 157 FS(H) will 
be hereinafter simply named as Krytox. 
 
 
Figure 30: Carboxylic acid terminated perfluoropolyether. Trade name Krytox 157 FS(H) 
and here referred to as Krytox. 
 
Through its long fluorocarbon tail, Krytox offers long-term stabilization of water-in-oil 
droplets, however its charged headgroup may interact with biomolecules (e.g. in presence of 
cations with DNA, RNA, proteins, and lipids) what may be desirable, as in the case of droplet-
stabilized GUV formation (see Section 5.1.3) but may also lead to the loss of activity of the 
encapsulated biomolecules 206. Moreover, the pH change due to the carboxylic head group 
might also have an effect on the encapsulated biomolecules. Therefore, water-in-oil droplets for 
most biological application demand for non-ionic fluorosurfactant. The most widely used 
surfactant is a block copolymer comprising a hydrophobic Krytox part and an inert PEG 
hydrophilic part.193 The synthesis is based on a condensation reaction of the carboxylic acid 
group of Krytox and the functional group of PEG or PEG-diamine to an ester- or amide bond 
189,241, respectively, as will be described in the following section. 
 
3.2.2. PFPE-PEG-PFPE triblock 
 
The synthesis of the PFPE-PEG-PFPE triblock-copolymer surfactant was based on a protocol 
published earlier189 and modified as described in Platzman et al.241. In short, the reaction was 
carried out under argon atmosphere in dry Tetrahydrofuran (THF) solvent (Acros Organics, 
Germany) in a heated Schlenk-flask. PEG1400 (1400 mg, 1 mmol, molecular weight 1400 g/mol, 
Fluka, Germany) was solved in 80 ml dry THF and cooled down to -78 °C, followed by the 
dropwise addition of N-butyl lithium (1.22 ml of a 1.6 M solution in hexane, 2 mmol, Sigma- 
Aldrich, Germany) over a period of 60 min. Subsequently, the solution was stirred for additional 
30 min and was then slowly heated to RT, and allowed to be stirred for another 30 min. 
Following this the PFPE7500-carboxylic acid (5 g, 2 mmol, molecular weight 7500g/mol, 
DuPont, Netherlands) was added dropwise over a period of 30 min and stirred for another 12 
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h to allow the condensation reaction to happen (Figure 31). Afterwards, to remove the 
unreacted PEG from the product, the crude was washed with dry THF solvent for three times 
by means of a separatory funnel. Next, to separate the unreacted PFPE-carboxylic acid the 
product was dissolved in methanol (Carl Roth GmbH, Germany), in which mainly the PFPE-
PEG-PFPE product but not the PFPE-carboxylic acid educt is soluble. Finally, the PFPE-PEG-
PFPE product dissolved in the methanol was dried in a rotary evaporator at 40°C and 
subsequently on a vacuum line. The purity of the product was analyzed by NMR and IR 
measurements. This is shown esleweher.241 For reasons of simplicity this costom-made 
synthesized surfactant is hereinafter referred to as “costum-made triblock surfactant”.  
 
 
Figure 31: Synthesis of PFPE7500-PEG600-PFPE7500 triblock-copolymer surfactant, 
referred to in this research simply as custom-made triblock surfactant. Reprinted from 2 4 1.  
 
3.2.3. Gold-linked Surfactant 
 
The synthesis of the gold nanoparticle-linked surfactant was performed by Dr. Jan-Willi 
Janiesch as shown in Figure 32 in a one step process. PFPE7000-carboxylic acid (2.1 mg, 0.3 
μmol, molecular weight 7000 g/mol, DuPont, Netherlands) and KOH (5N, 10 μl, Sigma Aldrich, 
Germany) were added to the (11-Mercaptoundecyl)tetra(ethylene glycol) functionalized gold 
nanoparticle solution (2% w/w solution in water, 5 ml, Sigma Aldrich, Germany) and stirred 
for 1 h leading to a flocculation of the PFPE-PEG-gold product and the unreacted PFPE 241.  
 
 
Figure 32: Synthesis of PFPE7000-PEG-gold polymer surfactant. Reprinted from 2 4 1.  
 
Afterwards the crude product was washed three times with water to remove remaining KOH, 
and the water was finally removed by freeze-drying the product for 24 h. Then it was dissolved 
in 1 ml FC-40 oil (Acros Organics, Germany) followed by a filtration step through a 
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hydrophobic filter (PTFE 0.2 μm, Carl Roth GmbH, Germany) to remove unreacted (11-
Mercaptoundecyl)tetra(ethylene glycol) functionalized gold nanoparticles.  
 
3.2.4. Amine Surfactant 
 
The synthesis of the PFPE-PEG-NH3 diblock-copolymer surfactant was done by Dr. Jan-Willi 
Janiesch and followed a procedure reported earlier242 but with several modifications. Krytox 
157-FSH (7500 g/mol) was mixed in an equal volume of HFE-7100 oil and the carboxylic groups 
were activated with a 10x molar excess of oxalyl chloride (Sigma-Aldrich). Following the 
activation, the solvent and unreacted oxalyl chloride was evaporated and neutralized by 
bubbling the vapors through 2 M KOH. For the hydrophilic part, distinct to the above described 
triblock surfactant, a diamine Jeffamine was used (Jeffamine ED600: O,O’-bis(aminopropyl) 
polypropylene glycol-b-polyethylene glycol-b-polypropylene glycol, Huntsman, USA), which 
comprises an amino group at each end of the molecule. A stock solution was prepared in 
anhydrous dichloromethane and HFE-7100 and a 10 x molar excess (in regard to Krytox) of 
Jeffamine was added - under continuously stirring - to the activated Krytox to initiate the amide 
reaction. Due to the significant molar excess of Jeffamine, the reaction of a diblock was in favor. 
Following the reaction, the crude product was diluted in HFE-7100 and centrifuged overnight. 
A clear bottom phase product was separated from a white top layer consisting of the unreacted 
Jeffamine. The solvent was evaporated at 65°C for 2 days. This surfactant is hereinafter referred 
to as “amine surfactant”. 
 
3.2.5. Hydrophobic PFPE(7000)-PEG-Beads 
 
In order to break the symmetry of water-in-oil droplets hydrophobic beads that are supposed 
to bind from the oil phase to the droplets have been synthesized by Dr. Jan-Willi Janiesch 
according to a protocol described in Kim et al.243 Therefore polystyrene beads (d=2:077 μm, 
Polyscience Inc, USA) were incubated for 5 h with PEG-PPG-PEG (Pluronic F-127) solution 
(Sigma-Aldrich, Germany). 50 μL of toluene was added and subsequently removed after 2 h by 
heating up the solution to 98°C. The beads are then washed with milli-q water and dried under 
vacuum. Next, these functionalized beads were coupled to Krytox (PFPE7000-carboxylic acid) 
by mixing the Krytox with the beads, 1.5 ml water and 10 µl of 5N KOH. The resulting 
hydrophobic beads precipitated and finally could be dried under vacuum before they were 
dissolved in HFE-7500 oil. 
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3.2.6. Commercial PEG-based Surfactant 
 
Besides the custom-made triblock surfactant, I made use of a commercially available PFPE-PEG 
block copolymer from RAN biotechnologies (USA). As the company provides only few 
information about the chemical and physical properties of the surfactant, the surfactant was 
characterized in my thesis by FTIR, MALDI-TOF and by means of a partitioning experiment 
(see Section 5.1.1.1 and 5.1.1.2). To distinguish in the following from the custom-made triblock 
surfactant, the commercial surfactant is hereinafter referred to as “PEG-based 
fluorosurfactant”.  
 
3.3. Oil-Phase 
The fluorosurfactants used in my thesis are soluble only in fluorinated oil. While for 
experiments performed with the custom-made triblock surfactant mainly FC-40 oil was used, 
HFE-7500 (3M, USA) was used when experiments were performed with commercially available 
PEG-based fluorosurfactant. For stable droplets production, the surfactants were dissolved to a 
final concentration ranging from 3 to 15 mM.   
 
 
3.4. Proteins 
The proteins used in this research were partly extracted and purified in our lab. Thus, the 
protocols for their purification is described shortly in the following sections. 
 
3.4.1. Actin 
 
Actin was purified by Christine Mollenhauer or Cornelia Weber (technical assistants, MPI, 
Prof. Spatz Department) based on a previously published protocol.244 In short, actin was 
extracted from rabbit skeletal muscle acetone powder by stirring the acetone powder in actin 
storage buffer (see Section 3.5.) on ice for 30 min following a centrifugation step at 16 000 rpm 
for 30 min (Sorvall RC6 centrifuge, SS-34 rotor). The supernatant was resuspended in actin 
storage buffer and then adjusted to 50 mM KCl and 2 mM MgCl2, which leads to the 
polymerization of actin. While stirring for 30 min the KCl concentration was increased to 0.8 M 
KCl to dissociate tropomyosin and subsequently stirred for another 15 min followed by a 
centrifugation step of 2 h at 35 000 rpm (Optima L-80 XP ultracentrifuge Beckman Coulter, 
Ti 42 rotor). The supernatant was discarded and the pellet resuspended in actin storage buffer 
followed by a dialysis against actin storage buffer (see Section 3.5.). Afterwards it was 
centrifuged again for 2 h at 35 000 rpm and the upper 2/3 of the supernatant was finally purified 
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by gel filtration with Ge-column Hi Load 26/60 Superdex 200 prep grade (General Electric, 
USA) and then aliquoted, snap frozen in liquid nitrogen and stored at -80°C. Phalloidin and 
fluorescently labeled actin was purchased from Life Technologies (Alexa Fluor 568, and Alexa 
Fluor 647 actin conjugate). 
 
3.4.2. Actin-binding proteins 
 
Human recombinant fascin was purchased from Novubio (Bio-Techne) and α-actinin was 
purchased from Cytoskeleton. The proteins are bundling or crosslinking proteins, 
respectively, that help to connect the actin network.35 
 
3.4.3. αIIbβ3 Integrin  
 
Integrin αIIbβ3 was purified from outdated human blood platelets (Katharinenhospital 
Stuttgart) based on a protocol described in Fritzgerald et al.245 and further optimized by Stojan 
Perisic (Ph.D. student, MPI, Prof. Spatz Department). In short, to remove other cells from the 
platelets a differential centrifugation step was applied at RT for 20 min at 1400 rpm (Sorvall 
RC6 centrifuge, SLA 3000 rotor). Following centrifugation, the platelets were washed three 
times by pelleting the platelets at 4000 rpm for 30 min and resuspending in 100 ml platelet lysis 
buffer 1 (see Section 3.5). Platelets were broken with a Turrax homogenizer (IKA, Germany). 
The lysate was afterwards centrifuged for 30 min at 39 000 rpm (Optima L-80 XP 
ultracentrifuge, Beckman Coulter, 45 Ti rotor) at 4°C followed by the resuspension of the pellet 
in 150 ml lysis buffer 2 (see Section 3.5.). Then another two lysis steps with the Turrax in platelet 
lysis buffer 2 were performed. After 1 h incubation at 4 °C the solution was centrifuged for 15 
min at 4°C at 19 000 rpm (Optima L-80 XP ultracentrifuge, Beckman Coulter, 45 Ti rotor). This 
supernatant was then loaded for affinity chromatography onto an equilibrated Concanavalin A 
column (GE Healthcare Life Sciences, USA) using an ÄKTA protein purification system.  The 
bound glycoproteins were eluted the next day by adding 100 mM mannose to the equilibration 
buffer. Fractions containing integrin (tested by SDS PAGE) were pooled and loaded on a 
heparin column (GE Healthcare Life Sciences, USA). The eluted fractions were again checked 
for integrin content by SDS PAGE and the pure fractions were pooled. As a next step, the 
integrin containing fractions were concentrated by a filter step through an Amicon Ultra-15 
filter (50 kDa MWCO, Merck, Germany). Following this step, the integrin was loaded onto a 
Superdex 200 column (GE Healthcare Life Sciences, USA) and eluted overnight. The most pure 
and concentrated fractions were further sterile filtered, aliquoted, snap frozen and stored at -
80°C. The biological activity of the purified integrin was tested by ELISA using AB1967 anti-
integrin αIIb antibodies (Merck, Germany). Further the purified integrin was partly used for 
fluorescence labelling by means of a NHS (succiniminidyl) ester –conjugated Alexa Fluor 568 
fluorescent dye (Life technologies) that reacts with primary amines (R-NH2) on the integrin 
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and create a stable amide bond. Aiming so, 50 µg of NHS ester-dye was dissolved in dimethyl 
sulfoxide (DMSO, Sigma Aldrich), then added to 1 ml of 1 mg/ml integrin solution and allowed 
to react under stirring for 1 h at RT. The protein was separated from unbound dye via an 
equilibrated PD-10 desalting column (GE Healthcare Life Sciences, USA), aliquoted, snap 
frozen and stored at -80°C. 
Besides this purified native integrin protein also a recombinant intracellular fragment of the b3 
integrin was used in my thesis. This was a gift from Prof. Geiger, Weizmann institute Israel. 
 
3.4.4. Adhesion-Associated Proteins 
 
Talin protein was extracted and purified from chicken gizzards by Christine Mollenhauer based 
on a protocol described in Halloran et al.246 and kept in -80 °C until used. 
The FAK protein used here was a gift from Prof. Geiger, Weizmann institute Israel. It was 
shipped to Germany on dry ice and kept at -80°C until usage. 
 
3.4.5. Myosin Motor 
 
Myosin II was isolated by Christine Mollenhauer from rabbit skeletal muscle according to the 
purification protocols published before.247 In short, muscle tissue from a freshly sacrificed rabbit 
was collected, grinded in a meat grinder and mixed with three volumes of extraction buffer for 
exactly 10 min with constant stirring at 4°C. Afterwards, the muscle tissue residues were 
separated by a centrifugation step for 15 min at 12 000 rpm (Sorvall RC6 centrifuge, GSA rotor) 
at 4°C. The pH of the supernatant was adjusted to 6.6 and then diluted very slowly with 10 
volumes of cooled milli-q water, leading to a precipitation of myosin. The pellet could be 
collected by centrifuging for 15 min at 7 000 rpm (Sorvall RC6 centrifuge, GSA rotor) followed 
by the resuspension of the pellet in 0.25 ml per gram pellet in buffer M1 and the dialysis 
overnight against buffer M2 (see Section 3.5.). The next day, the dialysed myosin solution was 
diluted slowly with an equal volume of cold milli-q water and stirred on ice for 30 min. Then a 
centrifugation step followed at 18 000 rpm (Sorvall RC6 centrifuge, SS34 rotor) for 30 min at 
4°C to separate the actomyosin from the myosin. The supernatant containing the myosin was 
diluted with 7 volumes of milli-q water and centrifuged for 15 min at 12 000 rpm (Sorvall RC6 
centrifuge, GSA rotor) at 4 °C. The pellet was resuspended in 2 M KCl to bring it to the final 
KCl concentration. Following resuspension, the solution was salted out with two steps of 40% 
and 50% saturated ammonium sulfate, respectively, and centrifugation steps for 10 min at 
13 000 rpm (Sorvall RC6 centrifuge, SS34 rotor) at 4°C. The freshly purified myosin II was 
aliquoted in Buffer D (see Section 3.5), snap frozen and stored at -80°C. 
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3.4.6. ATP Sensor 
 
The PercevalHR was developed by Tantama et al. by mutagenesis of the original Perceval 
sensor.248 Dr. Amelie Benk (postdoc, MPI, Prof. Spatz Department) and Christine 
Mollenhauer performed the protocol to produce the PercevalHR sensor, which is described 
in details somewhere else.249 The plasmid pRsetB-PercevalHR was a gift from Gary Yellen 
(Addgene plasmid # 49081). The protein was expressed in 150–200 ml E.coli cultures 
overnight at 37 °C and then allowed for additional growth for 2–3 days at RT. The cell pellets 
were collected and lysed in three freeze–thaw cycles followed by agitation in lysis buffer. The 
lysate was further purified by centrifugation at >15,000 g for 10 min at 4 °C and by nickel-
affinity low-pressure chromatography (HiTrap Chelating HP, 1 ml bed volume, GE 
Lifesciences). Protein concentration was determined by the BCA method (Pierce) and 
aliquots were snap frozen and stored at −80 °C. 
 
3.5. Buffers 
 
All buffers were prepared with ultra-pure milli-q water (R = 18 MΩ, milli-Q filtered) 
and stored at 4°C. 
 
3.5.1. Buffers for dsGUV Formation 
 
Table 2: Buffers for dsGUV formation. 
Lipid charge Surfactants Buffer 
neutral/negative PEG-based surfactant 
plus Krytox 
30 mM TrisHCl, pH 7.4 
 10 mM MgCl2 
neutral PEG-based surfactant 
plus Krytox 
30 mM TrisHCl, pH 7.4 
 50 mM or 100 mM KCl 
positive  PEG-based surfactant 
plus Krytox 
30 mM TrisHCl, pH 7.4 
 
neutral/negative PEG-based surfactant 
plus amine surfactant 
30mM TrisHCl, pH 7.4 and 9.5 
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3.5.2. Buffers for Actin and Actomyosin Experiments 
 
Table 3: Buffers for actin and actomyosin experiments. 
 
Buffer     
M1 1 M KCl         
pH 6.5 
0.025 M EDTA 60 mM KH2PO4  
M2 0.6 M KCl pH 
6.5 
0,025 M KH2PO4 10 mM EDTA  
D-Buffer 50 M  K2HPO4 600 mM KCl pH 6.5  
Actin storage 
buffer 
2.0 mM TRIS  
pH 7.4 
0.2 mM CaCl2 0.2 mM ATP 1 mM TCEP 
Actin 
polymerization 
buffer 
50 mM KCl 10 mM MgCl2 1 mM ATP ± 0.4% methyl-
cellulose 
ATP recovery 
buffer (a) 
10 mM HEPES 0.12 mM DABCO 0.13 mM KCl 0.1% BSA 
 1 mM TCEP    
ATP recovery 
buffer (b) 
10 mM HEPES 5 mM Creatine-
phosphate 
Creatine kinase 0.5 
mg/ml 
 
 1 mM TCEP Creatine kinase 0.5 
mg/ml 
5 mM Creatine-
phosphate 
 
 3 mg/ml 
glucose 
0.1 mg/ml glucose-
oxidase 
0.02 mg/ml 
glucose-catalase 
pH 7.4 
 10 mM DTT    
Motility assay 
“AB buffer” 
25 mM Hepes 
pH 7.4 
25 mM KCl 25 mM MgCl2 25 mM EGTA 
 25 mM DTT 0.02 mg/ml 
glucose-catalase 
0.5 wt% 
methylcellulose 
3 mg/ml glucose 
 0.1 mg/ml 
glucose-oxidase 
   
Motility assay 
“Motility 
buffer” 
 
AB buffer 5 mM ATP   
PercevalHR 
assay buffer 
100mM MOPS  
pH 7.4 
50m M KCl 5mM NaCl 15 mM MgCl2 
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3.5.3. Buffers for Integrin Experiments 
 
Table 4: Buffers for integrin experiments. 
 
3.5.4. Buffers for Protein-Binding Experiments: 
 
Table 5: Buffers for protein-binding experiments. 
 
3.5.5. Buffers for SDS-PAGE and Western Blot 
 
Table 6: Buffers for SDS-PAGE and Western blot. 
 
Buffer     
Platelet washing 
buffer 
20 mM TrisHCl pH 
7.4 
150 mM 
NaCl 
 
1 mM EDTA 0.01 wt% 
acetylsalicylic acid 
Platelet lysis 
buffer 1 
50 mM TrisHCl pH 
7.4 
1 mM CaCl2 1 mM MgCl2  
Equilibration 
buffer 
20 mM TrisHCl pH 
7.4 
100 mM 
NaCl 
1 mM CaCl2 0.1 wt% Triton X-100 
Column buffer 20 mM TrisHCl pH 
7.4 
150 mM 
NaCl 
1 mM CaCl2 1 mM MgCl2,  
 0.1wt% Triton X-
100 
0.02 wt% 
NaN3 
2 mg/l 
Aprotinin 
 
Integrin buffer A 20 mM Tris HCl 
pH 7.4 
50 mM NaCl 1 mM CaCl2  
Integrin buffer B 
 
Integrin buffer A 0.1% Triton 
X 100 
  
Integrin 
activation buffer 
Integrin buffer A 1 mM MgCl2 1 mM MnCl2  
Buffer     
Talin buffer 50 mM Tris HCl, pH 8 
 
 
 
  
FAK buffer 20 mM Tris HCl pH 8 0.1 M NaCl 5 mM BME  
TBS 20 mM Tris HCl pH 7.5 500 mM NaCl   
Buffer     
6x Loading buffer 300 mM Tris HCl 
 
12% SDS 
 
36% Glycerol 30 mM DTT 
Running buffer 25 mM TrisHCl 192 mM glycerine 1% SDS  
Transfer buffer 25 mM Tris pH 8.3 192 mM glycine 20% Methanol  
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4. Methods  
In the following part, I will explain which methods I used in my thesis. I will first describe the 
methods towards characterization of surfactants. Then I will introduce the microfluidic 
technology. In this regard, I will describe the soft and photolithography methods and will 
continue, in particular, with illustration of different functional microfluidic units. Then I will 
describe how to generate lipid-based compartment systems and functional modules within 
water-in-oil droplets. 
 
4.1. Surfactant Characterization  
 
In the following section, I will describe the analytical methods that were implemented to 
characterize the block-copolymer surfactants used in this thesis.  
 
4.1.1. Infrared (IR) and MALDI Mass Spectrometry (MS) Measurements 
 
IR and MALDI MS measurements were performer to assess the purity of the commercially 
available PEG-based fluorosurfactant by Dr. Jan Willi Janiesch and Martin Schröter, 
respectively (Ph.D. Student, MPI, Prof. Spatz Department). IR measurements were conducted 
on a Nicolet Nexus 870 Fourier transform infrared spectrophotometer (Thermo Electron 
GmbH, Dreieich, Germany).  
MS measurements were performed using a MALDI-TOF MS system (AXIMA Performance, 
Shimadzu, Japan). Spotting was done by overlaying one spot of a stainless-steel plate with 0.5 µl 
1,8,9-trihydroxyanthracene (THA; 10 mg/ml in 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP). 
Immediately after drying at ambient temperature, the spot was covered with 2 µl of a mixture 
of surfactant (1 mg/ml in HFIP), THA (10 mg/ml in HFIP) and LiTFA (100 mM in HFIP) in a 
volume ratio of 10:1:1 and left to dry at ambient temperature. Afterwards, the spot was lined 
with 1 µl THA (10 mg/ml in HFIP). 
 
4.1.2. Partitioning Experiment 
 
Partitioning experiments were performed to examine the accumulation of Krytox molecules at 
the water-oil interface.28 Towards this end, 1 ml of HFE-7500 oil that contained Krytox 
concentrations between 0 and 1 mM (with and without 1.4 wt% PEG-based fluorosurfactants) 
was added to a 3.5 ml cuvette. A Tris buffer (30 mM Tris and 10 mM MgCl2) containing 
Rhodamine 6G (Rho6G 1 mM, Sigma Aldrich, Germany) was gently pipetted on top of the oil 
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solutions. Due to the 1:1 chemical interaction between the Krytox molecules and Rho6G and 
adsorption and desorption processes of Krytox at the interface, a partitioning of Rho6G 
molecules to the oil phase was observed.250 Following 48 h of incubation, samples from the oil 
and the aqueous phases were carefully collected and transferred into a 96 well plate. Rho6G 
content was determined in a plate reader (infinite 200, Tecan) by measuring the absorbance at 
500 nm.  
 
4.1.3. Interfacial Tension Measurements 
 
A contact angle system OCA (DataPhysics, USA) equipped with a CCD high-speed camera HS 
for pendant drop measurement, was used to determine the interfacial tension (IFT) between 
water and HFE-7500 oil droplets containing PEG-based fluorosurfactants and Krytox or amine 
surfactant. The Young-Laplace equation was chosen to fit the droplet shape in order to 
determine the IFT values (Section 1.4.3).209 To investigate the effect of ions on the IFT values, 0 
or 1 mM MgCl2 was added into freshly deionized water and was filled into a glass cuvette. A 
stable oil droplet was generated manually into this aqueous solution using a syringe. IFT values 
were recorded until a stable value was reached. When IFT values fell below 1 mN/m and stable 
droplet creation was not possible, values were set to 0 mN/m. 
 
4.2. Microfluidic Device Production 
 
The microfluidic devices used in this research were made of polydimethylsiloxane (PDSM) 
(Sylgard 184, Dow Corning, USA) and prepared by standard photo- and soft lithography 
methods (Figure 33) as described in the following sections.  
 
4.2.1. Photolithography 
 
The wafers for the microfluidic devices used in this thesis were produced by Christoph Frey 
(Ph.D. student, MPI, Prof. Spatz Department). The procedure is described in more detail 
elsewhere.251 In short, primarily, the designs of the devices were created with QCAD-pro a 
computer-aided design (CAD) software. These designs were then used to create chromium 
photomasks by means of reactive ion etching of the channels into chrome-coated soda lime 
glass (JD-Photodata, U.K.). In order to create a master with a positive relief of the channels a 
negative photoresist (SU8−3025, MicroChem, U.S.A.) was spin-coated (Laurell Technologies 
Corp., U.S.A.) onto silicon-wafer at 2500 rpm in order to get a uniform coating of 30 μm 
thickness. Next, a prebaking step followed to remove air bubbles and excess photoresist solvent 
(5 min soft bake at 65 °C then ramped slowly to 95 °C and held for 15 min). Afterwards, the 
resist was covered with the chromium mask and exposed to UV light for 7.5 s using a mask 
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aligner (MJB4, SÜSS MicroTec, Germany). This lead to the photoresist polymerization, where 
the channel structure was etched into the chromium mask and the UV light could pass through. 
Following baking steps for 1 min on a hot plate at 65°C and 5 min at 95 °C to solidify the 
photoresist, the part of the photoresist that was covered with the chromium was washed away 
with a developing agent (mr-DEV 600 developer (MicroChemicals, Germany)), disclosing the 
positive relief of the channel structure. The hard bake was carried out in an oven at 150 °C for 
15 min.  
 
 
Figure 33: Principle steps to manufacture microfluidic PDMS devices by means of photo- 
and soft lithography. 
 
All photolithography procedures were performed under clean room conditions (class 100). A 
profilometer (DektakXT, Bruker, Germany) was used to analyze the heights of the created 
structures. These master molds were used to produce PDMS devices by the soft lithography 
method.  
 
4.2.2. Soft Lithography 
 
The first step in soft lithography was to prepare the polydimethylsiloxane (PDMS; Sylgard 184, 
Dow Corning, U.S.A.) elastomer. Towards this end, a liquid oligomer and the polymerization 
catalyst was mixed together in a 1:10 ratio (w/w) and was then poured into the mold of the 
master wafer. To remove air bubbles the polymer was degassed in a desiccator under vacuum 
and then crosslinked at 65°C for 2 h. Following polymerization, the replica can be peeled off the 
mold and holes for in- and outlet channels were punched into the PDMS device with a biopsy 
puncher (0.5 mm diameter, Biopsy Punch, World Precision Instruments, U.S.A.). Afterwards, 
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the devices and 25 x 60 mm cover slips (#1, Carl Roth, Germany) were cleaned with iso-
propanol and ethanol, blow dried and activated with oxygen plasma (PVA TePla 100, PVA 
TePla, Germany; 0.45 mbar, 200 W, 20 s) to produce polar groups on the PDMS and the glass. 
Upon contact of the glass with the PDMS device, a condensation reaction happens of silanol 
groups with the functional groups of alcohol,233 leading to a tight fixation of the PDMS to the 
glass and thus, to the sealing of the microfluidic channels. To improve stability of the contact, 
the devices were kept in 65 °C for at least 2 h.  
Pico-injection devices were additionally equipped with electrodes. In this concern, the devices 
were heated up on a hotplate to 85°C and Indalloy 19 (51% indium, 32: 5% bismuth, 16: 5% tin, 
Indium Cooperation, USA) was melted into the inlets of the electrode channels and connected 
to striped wire tips (MC6A-1, Farnell, UK) that were fixed to the device with the glue Loctite 
352 (Henkel, Germany).  
Before the use, devices were flushed with sigmacoat® (Sigma-Aldrich, Germany) to render the 
channels fluorophilic. After around 1 min incubation the channels were flushed with HFE-7500 
oil. Devices can be used several times if not contaminated or clotted.  
 
4.3. Different Microfluidic Devices 
 
Most of the designs described in the following were adapted from literature and were further 
optimized and adjusted for the needs of the research. Figure 34 shows representative sketches 
of the microfluidic device designs implemented in this research. The bright-field images are 
colored for clarity (brown, violet: oil phases / blue, red, green: aqueous phases). 
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Figure 34: Schematic representations of different droplet-based microfluidic units. (A) 
droplet production device with one aqueous inlet (colored in blue), (B) droplet production 
device with two aqueous inlets (colored in red and green) and a zick-zack mixing unit to 
mix the two aqueous phases after droplet production, (C) droplet trapping device. Droplets 
are introduced via the red-colored droplet inlet channel and captured in the cavities. Then, 
the trapped droplets can be exposed to 2 different oil phases applied from the oil inlets 
(violet and brown). (D) Picoinjection device for sequential loading of biomolecules into the 
droplet. Electrodes apply an AC electric field at the injection inlet allowing for injection of 
biomolecules into the passing droplets. Scale bars 50 µm. 
 
4.3.1. Droplet Production Device  
 
A droplet-production device (Figure 34A) comprising of an aqueous inlet and an oil inlet was 
connected to 0.5 ml or 1 ml syringes (Omnifix-F, B.Braun, Germany), respectively, via PTFE 
tubing (0.4 x 0.9 mm, Bola, Germany) and cannulas (Sterican, 0.4 x 20 mm, BL/LB, B.Braun, 
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Germany). Monodisperse water-in-oil emulsion droplets were produced with flow rates in the 
range of 200 to 2000 µl/h and 50 to 200 µl/h of oil and aqueous phases, respectively, controlled 
via syringe pumps (Pump11Elite, Harvard Apparatus, USA) (see setup in Figure 35).  
The oil channel within the device was designed as such that it encounters the aqueous phase at 
the flow focusing junction (inset Figure 34A) from two opposite direction. When the flow rates 
of aqueous and oil phases are well adjusted, the aqueous phase will form a droplet-producing 
nozzle. Immediately, surfactants from the oil phase diffuse to the water-oil interface and hence 
stabilize the droplets. The size of the produced droplets depends on the dimension of the 
channel at the flow focusing junction and on the applied flow rates. To create 30 µm droplets, a 
channel width at the flow focusing junction of 20 µm and an oil/aqueous phase ratio of 10:1 
were used. The outlet of the device was connected via a PTFE tubing to a micro tube, where the 
produced droplets can be collected.  
In some biological applications, it is important to avoid interactions between different bio 
molecules prior to their encapsulation within the droplets (e.g. actin monomers and its 
polymerization buffer). Towards this end, a droplet production device with two aqueous inlet 
channels (Figure 34B) was implemented. Due to the laminar flow in the micrometer sized 
channels (Section 4.3), the mixture between the parallel-flowing solutions is minimized. 
Subsequently, after the droplet formation, the aqueous phases are then mixed by a zick-zack 
pattern of the production channel. Finally, the produced droplets can be analyzed in an 
observation chamber (Figure 36) or introduced into a picoinjection or trapping device. 
 
 
Figure 35: Image of the setup for the microfluidic production of water-in-oil droplets. The 
inlets of the microfluidic PDMS device (inset) are connected via PTFE tubing to the syringes 
containing the oil and aqueous buffers. Flow rates were controlled by syringe pumps.  
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4.3.2. Droplet Observation Chamber 
 
For observation, droplets were collected at the outlet of the device and then transferred into an 
observation chamber (Figure 36). This chamber consisted of two cover slips (60 x 24 mm 
(bottom) and 20 x 20 mm (top), Carl Roth, Germany) glued together by a double sided sticky 
tape (Tesa, Germany), providing thereby a spacing between the two slips of around 90 µm. The 
chamber was filled up with oil/surfactant solution and, finally sealed with a two-component 
dentist glue (Twinsil, Picodent GmbH, Germany). 
 
 
Figure 36: Sketch of observation chamber containing the water-in-oil droplets. The 
chamber is made of two cover slips glued together by a double sided sticky tape and is sealed 
with a two-component dentist glue. Inset shows the cross-section through the observation 
chamber with a water-in-oil droplet that floats to the upper glass of the chamber due to the 
difference in the density between the HFE-7500 oil (ρ  = 1614 kg/m3) and the water phase 
(ρ  = 998 kg/m3). Image modified from 1 6.  
 
4.3.3. Trapping Device 
 
Microfluidic trapping device was used for time-lapse observation of immobilized droplets 
under distinct oil phase conditions (Figure 34C). This trapping device comprises of an inlet to 
introduce the droplets and inlets to apply constant oil flow. In V-shaped cavities the droplets 
are trapped and hold in place by the applied oil flow.  
 
4.3.4. Picoinjection Device 
 
To further manipulate and sequentially load biomolecules into water-in-oil droplets, a 
picoinjection device, developed by Abate et al.130 was applied here. The picoinjection device 
(Figure 37, Figure 34D) consists of an inlet channel where the produced droplets are introduced 
using a MFCS-EZ flow control system (Fluigent, France). To prevent fusion of the passing 
droplets under the electrical field, droplets were separated by a stream of surfactant-containing 
oil from a second oil channel before approaching the injection unit. The injection unit 
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comprises of two electrode channels filled with Indalloy 19 (51% indium, 32.5% bismuth, 16.5% 
tin, GPS Technologies, Germany). Here an alternating electrical (AC) field in the opposite to 
the injection channel is applied in order to achieve the poration and destabilization of the 
surfactant shell and the lipid bilayers. This allows for controlled picoinjection of biomolecules 
into the droplets that are passing the injection channel. Electrical field (frequency 1 kHz, 
potential 250 V) was generated by HM 8150 signal generator (HAMEG, Germany) and 
amplified by a 623B-H-CE amplifier (TREK, USA). Dependent on the applied pressure, the 
injection volume can be precisely controlled between 1 to 100 picoliter.  
 
 
Figure 37: Photo of a microfluidic PDMS device with electrodes glued on a glass slide. Fluid 
channels are colored in brown for better visibility. 1: inlet for droplets, 2: inlet for spacing 
oil,  3: injection inlet, 4: outlet. 
 
 
4.4. Analysis of the Droplets 
 
In the following section, I will describe which methods I used to analyze the microfluidic water-
in-oil droplets. 
 
4.4.1. High Speed Camera  
 
In order to observe the droplet-production and picoinjection, an Axio Vert.A1 (Carl Zeiss AG, 
Germany) inverse microscope equipped with a 20x objective (LD A-Plan 20x/0.35 Ph1, Carl 
Zeiss AG, Germany) was used. High-speed videos were recorded with a Phantom 7.2 (Vision 
Research, USA) CCD camera in bright-field with 80 μs exposure time and 10 000 pps.  
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4.4.2. Confocal Imaging 
 
Confocal fluorescence microscopy was performed with an inverted confocal Laser-Scanning-
Microscope (SP5, Leica Germany) equipped with an argon and a white light laser (WLL). 
Imaging was carried out using a 63x oil-immersion objective (HCX PL APO 63x/1.40-0.60; 
Leica Microsystems GmbH, Germany). The pinhole for data acquisition was set to 1 Airy unit, 
which corresponds to an Airy disk diameter of 96 μm and a 0.9 μm thickness of the optical slice. 
Fluorophores were exited at 488, 558 and 647 nm and the detection windows were set at 500-
540 and 568-610 nm and 657-700 nm in case of ATTO 488, Alexa Fluor 568 and Alexa Fluor 
647 -labeling, respectively.  
Further a LSM 880 confocal microscope (Carl Zeiss, Germany) using a C-Apochromat 40 × /1.2 
W water-immersion objective (Carl Zeiss, Germany) was used for fluorescence intensity 
measurements of flowing droplets. The pinhole was fully opened, to maximize photon 
collection. 
 
 
4.5. Lipid-based Compartment Systems  
 
In the next sections I will explain how the surfactant stabilized water-in-oil droplets were tuned 
to create lipid-based compartment systems, namely multicompartment systems or droplet-
stabilized GUVs, or free-standing GUVs. Further I will describe how I characterized these lipid-
based compartment systems. 
 
4.5.1. Microfluidic Formation of Multicompartment System and 
dsGUV 
 
For the formation of multicompartment systems and dsGUVs, solutions of SUVs with different 
lipid compositions were generated according to previously reported protocols.16 In brief, the 
lipids were mixed at desired ratios in a glass vial and dried under a gentle stream of nitrogen. 
To remove traces of the solvent, the lipids were kept under vacuum in a desiccator for at least 2 
h. The dried lipids were resuspended to a concentration of 2.2 mM in 30 mM Tris buffer at pH 
7.4 (storage buffer) and the resulting SUV solution was then extruded 7 times through a 
polycarbonate filter with a pore size of 50 nm (Avanti Polar Lipids, Inc.). The mean SUV 
diameter was determined using dynamic light scattering (DLS, Malvern Zetasizer (Nano ZS)). 
Solutions containing SUVs were stored at 4 °C for up to 48 h or encapsulated into microfluidic 
droplets immediately.  
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A microfluidic droplet production device (Figure 34A) made of PDMS was utilized to form 
multicompartment systems or dsGUVs. For this purpose, the flow rate of the water and oil 
phase was set to 200 µl/h and 2000 µl/h, respectively. These conditions allowed production of 
phospholipids-containing droplets with a diameter of 30 µm at a rate of 4.2 kHz. 
The SUV solution was diluted to a final lipid concentration of 1.1 mM (equivalent to 26.5 µM 
SUVs / 1.6 x 1016 SUVs/ml) in 30 mM Tris and 10 mM MgCl2, so as to form a continuous lipid 
bilayer within the droplets that were 30 µm in diameter (see Section 4.5.2). To create dsGUVs 
containing free-floating SUVs in the droplet volume, a lipid concentration of 2.2 mM 
(equivalent to 53 µM SUVs / 3.2 x 1016 SUVs/ml) was used. Finally, the SUVs were introduced 
into the aqueous channel of the microfluidic device for droplet formation. The oil phase 
consisted of HFE-7500 oil including 1.4 wt% PEG-based fluorosurfactant and Krytox at 
concentrations ranging from 0.15 to 15 mM. Droplets were collected in a micro tube, 
transferred into observation chambers (Figure 36) and observed after compartment formation 
and after 7 days of storage at 4 °C by confocal fluorescence microscopy to assess compartment 
formation and stability. Moreover, fluorescence recovery after photobleaching (FRAP) (see 
Section 4.5.3) and cryo-SEM analysis (see Section 4.5.4) was carried out to characterize bilayer 
formation. Additionally, droplets sealed in a microfluidic trapping device were imaged under 
the same conditions.  
 
4.5.2.  Minimal Lipid Concentration Required for a Formation of 
dsGUVs  
 
To ensure a complete coverage of the droplet’s inner interface with a lipid bilayer the necessary 
amount of lipids was calculated according to a droplet with a diameter of 30 µm, the volume 
Vdroplet and the surface Adroplet.  
 
Vdroplet = de 	𝜋𝑟e =	1.4 x 104 µm3  
Adroplet = 4𝜋𝑟I = 2.8 x 103 µm2  
 
The area Alipid that a single lipid occupies in a lipid bilayer was assumed to be  
 
Alipid = 0.7 nm2 = 7 x 10-7 µm2 
 
Thus, the amount of lipids Nlipids necessary to create a lipid bilayer of a size of Adroplet is 
 
Nlipids = Adroplet/Alipid x 2 = 8 x 109 lipids 
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This corresponds to a minimal concentration cmin of  
 
cmin = Nlipids	 iSjkjlimnopqlroslrokStu	 = 950 µM 
 
as the minimal amount of lipids necessary to create dsGUVs with a diameter of 30 µm. To 
compensate possible loss of lipids during SUV extrusion or droplet production a 15% lipid 
excess was used in the experiments (1.1 mM). 
  
4.5.3. Fluorescence Recovery after Photobleaching (FRAP) 
Measurements 
 
FRAP measurements were performed to assess the diffusion coefficients of the fluorescently 
labeled lipids close to the periphery of the droplet. To that end, the droplets were scanned in z-
direction until reaching the bottom slice that was not in contact with the glass surface of the 
observation chamber. This was chosen as the confocal plane to perform FRAP measurements. 
A circular spot of 5 µm in diameter was used as a bleaching spot (7 cycles, until fluorescence of 
bleaching spot vanished). Further, 10 pre-bleaching images and 30 post-bleaching images were 
recorded from the bleaching spot and from the whole droplet base (as a reference). FRAP 
measurements were performed at least for 20 droplets per condition. The analysis followed the 
protocols proposed by Axelrod et al.252 and Soumpasis.253 In this regard, first, the background 
noise Ibg of the detector, measured in the oil phase, was subtracted from all measured intensity 
values of the bleached spot. Next, average intensity values of the bleaching spot, I(t), and of the 
whole droplet base, T(t), were extracted from the recorded images and their post bleaching 
values were normalized by the averages of the prebleaching values, Ipb and Tpb, leading to Inor. 
Photofading was corrected by multiplying the intensities of the bleached spot with the 
reciprocal, normalized intensities of the droplet base, T(t).  
 
Inor = 
v E wvQpvkQwvQp 	 ∙ 	 xkQwvQpx(E)wvQp 
 
To fit the normalized intensities Inor to an exponential function a nonlinear-square fit (Figure 
53A und B) was applied using MATLAB R2015a SP1 (as further described in Weiss et al.20 ) 
resulting in the coefficient values 𝜆  
 𝑓 𝑡 = 	𝑎(1 − exp	(𝜆 ∙ 𝑡) 
 
The coefficient values 𝜆 were then applied to calculate the half time recovery τ1/2 of the bleached 
spots. 
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τ1/2 = w	(.)  
 
Based on the half time recovery τ1/2 and the square radius of the bleaching spot, the diffusion 
coefficient D can be calculated, assuming a Gaussian bleaching profile: 
 
D = 0.32	 @/@ 
 
4.5.4. Cryo-Scanning Electron Microscopy (cryo-SEM) 
 
For cryo-SEM sample preparation, the droplet emulsion solution (3 μl) was dropped on 0.8 mm 
diameter gold specimen carriers assembled on a freeze fracture holder (Leica Microsystems, 
Wetzlar, Germany) and immersed immediately in liquid nitrogen. Next, the droplets were 
transferred by an evacuated liquid nitrogen-cooled shuttle Leica EM VCT100 (Leica 
Microsystems, Wetzlar, Germany) into a Leica EM BAF060 (Leica Microsystems, Wetzlar, 
Germany) freeze fracture and etching system. For cryo observations, the droplets were fractured 
in the 10-6 - 10-7 mbar vacuum chamber at -160 °C with a cooled knife. To allow the water in the 
fractured droplets to sublimate, the sample holder stage was heated to -90 °C for 60 min. 
Following sublimation, the freeze fractured droplets were coated with 4 nm of Pt-C by electron 
beam evaporation. For image acquisition, the samples were transferred via an evacuated liquid 
nitrogen cooled shuttle into the imaging chamber of a Zeiss Ultra 55 field emission electron 
microscope (FE-SEM) equipped with in-lens, secondary electron (SE) and angle selective 
backscattered electron (ASB) detectors (Zeiss SMT, Oberkochen, Germany). Top-view imaging 
was performed under low temperature conditions (Top = -115 ± 5 °C), and with a working 
distance between 3 to 5 mm. Due to the low conductivity of the emulsion droplets low 
acceleration voltages of 1.5-2.0 kV were used. Signals were detected with the in-lens detector. 
 
4.5.5. GUVs Release into a Physiological Environment 
 
After formation, dsGUVs were collected from the outlet of the microfluidic chip in a micro 
tube. The collected droplets were stored at 4 °C overnight for equilibration of the lipid and the 
ionic conditions within the droplets.  
To release the GUVs from the oil phase and from the stabilizing polymer shell into an aqueous 
environment, 50 µl of 30 mM Tris buffer supplemented with 10 mM MgCl2 (matching the 
osmolarity of the encapsulated aqueous phase) was pipetted onto the droplet emulsion (Figure 
38). To destabilize droplets, 10 – 100 µl of 30 vol% perfluorooctanol (PFO)-containing HFE-
7500 oil (de-emulsifier) was slowly added until the milky emulsion turned into a clear aqueous 
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phase (detected by eye). Following de-emulsification, the released GUVs were carefully 
removed with a pipette and transferred into observation chambers passivated with BSA (Bovine 
serum albumin, SERVA Electrophoresis GmbH). For this end, cover slides were incubated with 
PBS containing 1 mg/ml BSA for 2 h at RT and then washed twice with PBS and with milli-q 
water. Confocal imaging was performed after 1 h to allow for the GUVs to sediment to the 
bottom of the chamber. For statistical analysis (see next section), GUVs were counted, but only 
GUVs with diameters > 20 µm were taken into account. 
 
4.5.5.1. Calculation of Release Efficiency 
 
To quantify the success rate of the release, GUVs were transferred into a BSA coated 
observation chamber and allowed to sediment to the bottom of the observation chamber for 1 
h. An area of 246.5 x 20,000 µm within the observation chamber was screened for released 
GUVs and the amount of GUVs (Ncount) in that area was counted. Assuming that all GUVs have 
sunk to the bottom of the observation chamber, Ncount can be referred to the number of GUVs 
in the volume Vaq_count = 246.5 x 90 x 20,000 µm.  
 
 
 
Figure 38: Schematic representation of bulk release approach. I. Collection of dsGUVs for 
10 min with production rate of 4.2 kHz lead to 2.52 x 106 dsGUVs. II. Addition of aqueous 
buffer Vb u f f e r .  III. Addition of de-emulsifier to release GUVs into the aqueous phase. IV. 
Observation chamber made from two BSA-coated cover slides and a double-sticky tape as 
a spacer. Edges are sealed with two component glue. In a volume of 246.5 x 20000 x 90 µm 
(Va q _ c o u n t,  marked in red) released GUVs were counted (NG U V s ,  c o u n t) and total number of 
GUVs in Va q _ t o t a l  was extrapolated. 
 
To get the total number of released GUVs (NGUVs,total) in the total aqueous volume of the micro 
tube (Vaq_total) Vaq_total was calculated by the sum of the added release buffer (Vrelease buffer) and the 
encapsulated aqueous volume within the emulsion: 
 
Vaq_total= Vrelease buffer + Vaq_encapsulated = 83.3 µl 
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The total number of GUVs can be calculated as 
 
 NGUVs,total = NGUVs,count * (Vaq_total / Vaq_count) = NGUVs, count * 187.8 
 
The efficiency of the release Erelease is then gained by dividing NGUVs,total with the initial amount 
of dsGUVs in the micro tube. 
 
Efficiency of release: Erelease [%] = (NGUVs,total / NdsGUVs) * 100  
 
 
4.5.5.2. Osmotic Manipulation of GUVs 
 
For manipulation of the released GUVs, a release buffer was used that did not match the 
osmolarity of the buffer within the GUV. To achieve hypoosmotic or hyperosmotic conditions 
30 mM Tris without MgCl2 or with 15 mM MgCl2 was used. For hyperosmotic conditions 35 µl 
of the GUV solution could be also placed on the bottom cover slip of the BSA coated 
observation chamber and allowed to partly evaporate for 10 min before the observation 
chamber was closed with the second cover slip on top. GUVs were observed after ½ h 
equilibration time. 
 
4.5.5.3. Purity Assessment of the Released GUVs: Raman Microscopy 
 
For Raman spectra collection released GUVs or dsGUVs were transferred into an observation 
chamber. Using a confocal Raman microscope (Alpha300RA, WITec GmbH, Germany) GUVs 
or dsGUVs were observed via a 100x oil objective (NA 1.2, Zeiss, Germany). The same objective 
was used for focusing a 532 nm laser (20 mW, spot size 350 nm) onto single GUVs or dsGUVs 
to collect Raman scattered light. Acquisition time was set to 2.14 seconds with five 
accumulations for each collection window. After the spectra collection, the location of the GUV 
or the dsGUV was checked again and, in case the GUV or dsGUV stayed in the same location 
the collected data was saved.  
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4.6. Functional Cellular Modules in Droplets 
 
After having introduced how to produce the lipid-based compartment system, I will now 
describe how I assembled functional units in bulk and inside of the water-in-oil droplets 
towards the reconstitution of cellular motility: namely actin networks adhesion-associated 
proteins. 
 
4.6.1. Actin-based Dynamics 
 
In this section, all methods related to the assembly of functional actin networks will be 
described. Thereby, I will explain how actin dynamics were studied in bulk as well as in water-
in-oil droplets.  
 
4.6.1.1. Actin Polymerization in Bulk 
 
Actin monomers (G-actin) and ATP solutions were rapidly defrosted and then placed on ice. 
For the polymerization of G-actin to actin filaments (F-actin) in bulk, G-actin (1% was 
conjugated with Alexa Fluor 568 or Alexa Fluor 647) was diluted to a concentration of 10.1 µM 
in actin storage buffer (see Section 3.5). Then a 10x concentrated actin polymerization buffer 
supplemented with freshly thawed ATP was added in order to achieve polymerization 
conditions for actin. Actin in polymerization buffer was allowed to polymerize at RT for 30 min. 
Afterwards 25 µl of the polymerized actin was transferred onto a PLL-PEG coated cover slip 
(see next section) and observed by means of confocal fluorescence microscopy. 
 
4.6.1.2. Piranha Cleaning of Cover Slips 
 
In order to remove organic residues from glass and render it hydrophilic, the glass was treated 
with a highly oxidative acid bath. Towards this end, cover slips were placed in a Teflon holder 
in a beaker under the fume hood and 75 ml sulfuric acid was poured into the beaker followed 
by slowly adding 15 ml H2O2 (1:5). After 45 min incubation, the Teflon holder with the glass 
cover slips were carefully removed from the solution. Subsequently, cover slips were rinsed in 
a beaker with deionized water for 5 min before the glasses were dried with a flow of nitrogen 
and then treated with oxygen plasma for 10 min at 150 W and 0.4 bar. 
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4.6.1.3. PLL-g-PEG Passivation 
 
In order to passivate the glass surfaces with PLL-g-PEG (SuSoS, USA) cover slips were first 
cleaned with piranha solution (see previous section) and then activated with oxygen plasma for 
10 min, 0.4 bar at 150 W. PLL(20kDa)-g[3.5]-PEG(2kDa) was diluted to a concentration of 0.25 
mg/ml in a 10 mM HEPES buffer at pH 7.4 and was pipetted on the freshly activated glass 
surfaces and allowed to incubate in a moist chamber for 45 min at RT. Afterwards the glass 
surfaces were rinsed with milli-q water and dried under a nitrogen flow. 
 
4.6.1.4. Actin Network Assembly within Microfluidic Droplets 
 
To create water-in-oil droplets containing actin networks a microfluidic production device with 
two aqueous inlets was used. One of the aqueous solutions comprised 20 µM G-actin (1% Alexa 
Fluor 568-labeled) in storage buffer, the other aqueous phase contained a double concentrated 
polymerization buffer (see Section 3.5.). In some cases, both aqueous phases were substituted 
with 0.4 wt% methylcellulose. Prior to the encapsulation experiments all aqueous solutions were 
kept on ice. For droplets production HFE-7500 oil containing 1.4 or 1 wt% PEG-based 
fluorosurfactant was used. After droplet production, droplets were transferred into an 
observation chamber that was thoroughly sealed to prevent an  directed oil flow in the chamber. 
Network and droplet dynamics were analyzed at RT using confocal fluorescence microscopy. 
 
4.6.1.5. Actomyosin Network Formation in Bulk 
 
G-actin, myosin and ATP solutions were rapidly defrosted and then placed on ice. G-actin (1% 
was conjugated with Alexa Fluor 568) was diluted to a concentration of 10.1 µM in actin storage 
buffer supplemented with 0.75 mM KCl. Then 0.5 µM myosin II was added slowly to the 
solution to prevent precipitation of myosin clusters and allowed to sit for 30 min on ice. Then 
a 10x concentrated actin polymerization buffer supplemented with freshly thawed ATP was 
added in order to achieve polymerization conditions for actin. Actomyosin networks were 
afterwards transferred onto a PLL-PEG coated cover slip (see Section 4.6.1.3) and was then 
observed by means of confocal fluorescence microscopy. 
 
4.6.1.6. Actin Motility Assay 
 
For the actin motility assays flow cells (Figure 39) have been fabricated. Towards this aim, a 
cover slip was coated with a thin layer of nitrocellulose (Zaponlack, Clou, Germany) diluted 
with ethylacetate (Carl Roth, Germany) in a 1:3 ratio. The two sides were not sealed in order to 
flush it with liquid samples. In this regard, 40 µl myosin II solution (1 mg/ml in D-buffer, for 
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buffers see Section 3.5.) was introduced into the flow chamber to allow the myosin to be 
immobilized on the nitrocellulose coating. After 3 min, unbound myosin was washed with 40 µl 
AB Buffer containing 1 mg/ml BSA to block free nitrocellulose binding sites. Prepolymerized 
F-actin (see Section 4.6.1.1) was labeled and stabilized with Atto488-phalloidin (Thermo Fisher 
Scientific, Germany), fragmented with a syringe and dissolved to 0.5 µM with AB buffer. 40 µl 
of this F-actin solution was pipetted into the flow chamber and allowed to bind to the myosin 
heads. The flow chamber was mounted on a confocal fluorescence microscope and 40 μl of 
ATP-containing motility buffer was added into the flow chamber. The movement of actin 
filaments running over myosin was recorded and then tracked with the help of a manual 
tracking plugin in ImageJ.  
 
 
Figure 39: Sketch of a flow chamber to perform a motility assay of F-actin filaments gliding 
over immobilized myosin II heads. 
 
4.6.1.7. ATP Sensor Experiment 
 
The PercevalHR was developed by Tantama et al.249 and purified and characterized by Dr. 
Amelie Benk and Christine Mollenhauer (see Section 3.4.6). Fluorescence characterization 
was performed in a multi-well plate (96 well microplates black, flat clear bottom, VWR) in a 
plate reader (Infinite 200 PRO, Tecan) in a ATP / ADP (both Sigma Aldrich, Germany) 
dependent manner (Figure 40B).  
To assess the activity of the actomyosin system, the PercevalHR assay buffer (see Section 3.5.) 
was adjusted to actomyosin conditions (100 MOPS, 75 KCl, 5 NaCl, 0.5 MgCl2; pH 7.4 plus 
15 mM MgCl2). Further, 10 µM of F-actin, 0.5 µM of myosin II and 0.1 mM of PercevalHR 
sensor were dissolved in the buffer and then split into 3 micro tubes. Following splitting, 0 
or 100 µM Mg-ATP or 100 µM ADP was added, respectively, and 100 µl of each solution was 
pipetted into a 96-well plate (Figure 40A). A plate reader was used to collect excitation 
spectra (from 350 to 520 nm excitation, emission from 545 with a bandwidth of 20 nm) 
immediately after sample preparation, after 25 min, 1 h and 1.5 h incubation at RT. 
Accordingly, a control was performed comprising 100 µM Mg-ATP and F-actin but no 
myosin II.  
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Figure 40: ATP sensor approach. (A) Sketch of sample preparation in a multi-well plate to 
test ATP hydrolysis of the actomyosin system. (B) Excitation spectra (350 nm – 520nm, 
emission: 545 nm) of samples containing 100 µM PercevalHR sensor and ATP and ADP in 
different ratios (black: ADP 100%, red: ATP 100%, 1 mM). Reprinted with permission from 
Tantama et al. ,  2013. Copyright © 2013, Springer Nature. 
 
 
4.6.1.8. Actomyosin Network Formation within Water-in-Oil Droplets 
 
In order to create an active actomyosin network within the water-in-oil droplets, a microfluidic 
production device with two aqueous inlets was used (Figure 34B) Therefore, two aqueous 
solutions were prepared: The 1st solution contained: G-actin (20 µM, 1% Alexa Fluor 568-
labeled) in storage buffer as well as the ATP recovery buffer ‘a’. The 2nd solution contained: 
myosin II (mainly 1 µM, when not mentioned explicitly), the double concentrated 
polymerization buffer including the ATP for myosin activity (1 mM) as well as a ATP recovery 
buffer ‘b’ (see Section 3.5.) and the F-actin crosslinking protein fascin (0,5 µM, Novus 
Biologicals, USA). Since size of myosin clusters is depending on the KCl concentration both 
aqueous solutions were substituted with KCl to reach a final concentration of 75 mM. Myosin 
was adjusted to KCl conditions for 30 min before encapsulated into the droplets. Further an 
oxygen scavenger system was included in both solutions to prevent photo-bleaching. As control 
experiments blebbistatin (0.1 mM, Sigma-Aldrich, Germany) was added to inhibit myosin 
activity. To track the motility of the droplets fluorescently labeled beads (1µm, Thermo Fisher 
Scientific, Germany) were included in the aqueous phase.  
As an oil phase for droplet production HFE-7500 oil containing 1.4 or 1 wt% PEG-based 
fluorosurfactant or FC-40 oil containing 5 to 10 mM custom-made triblock surfactant were 
used. In some experiments, 100 µM gold-surfactant or hydrophobic polystyrene beads (d= 2 
μm) were added to the oil phase in order to create actin filament interaction or to label the 
droplets from the oil phase, respectively.  
After droplet production, actomyosin-containing droplets were transferred into an observation 
chamber that was thoroughly sealed to prevent an oil flow in the chamber. Network and droplet 
dynamics were analyzed using confocal fluorescence microscopy. 
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4.6.2. Evaluation of Marangoni Effect on Droplets Motility 
 
To test for droplet dynamics in a millimeter length scale based on the Marangoni effect, 3.5 ml 
of HFE-7500 oil containing 1.4 wt% PEG-based fluorosurfactant and 0 mM, 1.5 mM or 10.5 
mM Krytox was pipetted into petri dishes (35 mm in diameter, VWR International GmbH, 
Germany). F-actin was prepared as described in Section 4.6.1.1 and allowed overnight at 4 °C 
to be polymerized completely. A 10 µl droplet of the polymerization buffer labeled with red ink 
with and without substitution of F-actin (10 µM) was pipetted carefully on top of the oil phase 
and droplet motion was recorded for 2 min using a simple smart phone camera (Samsung A3). 
The motion of the droplet swimming on top of the oil was then tracked with ImageJ and 
velocities were extracted to compare droplet movement of samples with and without F-actin in 
presence of different Krytox concentrations. 
 
4.6.2.1. Synthesis and Encapsulation of CaCO3 Microspheres 
 
The CaCO3 microspheres were fabricated by Dr. Ilia Platzman following a previously published 
protocol.254 In brief, ≈6 μm microspheres were prepared by colloidal crystallization from 
supersaturated solution. Towards this end, equal volumes of 0.33 mM solutions of CaCO3 and 
Na2CO3 were rapidly mixed and agitated on a magnetic stirrer for 40 min in RT. Following 
agitation, the mixture was left without stirring for another 15 min. Finally, the microspheres 
were thoroughly washed with pure water and acetone and dried in air. To encapsulate dextran-
FITC (4k, Sigma-Aldrich, Germany) into CaCO3 microspheres by physical adsorption, 400 µl 
of dextran-FITC dissolved in water (2.5 mg/ml) was added into solution of preformed CaCO3 
microspheres.  
A microfluidic approach failed to deliver efficiently the microspheres into the droplets due to 
the blockage of channels by the CaCO3 microspheres. Therefore, to encapsulate the 
microspheres into water-in-oil droplets, a simple emulsification approach through shaking was 
applied. In this concern, the CaCO3 beads were dissolved in milli-q water in a concentration of 
20 mg/ml and 20 µl were pipetted on top of 100 µl of HFE-7500 oil containing 1.4 wt% PEG-
based fluorosurfactant with 10.5 mM Krytox in a micro tube. Following this step, the solution 
was vortexed vigorously for 15 s until the aqueous phase turned into a milky emulsion. Droplets 
were transferred into an observation chamber and investigated by bright field and fluorescence 
microscopy.  
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4.7. Functional Modules within dsGUVs 
 
The ultimate aim of this thesis is to assemble motility functional modules in a cell-like 
architecture. In this regard, actin networks as well as adhesion-associated modules were 
implemented within dsGUVs. The methods how to encapsulate these functional modules 
within dsGUVs, will be explained in the following.  
 
4.7.1. Actin Polymerization within dsGUVs 
 
Two methods were tested to polymerize actin inside the dsGUVs, a pre-mixed approach and a 
picoinjection approach. For the pre-mixed approach, actin-containing dsGUVs were produced 
by means of a droplet production device with two aqueous inlets (Figure 34B). To avoid the 
actin monomers to polymerize prior to droplet formation one aqueous phase contained the 
polymerization buffer and the SUVs (2.2 mM) and the other aqueous phase 20 µM actin 
monomers (1% Alexa 568-labeled actin) in actin storage buffer. Due to the MgCl2 in the 
polymerization buffer the SUV (70% DOPC, 29,5% DOPG, 0,5% Atto 488 –DOPE) were 
dragged to the droplet’s interface. 
For the second approach, two experimental steps were performed. First the dsGUVs were 
produced as described in Section 4.5, containing actin polymerization buffer and an excess 
amount of SUV (1.3 mM, 70% DOPC, 29,5% DOPG, 0,5% Atto 488 –DOPE) to allow for 
maintenance of a continuous lipid bilayer after picoinjection. Following their production, 
dsGUVs were introduced into the picoinjection device (Figure 34D) and, subsequently, actin 
monomers (10 μM final concentration, 1% Alexa 568-labeled actin) in storage buffer was 
injected into these droplets. 
 
4.7.2. Actin Linkage to dsGUV via Biotin-Streptavidin 
 
In order to link actin to the lipid bilayer of the dsGUVs 20% of biotinylated lipids (Avanti Polar 
Lipids, Inc.) were used to generate SUV (59.5% DOPC, 20% DOPG, 20% biotinylated DOPE, 
0.5% Atto488-DOPE). 1.3 mM of these SUVs plus 50 µM streptavidin were dissolved in the 
actin polymerization buffer and encapsulated into water-in-oil droplets. The dsGUVs were 
further introduced into a picoinjection device (Figure 34D) and actin monomers containing 1% 
biotinylated actin and 1% Alexa Fluor 568 labeled actin was injected into the dsGUVs. As an oil 
phase FC-40 containing 5 mM custom-made triblock surfactant was used.
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4.7.3. Integrin Reconstitution into dsGUVs 
 
The reconstitution of αIIbβ3 integrin into the liposomes was based on a previously published 
protocol255 (see also Figure 17). In brief, 435 µM eggPC and 435 µM eggPG was dried under a 
gentle stream of nitrogen and then placed in a desiccator under vacuum for 2 h or overnight. 
Next, the dried lipids and Alexa Fluor 568-labeled αIIbβ3 integrin (see Section 3.4.3) were 
dissolved in 1 ml of integrin buffer B (see Section 3.5.) to a final ratio of 1:1,000 integrin : 
lipid. Then the solution was incubated on a Thermomixer (Eppendorf, Germany) for 2h at 
37 °C and 600 rpm shaking. Afterwards, 50 mg/ml BT Bio-Beads SM-2 (BIO-RAD, 
Germany) was added into the micro tube and was stirred on a magnetic stirrer for 3.5 h. This 
step was repeated once in order to remove the Triton X-100 completely. The proteoliposome 
solution was used immediately for dsGUV formation or stored up to 48 h at 4°C.  
In order to create integrin-reconstituted dsGUV, the integrin proteoliposomes were mixed 
1:10 with SUVs (27.25% DOPC, 27.25% POPC, 30% DOPG, 15% cholesterol and 0.5% Atto 
488 DOPE) to a final lipid concentration of 1.1 mM in integrin buffer A and 10 mM MgCl2. 
This liposome mixture was used as an aqueous phase for dsGUV formation. Reconstitution 
of integrins within the dsGUVs was controlled by monitoring fluorescence colocalization of 
the Atto 488 labeled lipids and the Alexa Fluor 568 labeled αIIbβ3 integrin proteins with a 
confocal fluorescence microscope.  
 
4.7.4. Incorporation of Actin into Integrin-Reconstituted dsGUVs 
 
In order to incorporate both, αIIbβ3 integrin proteins and actin networks, into dsGUVs a two-
step or a premix approach was used. For the two-step approach, the integrin-dsGUVs were 
created comprising the integrin buffer A (see Section 3.5.) and additionally 15 mM MgCl2. In a 
second step actin monomers were picoinjected (Figure 34D) into these dsGUVs (final 
concentration 10 µM actin, Phalloidin Alexa fluor 647 labeled).  
For the premix approach, actin-containing integrin-dsGUVs were produced by means of a 
droplet production device with two aqueous inlets (Figure 34B). 1st aqueous phase contained 
the integrin buffer A and 30 mM MgCl2, the proteoliposomes and the SUVs (in total 2.2 mM 
lipids). The 2nd aqueous phase contained 20 µM actin monomers (Phalloidin Alexa fluor 647 
labeled) in integrin buffer A. After droplet formation at the flow-focusing junction the two 
aqueous phases were mixed and the assembly of the actin network as well as the dsGUV 
formation was controlled by means of confocal fluorescence microscopy. 
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4.8. Protein Binding Studies 
Protein binding studies have been performed in bulk based on QCM-D analysis as well as 
pull-down assays in order to identify a linker between αIIbβ3 integrin and actin networks. 
 
4.8.1. QCM-D Analysis 
 
The quartz crystal microbalance (QCM) is a sensitive label-free technique based on an 
oscillating piezoelectric, crystal quartz plate.256 Upon adsorption of mass on the crystal, the 
frequency of the oscillating crystal is changed and can thus be monitored (Figure 41). A QCM 
with dissipation monitoring (QCM-D) allows further for measuring the energy loss or 
dissipation of the system, thus the viscoelastic properties of the adsorption layer.257  
 
 
Figure 41: Schematic representation of the QCM-D setup. A QCM-D sensor coated with 2 
Au electrodes that apply an alternating current and lead to an oscillation of the piezo 
element. Upon adhesion of molecules on the sensor the frequency of the oscillating crystal 
is decreased related to the mass adsorbed on the surface. The energy dissipation is related 
to the viscoelastic properties of the adsorbed mass.  
 
QCM-D is used here for evaluation of protein-protein interactions, namely to identify a 
potential protein linker between αIIbβ3 integrin and actin networks. In this regard, SiO2 coated 
sensor crystals (QSX 303, Q-Sense AB, Sweden) were first cleaned by detergent treatment (2% 
Hellmanex solution, Hellma, Germany) and oxygen plasma (150 W with 0.4 mbar, 45 min, 
Gigabatch, PVA TePla Ag., Germany) and then mounted in the flow module of a QCM-D (Q 
Sense Analyzer, Biolin Scientific). Then a constant flow of 25 µl/min through a peristaltic pump 
(Ismatec IPC, IDEX, Germany) with the according buffer was applied and the air-buffer 
exchange was recorded until the frequency and dissipation signal reached a stable value again. 
After this equilibration step, both signals were set to 0 and the data collection window was 
renewed. Six harmonics (15 – 65MHz) were measured simultaneously, however, for reasons of 
simplicity in the results only the 7th overtone (35 MHz) is shown. Next, the crystals were either 
coated with the extracellular matrix protein, fibrinogen (purified from human plasma, 
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Calbiochem, USA), by applying integrin buffer A with 50 µg/ml fibrinogen or a supported lipid 
bilayer (SLB) was assembled on the crystals. For the SLB assembly SUVs were created (see 
Section 4.5) (eggPC lipids and 5% NTA-Ni2+ linked DOPE) and applied in integrin buffer A 
into the QCM-D flow chamber. The NTA-Ni2+ functional groups were used to immobilize His-
tagged focal adhesion kinase (FAK) proteins. On fibrinogen-coated sensors, αIIbβ3 integrin was 
applied to bind to fibrinogen, exposing thereby their intracellular tail to further binding 
partners. Table 7 contains a summary of the experimental steps performed in the QCM-D 
experiments. 
 
Table 7: Experimental steps of buffers and proteins, introduced in the QCM-D. 
Experiment I Integrin-FAK 
Equilibration Integrin buffer A  30 min 
 fibrinogen 50 µg/ml in Buffer A 60 min 
Washing step activation buffer   30 min 
 Integrin 50 µg/m in activation buffer  45 min 
Washing step activation buffer  20 min 
 FAK 50 µg/ml in activation buffer 45 min 
Washing step activation buffer  90 min 
    
Experiment II SLB-FAK-Integrin 
Equilibration Integrin buffer A  30 min 
 liposomes 0.5 mM, eggPC plus 5% NTA-Ni2+ linked DOPE in 
FAK buffer 
30 min 
Washing step FAK buffer   30 min 
 FAK 50 µg/ml in FAK buffer 15 min 
Washing step activation buffer  60 min 
Washing step activation buffer  40 min 
 Integrin 50 µg/ml 45 min 
Washing step activation buffer  30 min 
    
Experiment III Integrin - Talin 
Equilibration Integrin buffer A  30 min 
 fibrinogen 50 µg/ml in Buffer A 20 min 
Washing step activation buffer   20 min 
 Integrin 50 µg/m in activation buffer  45 min 
Washing step activation buffer  20 min 
 FL talin 50 µg/ml in activation buffer 90 min 
    
Experiment IV Integrin - THD 
Equilibration Integrin buffer A  30 min 
 fibrinogen 50 µg/ml in Buffer A 20 min 
Washing step activation buffer   20 min 
 Integrin 50 µg/m in activation buffer  45 min 
Washing step activation buffer  20 min 
Washing step Talin buffer  15 min 
 THD 20 µg/ml in talin buffer 60 min 
Washing step Talin buffer  15 min 
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Between the introductions of different proteins, washing steps with buffer were performed. For 
further details of the buffer components see Section 3.5. 
 
The mass m of the adsorbed protein layers on the crystal was estimated according to the 
Sauerbrey relation by means of the software QTools (Q-Sense, Sweden) which is 
 Δ𝑚 =	−(𝐶 ∙ Δ𝑓C𝑛 ) 
 
with C = mass sensibility (for a 5 MHz quartz crystal) = 17.7 ng*Hz-1*cm-2, ∆f the frequency 
change and n = 1, 3, 5, 7 is the overtone number. 
 
4.8.2. Bead Pull-Down Assay  
 
A pull-down assay was implemented as an additional method to assess the integrin-THD 
interactions. The first step in the pull-down assay was to immobilize the intracellular fragment 
of the b3 integrin (a kind gift from Prof. Geiger, Weizmann institute Israel) on beads to allow 
for separation of unbound material through centrifugation.  
 
 
Figure 42: Schematic representation of a NTA-Ni2 + bead incubated either with (a) His-
Ubiquitin and THD, (b) His-b3  integrin, His-Ubiquitin and THD or (c) His-b3  integrin and 
His-Ubiquitin. 
 
In this regard, 50 µl of NTA-Ni2+ resins (HisPur™Thermo Fisher Scientific) was incubated with 
the His-tagged b3 fragment (100 µg/ml) at RT for 45 min in TBS plus 3 mM NiCl2. Then the 
beads were separated by centrifuging for 10 min at 1,000 g (Eppendorf table top centrifuge). 
The supernatant was discarded and the pellet washed twice with TBS plus 3 mM NiCl2 (see 
Section 3.5.). Following this step, free NTA-Ni2+ binding sites were blocked with His-Ubiquitin 
(100 µg/ml, a kind gift from Prof. Geiger, Weizmann Institute, Israel) in TBS plus 3 mM NiCl2 
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and 0.5 mg/ml BSA for 1 h at RT. After centrifuging and washing the pellet twice with TBS, the 
THD was added to the beads and left for binding overnight at 4°C. Following the incubation, 
the pellet was washed twice with TBS. Then the bound protein was eluted from the beads by 
means of 50 µl TBS plus 300 mM immidazol (Figure 42b). Control samples consisted of beads 
that were not incubated with b3 fragment or with the THD, respectively (Figure 42, a and c). 
Finally, the samples were prepared for SDS-PAGE. 
 
4.8.3. Actin Filament-based Pull-Down Assay 
 
In pull-down assays involving actin filaments no beads are necessary as the actin binding 
proteins will co-sediment with actin filaments during centrifugation and will be separated from 
the unbound material. In this regard, actin was polymerized (10 µM) as described in Section 
4.6.1.1. The actin filament solution (100 µl each) was incubated with THD, α-actinin, or BSA 
(final concentration 2 µM) as shown in Figure 43. To test the combined integrin-THD-actin 
binding all three proteins were mixed accordingly. After incubation over night at 4°C, the 
samples were centrifuged at 150 000 g for 1.5 h at 4 °C (Tabletop ultracentrifuge (Beckman) 
with TLA-100 rotor).  
The supernatant was removed and the pellet dissolved in 50 µl of actin polymerization buffer. 
Both, supernatant and pellet, were then prepared for SDS PAGE, followed by Western Blot 
analysis (see Section 4.8.4). 
 
 
Figure 43: Sketch of procedure for actin pull-down assay. Actin filaments were incubated 
with a) BSA, b) α-actinin, c) THD, or d) THD and integrin together. After centrifuging / 
“pull-down” the presence of the according binding proteins in the supernatant or the pellet 
was analyzed. 
 
4.8.4. SDS PAGE and Western Blot 
 
To prepare samples for SDS PAGE, 3 µl of 6x loading buffer was pipetted to 15 µl of the samples, 
followed by incubating them for 5 min at 95 °C and then allowed to cool on ice. A SDS gel 
containing 8% polyacrylamid was mounted in the electrophoresis apparatus followed by the 
addition of the Tris-glycine electrophoresis running buffer (see Section 3.5.). Then the gel was 
loaded with 12 µl of the samples and a protein marker (MagicMark™ XP Western Protein 
Standard, Thermo Fisher Scientific, Germany). Next, the electrophoresis apparatus was 
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attached to an electric power supply (Bio-rad, USA) and a voltage of 200 V was applied for 45- 
60 min. Afterwards the gel was removed from the cassette and incubated in the Western blot 
transfer buffer for 10 min to remove the SDS or stained with Coomassie dye (Simply Blue, 
Thermo Fisher). 
In the meantime, the Western blot membranes (Whatman Optitran nitrocellulose membranes, 
Sigma Aldrich) and filter papers were cut to the dimensions of the gel followed by the soaking 
of the membrane, filter paper and fiber pads in the transfer buffer. To prepare the gel sandwich, 
the Western blot cassette was prepared as shown in Figure 44, then closed and mounted into 
the reservoir equipped with an ice pad and filled with the blotting buffer. An electric power 
supply was attached and the transfer of the proteins from the gel into the membrane was 
performed for 1 h at 100 V. After the transfer the membrane was removed blocked with TBS 
containing 1 mg/ml BSA for 1 h with shaking and washed subsequently with TBS containing 
0.1% Tween20 three times for 10 min each. The membrane was incubated in TBS containing 1 
mg/ml BSA for 1 h plus either an anti-His antibody (1:500, H1029 IgG mouse, Sigma Aldrich 
Germany) for β3 integrin tail detection, or an anti-THD antibody (1:500, mouse, TL1 MAB1676, 
Millipore, Germany). Accordingly, for actin detection in the experiment of Section 4.8.3 an 
anti-actin antibody was used (A4700, IgG mouse, Sigma Aldrich Germany). Afterwards, 
membranes were washed three times with TBS containing 0.1% Tween20, 10 min each time. A 
horseradish peroxidase (HRP)-conjugated anti-IgG mouse antibody (1:500, goat, AB6789 
Abcam, Germany) was added onto the membranes as secondary antibody for 1h at RT, followed 
by three washing steps with TBS with 0.1% Tween20, 10 min each time. Finally, the detection 
of the bands was performed by means of a chemiluminescent substrate for HRP (Pierce™ ECL 
Western Blotting Substrate, Thermo Fisher Scientific) in a luminescent image analyzer (LAS-
3000 Imager, Fuji, Japan). 
 
 
Figure 44: Assembly of the cassette containing the SDS gel and the Western Blot membrane 
for Western Blot Transfer.  
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5. Results and Discussion 
 
After explaining the materials and methods, I will now present the results of my thesis. In this 
regard, I structured the section in three parts. In the first part I will show within the water-in-
oil droplets the formation of lipid membrane-enclosed compartment systems – including 
intracellular structures – towards mimicking a eukaryotic architecture. I will further elucidate 
the mechanism behind the on-demand creation of these lipid structures and further I will show 
the release of the assembled lipid compartment systems out of the oil phase into a physiological 
environment.  
In the second Part – towards mimicking eukaryotic cell motility – I will present the 
reconstitution of the functional module of actin-based dynamic networks. Thereby I will 
explain the mechanisms behind elongation and contraction of the cell body during locomotion.  
In the third and last part I will show the reconstitution of transmembrane adhesion proteins 
within lipid compartment systems. Adhesion is – certainly not limited to – one of the crucial 
steps in cellular motility and another important functional module in the here presented 
synthetic cell approach towards mimicking eukaryotic cell motility.   
Furthermore, I will present protein binding studies that revealed a single protein 
fragment as a potential linker between integrin and actin. Thus, this linker may resemble the 
regulatory and mechanical connection between transmembrane adhesion proteins and actin 
cytoskeleton, which in a living cell is provided by recruiting several proteins to the adhesion 
site. 
Finally, I want to combine my results by creating a lipid-based compartment system with 
reconstituted transmembrane adhesion proteins and actin cytoskeleton. This combination of 
adhesion-based and cytoskeletal functional modules has never been shown in synthetic cell 
systems before and thus, provide major progress towards creation of cell-mimetic motility. 
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 Part I 
 
5.1. Water-in-Oil Droplets for Lipid-based Compartment 
Systems 
 
The most fundamental module for the establishment of a synthetic cell system, is a cell-sized 
compartment, where biochemical reactions can take place in a defined space. Water-in-oil 
emulsion droplets stabilized by fluorosurfactants were chosen here as stable outer containers 
for the stepwise reconstruction of cellular modules. These water-in-oil droplets are created by 
a droplet-based microfluidic technology. This technology offers versatile strategies to 
manipulate the encapsulated content, either through sequential injection of building blocks or 
through the functional surfactants in an oil phase. Following the assembly of the surfactants at 
the water-oil interface, the surfactants deliver different functionalities to the encapsulated 
content, and by this, inhibit or trigger interaction between the surfactant shell and the 
encapsulated biomolecules, e.g. as presented in the following, the interaction with lipid vesicles. 
This results in the masking of the surfactants with a lipid bilayer, the formation of the so-called 
droplet-stabilized GUVs (dsGUVs), or multicompartment systems, where the lipid vesicles do 
not interact with the periphery and stay homogeneously distributed within the aqueous phase. 
To prevent or trigger lipid interactions with the periphery in this thesis, three different types of 
surfactants were used. An inert PEG-based, a negatively charged (Krytox) and a positively 
charged amine fluorosurfactant. In the following sections, the analysis and the role of the 
polymer-based surfactants in the assembly of lipid-based compartment systems will be 
described.  
Note that some results of this part have been published. Thus, some figures and parts of the text 
in the following sections were adapted with permission from Haller et al., 2018.86 
 
5.1.1. Surfactant Analysis  
 
In this part of the thesis I mainly used the commercial PEG-based surfactant from 
RANbiotechnology, USA. However, as the company do not provide much information about 
the chemical structure and its purity – which is crucial for the synthetic cell approach – I first 
want to start this section with the qualitative and quantitative analysis of this surfactant based 
on FTIR, MALDI-TOF, partitioning experiments and interfacial tension measurements (IFT). 
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5.1.1.1. Fourier-Transform Infrared Spectroscopy (FTIR) 
 
In order to investigate the chemical structure of the commercial PEG-based surfactant, a FTIR 
spectrum were obtained from the PEG-based fluorosurfactant by Dr. Jan-Willi Janiesch. The 
spectrum (Figure 45) showed a typical fingerprint of a PFPE-PEG block-copolymer which was 
characterized already elsewhere.241 
To control the purity of the block-copolymer, the surfactant was checked especially for the 
presence of its educt Krytox, since the negatively charged Krytox can interfere with 
encapsulated bio-content. The interaction of encapsulated content with the surfactant shell is 
only in specific applications required. Thus, the band at 1777 cm-1, which is attributed to a 
stretching mode of the (C=O) bond of the Krytox27 was examined with special care. In this 
regard, a tiny band at 1777 cm-1 could be observed revealing the presence of Krytox traces within 
the surfactant. 
  
 
Figure 45: FTIR spectrum of perflouro-polyether-polyethylene glycol (PFPE-PEG) block-
copolymer fluorosurfactants (commercial PEG-based fluorosurfactant). Absorption peaks 
at 3449 cm- 1  and 3311 cm- 1correspond to the symmetrical and unsymmetrical stretching 
vibration of primary amines. The band at 1720 cm- 1  is attributed to a stretching mode of 
the (C=O) band of the amid group, which connects the PEG-diamine with the Krytox.2 4 1  A 
tiny band is visible at 1777 cm- 1  representing the stretching mode of the (C=O) band of the 
carboxylic acid group of the Krytox educt. Reprinted from with permission from Haller et 
al . ,  2018.8 6   
 
5.1.1.2. MALDI-TOF 
 
A further characterization of the commercial PEG-based fluorosurfactant was performed by 
Martin Schröter by means of MS measurements to reveal information regarding the purity and 
molecular weight of the chemical components. In Figure 46B the region around 2000 m/z is 
increased showing a series of peaks with the mass difference of 166 (region 1, shown in blue in 
Figure 46A). This mass difference correlates exactly to the molecular weight of PFPE 
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monomers. Thus, the presence of Krytox molecules with a molecular weight of around 2000 Da 
could be confirmed. In m/z regions II and III (Figure 46C and D) a series of peaks with the mass 
difference of a PEG- (44 Da) plus PFPE- (166 Da) monomers was observed, referring to a 
brought size range of PFPE-PEG block-copolymers between 3500 Da and 6500 Da. Based on 
the Krytox pattern in region I of around 2000 Da, it can be assumed that the fluorosurfactant 
consists of a mixture of diblock- and triblock-copolymer, with an average molecular weight of 
around 4000 Da and 6000 Da, respectively. This means that depending on the ratio between di- 
and triblock-polymer, a 1.4 wt% solution of the surfactant in HFE-7500 (ρ = 1.61 g/ml) has a 
molar concentration between 3.8 mM (100% triblock-polymer) and 5.7 mM (100% diblock-
polymer). Note, in the calculation of surfactant concentration, the amount of Krytox was 
ignored. 
 
 
Figure 46: MS (MALDI-TOF) measurement of PEG-based fluorosurfactant. (A) Complete 
spectrum in m/z range of 1500 to 8000. (B) Spectrum of region I with a mass pattern of 
PFPE polymer (OCF(CF3)CF2, ∆m = 166) referring to Krytox molecules of around 2000 
Da. (C) Spectrum of region II showing the MW of diblock-polymers with mass differences 
of PFPE/PEG monomers (OCF(CF3)CF2, ∆m = 166 + OCH2CH2, ∆m = 44). D: Spectrum 
of region III showing the MW of triblock-polymers with mass differences of PFPE/PEG 
monomers. Reprinted from with permission from Haller et al . ,  2018.8 6   
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5.1.1.3. Partitioning Experiment 
 
As no quantitative statement can be made about the Krytox concentration by means of FTIR or 
MALDI-TOF measurements, partitioning experiments were performed. Towards this end, a 
Rhodamine 6G (Rho6G) solution was transferred onto HFE-7500 oil that contained Krytox 
concentrations between 0 and 1 mM and 1.4 wt% or no PEG-based fluorosurfactant. Due to the 
1:1 chemical interaction between the Krytox molecules and Rho6G250, and the adsorption and 
desorption of Krytox molecules at the interface, a partitioning of Rho6G molecules to the oil 
phase was observed (Figure 47A). Following 48 h of incubation, Rho6G content in the oil and 
the aqueous phases was determined by measuring the absorbance at 500 nm (Figure 47B). The 
values of samples containing 1.4 wt% PEG-based fluorosurfactant were compared to the values 
of samples on which Krytox was dissolved in pure HFE-7500 oil. Based on this analysis a 
concentration of approximately 0.04 mM free Krytox in 1.4 wt% PEG-based fluorosurfactants 
was interpolated. This concentration is order of magnitudes lower (around 1%) than the 3.8 – 
5.7 mM of the PEG-based fluorosurfactants, which was estimated to correspond to 1.4 wt% by 
MS.  
 
 
Figure 47: Representative image of the partitioning experiments (standard curves) and its 
analysis. (A) Aqueous solutions of 1 mM Rho6G (upper phase) are exposed to the HFE-
7500 oil phase containing Krytox at different concentrations (indicated at the bottom of 
the images) in a 3.5 ml cuvette. (B) Spectrometric analysis (absorbance at 500nm) of Rho6G 
in aqueous (blue) and oil phases (yellow) after 48 h incubation. The Y-axis intercept of the 
samples containing 1.4 wt% PEG-based fluorosurfactants corresponds to Krytox traces in 
the PEG-based fluorosurfactant (in 1.4 wt% ~0.04 mM). Reprinted from with permission 
from Haller et al . ,  2018.8 6   
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Note that partitioning experiments of the custom-made triblock and amine surfactant were 
performed as well, revealing partly much higher amounts of free Krytox (see Appendix, Figure 
SI 1). 
In the synthetic cell approaches as developed in this research, the purity of the PEG-based 
surfactant is of major importance. Krytox is a negatively charged surfactant and therefore 
actively assembles at the droplets interface. The charge at the inner droplets interface is not per 
se desired, but might be advantageous in several applications as the formation of dsGUVs (see 
following sections) or, later, for the recruitment of actin filaments to the droplets periphery. 
Therefore, control over the charge at the droplets interface is of particular importance and, 
therefore should be controlled and tuned on-demand.  
The here implemented approach in this concern, is to create mixtures of the inert PEG-based 
surfactant with Krytox or the positively charged amine surfactant. To characterize the 
interfacial activity of the surfactant mixtures pendant drop measurements have been performed 
that will be discussed in the following. 
 
 
5.1.1.4. Interfacial Tension (IFT) Measurements of Surfactant Mixtures  
 
Pendant drop measurements were performed to evaluate the assembly of surfactant mixtures 
at the oil-water interface and their influence on surface tension. In this regard, IFT of HFE-7500 
oil (Figure 48 green) containing PEG-based fluorosurfactant with different amounts of Krytox 
(Figure 48 red) or amine surfactant (Figure 48 blue) was measured against water without 
(Figure 48A) or with (Figure 48B) 1 mM MgCl2. In pure water HFE-7500 oil had an IFT of 
around 38 mN/m, which decreased to around 4 mN/m upon the addition of 1.4 wt% PEG-based 
fluorosurfactant. This indicates the assembly of the PEG-based surfactant with a high interfacial 
coverage.193  
In contrast to that, by the addition of Krytox to the HFE-7500 oil the IFT decreased only until 
a value of around 20 mN/m. A denser packing of Krytox molecules at the interface is prevented 
due to the repulsion forces of the charged head group of Krytox.196 Similarly, when Krytox was 
mixed to the 1.4 wt% PEG-based fluorosurfactant the IFT increased until reaching a similar 
plateau value of around 20 mN/m. Thus, it seemed that the 1.4 wt% (according to 3.8 – 5.7 mM, 
see previous Section 5.1.1.2) PEG-based surfactant did not have a significant effect on IFT when 
mixed with Krytox concentrations greater than 6 mM. 
By the addition of amine surfactant to the 1.4 wt% PEG-based fluorosurfactant the IFT values 
did not increase, but slightly decrease. This shows that there is probably an increase in 
interfacial surfactant coverage due to the higher concentration of surfactants in the bulk (see 
Section 1.4.3 for theoretical details) and due to a possible denser packing of diblock surfactants 
in comparison to triblock surfactants.258 Further, this indicates that probably the lateral 
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repulsive charge effect of the amine group between the surfactant molecules is annulled by the 
PEG-PEG interaction. 
 
 
 
Figure 48: Interfacial tension measurements based on pendant drop analysis. Drop phase: 
HFE-7500 oil with and without (green) 1.4 wt% PEG-based surfactant and different 
amounts of x=Krytox (red) or x=amine surfactant (blue) against an ambient phase of pure 
water (A) or water containing 1 mM MgCl2 (B).  
 
The addition of MgCl2 into the aqueous phase (Figure 48B) leads to a change in IFT values. This 
is due to the fact that Mg2+ can screen the negative charge of Krytox196 and thus, leads to a denser 
packing at the interface. Interstingly, the mixture of PEG-based surfactant with increasing 
amounts of Krytox (red) showed a non-linear behavior. When 3 to 6 mM Krytox was added the 
IFT increased, however, with increasing amounts of Krytox the IFT dropped again to values of 
around 1 mN/m. The peak is indicating a less dense packing of surfactant molecules at the oil-
water interface in these Krytox-to-PEG surfactant ratios. This is, however, probably not due to 
electrostatic repulsion but rather due to a steric hindrance or due to interactions of the PEG-
based surfactant and Krytox, which can lead to a micellar exclusion of surfactant molecules.182,186  
For exact IFT values of the surfactant mixtures see Appendix, Table SI 1. 
Different IFT values due to different PEG-based fluorosurfactant to charged surfactant ratios 
revealed a very important outcome – one can tune the charge at the droplet interface in a 
controlled manner. This ability is of particular importance in the assembly of the single 
compartments (dsGUVs) that will be presented in Section 5.1.3. 
 
In this regard, I will now, after the analysis of the surfactant, present the formation of the lipid-
based compartment systems.  
The use of differently charged or uncharged surfactants and differently charged membrane-
lipids allow for the creation of two forms of lipid-based compartment system and a combination 
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of both. In the following, I will first describe the microfluidic creation of so-called 
multicompartment system, followed by their transformation to single compartment systems 
and, finally, I will discuss the release of these systems out of the oil and surfactant environment 
into a physiologically relevant buffer. 
 
 
 
5.1.2. Creation of Multicompartment Systems in Water-in-Oil droplets 
 
To generate lipid-based compartment systems, small unilamellar vesicles (SUVs) were 
produced and encapsulated into water-in-oil droplets stabilized by different surfactant 
combinations as described in Section 4.5.1.  
Besides the existence of a large outer compartment, an eukaryotic cell, in particular, is 
characterized by segregated internal reaction volumes that enable spatial and temporal 
assembly of biological processes.11,259 A way to mimic the crowded environment inside a living 
cell, in which membrane-enclosed compartments make up nearly half of the cell volume,11 is 
the development of a multicompartment system that is based on small lipid vesicles 
encapsulated within the microfluidic polymer-stabilized water-in-oil droplet.  
Formation of multicompartment systems requires strategies to inhibit the interaction between 
the inner shell of the surrounding compartment and the encapsulated SUVs, so that the latter 
remain randomly distributed within the compartment volume. To obtain this, I set out to create 
droplets with an inert inner surface and encapsulated SUVs within their lumen. Towards this 
end, fluorescently labeled neutral, negatively and positively charged SUVs were encapsulated 
into water-in-oil droplets stabilized by pure uncharged PEG-based fluorosurfactants using a 
microfluidic droplet production device (see Section4.5.1).  
Figure 49 A and B show a homogeneous distribution of the differently charged SUVs (DOPG 
are the negatively charged, DOTAP the positively charged, and DOPC/POPC the neutral 
phospholipids) and the combination of them (B) within the droplets, respectively. In none of 
the cases a bright ring at the periphery of the droplet was visible indicating that the inert and 
uncharged PEG on the inner droplet interface206 inhibited the interaction between the SUVs 
and the droplet periphery. Note, similar results were obtained independently on the presence 
of ions or lipid charge. 
The hereby created multicompartment system provides a confined space to observe and analyze 
SUV-based functional modules. The encapsulated small vesicular compartments resemble well 
the organelle structure in real cells. In this concern, an even more physiologically relevant cell-
like architecture was achieved through an advancement of this multicompartment system 
approach, which will be described in Section 5.1.3.5. 
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Figure 49: Representative images of homogeneously distributed fluorescence from 
encapsulates SUVs. A) SUVs comprised of DOPC 42.25 or 27.25% (neutral), POPC 42.25 
or 27.25% (neutral), ATTO 488-labeled DOPE 0.5%, cholesterol 15%, DOPG 0% or 30% 
(negatively charged), and DOTAP 0% or 30% (positively charged) within the droplets 
generated in the oil phase containing PEG-based fluorosurfactants (1.4 wt%). No 
interaction of SUVs with the surfactant shell is visible independent on the presence of Mg2 + 
ions. Scale bar 50  μm. B) Two kinds of SUVs were encapsulated (30% DOPG labeled with 
Atto 488 and 30% DOTAP labeled with Rhodamine). Scale bar 250  μm.  
 
For future synthetic biology applications, encapsulated SUVs could be equipped with special 
features as functional membrane proteins or pH or temperature sensitive lipids. The latter 
would allow to trigger the release of the SUV content by e.g. pH260 or temperature.136 This offers 
the possibility to carry out a stepwise reaction mediated by the successive release of substrate or 
reaction partners and thus, allows for a multitude of sophisticated processes as energy 
production and transfer as well as material transport. 
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5.1.3. Creation of Droplet-Stabilized GUVs (dsGUVs) 
 
Water-in-oil droplets as cell-sized compartments that exhibit stable physical properties 
however lack physiological membrane properties, as it is the case in lipid-based vesicles. To 
combine the advantages of the mechanically stable water-in-oil droplets with physiological lipid 
membrane properties Weiss et al.16 established recently the concept of so-called droplet-
stabilized GUVs (dsGUVs), which consist of a spherical lipid bilayer covering the surfactant 
shell. Supported lipid bilayer (SLB) formation in 2D has been studied already intensively in the 
past showing the influence of e.g. vesicle charge, buffer type and surface charge on vesicle 
fusion.100,261,262 
In order to create dsGUVs, electrostatic interactions between surfactant shell and encapsulated 
SUVs have to be generated. This interaction can be tuned by means of lipid charge, the presence 
of salts or by the addition of charged surfactants as Krytox or amine surfactant to inert PEG-
based fluorosurfactant-containing HFE-7500 oil. Through the electrostatic attraction force 
between the encapsulated SUVs and the periphery, SUVs fused to a 3D-supported lipid bilayer 
at the periphery of the droplet, resulting in the transition from a multicompartment system to 
one large single compartment system, a dsGUV. This effect in correlation with surfactant and 
lipid charge and the presence of salt is discussed in the following sections in detail. 
 
5.1.3.1. The Effect of Negative Interface Charge on Lipid-based 
Compartment Systems 
 
Time-lapse fluorescence confocal microscopy was performed to assess the effect of the 
negatively charged Krytox surfactant on the formation of dsGUVs (Figure 50A). For this 
purpose, SUV-containing droplets stabilized by inert PEG-based fluorosurfactants were 
trapped in a microfluidic trapping device (see Section 4.3.3) by applying a constant oil flow (200 
µl/h of HFE-7500 oil containing 1.4 wt% of PEG-based fluorosurfactants). The multi-
compartment systems, characterized by a homogeneous distribution of SUVs within the 
droplets, were observed under these conditions (Figure 50A). To transition from 
multicompartment system to dsGUV, 9 mM Krytox was added to the flow of PEG-based 
fluorosurfactant-containing oil. Upon Krytox addition, all SUVs within the droplets were 
attracted to the periphery within 1 min, thereby triggering the charge-driven fusion of SUVs to 
the surfactant shell. With the addition of Krytox to the oil, a sufficient proportion of Krytox 
molecules assembles at the interface to provide the necessary charge for dsGUV formation. The 
negatively charged inner droplet interface attracts Mg2+ ions from the SUV-containing buffer, 
which in turn, promotes SUV (lipid composition of 42.25% DOPC, 42.25% POPC, 15% 
cholesterol and 0.5% ATTO 488-labeled DOPE) adhesion and eventually rupture. For clarity of 
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presentation Figure 50B and C describe schematically the process of dsGUV formation. The 
accumulation of lipids at the droplet periphery was detected by means of confocal fluorescence 
microscopy as a bright ring in the confocal plane.  
Note that by fluorescence microscopy imaging only the recruitment of the lipids to the 
periphery could be assed, however, it could not be judged if vesicles fused to a bilayer. Thus, 
bilayer formation within the droplets will be confirmed in Section 5.1.3.2. by means of cryoSEM 
and FRAP. 
 
 
Figure 50: Controlled formation of multicompartment systems or dsGUVs depending on the 
surfactant charge at the interface. A) Time-lapse analysis of dsGUV formation (DOPC 
42.25%, POPC 42.25%, cholesterol 15% and 0.5% ATTO 488-labeled DOPE) in a 
microfluidic trapping device. Time point 0 s: Droplets are trapped in PDMS cavities by 
applying a constant flow of HFE-7500 oil containing PEG-based fluorosurfactants (“FS”). 
After 55 s: Addition of HFE-7500 oil containing Krytox (9 mM). For clarity, the oil 
containing Krytox was labeled with 10 nM Nile red. After 110 s: Attraction of SUVs to the 
droplet periphery. After 165 s: The accumulation of lipids on the droplet periphery is visible 
as a bright ring in the confocal plane. This indicates successful dsGUV formation. Scale bar 
50 μm B) Sketch and corresponding representative confocal fluorescence image (lower inset) 
of SUVs (in 30 mM Tris, 10 mM Mg2 +) encapsulated in a water-in-oil droplet stabilized by 
inert PEG-based fluorosurfactants without Krytox. The confocal image shows the lipids of 
homogeneously distributed SUVs (DOPC 42.25%, POPC 42.25%, cholesterol 15% and 0.5% 
ATTO 488-labeled DOPE). C) Krytox addition (9 mM) to the surrounding oil leads to 
dsGUV formation. The corresponding, representative confocal image (lower inset) shows 
fluorescence from lipids (DOPC 42.25%, POPC 42.25%, cholesterol 15% and 0.5% ATTO 
488-labeled DOPE) visible at the periphery of the droplet. Reprinted from with permission 
from Haller et al . ,  2018.8 6   
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To provide a more detailed understanding of how the surfactant charge influences the 
transition from multicompartment system to dsGUV, 1.4 wt% PEG-based fluorosurfactant was 
mixed with various Krytox concentrations ranging from 0.15 to 15 mM (Figure 51). The 
produced SUV-containing droplets were examined for lipid bilayer formation and investigated 
for their stability. As presented in Figure 51, no interaction between the SUVs and the interface 
can be observed at a Krytox concentration of only 0.15 mM (category I), therefore leaving the 
multicompartment systems unaltered. Attraction of the lipids to the droplet periphery, 
observed by the bright ring in the confocal plane, occurred at Krytox concentrations higher 
than 0.75 mM. However, based on FRAP measurements and cryoSEM analysis (see following 
Section 5.1.3.2) dsGUV formation has been approved only for Krytox concentration higher 
than 7.5 mM (category IV), whereas the bright ring at the droplets periphery in Krytox 
concentrations of 0.75 and 1.5 mM were ascribed rather to multicompartment or SUV adhesion 
(category II). 
 
 
Figure 51: Effect of Krytox concentration on formation of dsGUVs. Representative confocal 
fluorescence images of lipid-containing microfluidic droplets at various Krytox 
concentrations from 0.15 mM to 15 mM. Green fluorescence from lipids (0.5% ATTO 488-
labeled DOPE) encapsulated in the microfluidic droplets. Different Krytox concentrations, 
indicated on top of the fluorescence images, were mixed with 1.4 wt% PEG-based 
fluorosurfactant in the oil phase (HFE-7500 oil). Tris buffer supplemented with 10 mM 
Mg2 + and 26.5 µM SUVs (DOPC 42.25%, POPC 42.25%, cholesterol 15% and 0.5% ATTO 
488-labeled DOPE) were used as an aqueous phase for droplet formation. Based on 
fluorescence images and diffusion coefficients measured by FRAP (following section), lipid-
containing droplets were classified into 4 categories: I) multicompartment systems, II) 
multicompartment adhesion, III) flocculation or fusion of the droplets and IV) to the 
formation of single compartments (dsGUVs). Note that the difference between 
compartment system II and IV can only be judged by FRAP or cryoSEM that will be 
described in the following section. Scale bar 50  μm. Reprinted from with permission from 
Haller et al . ,  2018.8 6   
 
It is worth noting that partial clustering of SUVs can be observed at low Krytox concentrations, 
which may be attributed to Mg2+-lipid interactions or Krytox domain formation at the droplet 
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interface. Additionaly, at Krytox concentrations ranging between 3 and 6 mM flocculation of 
the droplets can be observed, which results in droplet fusion after few days (see Appendix, 
Figure SI 2) (category III). This observation correlates well with the IFT measurements (see 
Section 5.1.1.4), in which IFT values were increasing in the same range of PEG-surfactant-to-
Krytox ratios. Flocculation is a process of destabilization of emulsion, e.g. due to low interfacial 
coverage.184 In this concern a micellar exclusion due to surfactant interactions can explain this 
phenonema.182,186 Interstingly, this ratio corresponds to a 1:1 ratio, considering the 
concentration of 3.8 – 5.7 mM for 1.4 wt% PEG-based surfactant, estimated by MS-analysis 
(Section 5.1.1.2).  
To assess possible buffer conditions, the Mg2+ ion concentration for dsGUVs formation was 
reduced (neutral lipids) (Figure 52A) or exchanged by increased concentrations of K+ ions 
(Figure 52B). A recruitment of lipids could be observed to the droplets periphery for Mg2+ ion 
concentration of 5mM and above, or in the presence of 50 and 100 mM KCl, however, no lipid 
accumulation at the droplet periphery was detected in lower Mg2+ concentration (2 mM) or in 
the absence of ions, independent of the Krytox concentration. 
 
 
Figure 52: Representative images of fluorescence from SUVs (DOPC 42.25, POPC 42.25%, 
ATTO 488-labeled DOPE 0.5%, cholesterol 15%). (A) SUVs are dissolved in 30 mM Tris, 
pH 7.4 plus 2 mM or 5 mM MgCl2 and droplets are stabilized by PEG-based 
fluorosurfactants (1.4 wt%) with 1.5 mM or 10.5 mM Krytox. Lipid interaction with the 
periphery could only be observed for neutral lipids in buffers containing 5 mM MgCl2. (B) 
SUVs are dissolved in 30 mM Tris, pH 7.4 plus 0, 50 mM or 100 mM KCl and droplets are 
stabilized by PEG-based fluorosurfactants (1.4 wt%) and 10.5 mM Krytox. Lipid 
interaction with the periphery could be observed in buffers containing 50 mM and 100 mM. 
Scale bar 50  μm. 
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5.1.3.2. Investigation of Lipid Bilayer Formation in dsGUVs 
 
Due to the nanoscale dimensions of the SUVs (68 nm in diameter according to DLS 
measurements (See Appendix, Figure SI 4), it is not possible to optically resolve whether a 
supported lipid bilayer has been formed (dsGUV, category IV in Figure 51) or whether SUVs 
are simply adhering to the surface (multicompartment adhesion, category II in Figure 51). 
Further in contrast to 2D, where the successful formation of a SLB can be checked by e.g. 
Atomic force microscopy (AFM) or monitored in real-time by means of QCM-D262 (see Section 
5.3.4.1 for assessment of 2D SLB formation by QCM-D) the methods for this 3D approach are 
rather limited. A possible method, however, to probe bilayer formation in 3D is via the lipid’s 
diffusion coefficient, measured by means of fluorescence recovery after photobleaching (FRAP) 
(Figure 53A). In this regard, the here performed FRAP measurements revealed (see Table SI 3 
in Appendix for exact values) that depending on the Krytox concentration, the measured 
diffusion coefficient values could be grouped into the two catgories: 1.1 ± 0.1 μm2/s for Krytox 
concentrations between 0.75 mM and 3 mM (category II, multicompartment adhesion, Figure 
53C), and 5 ± 0.4 μm2/s for Krytox concentrations greater than 3 mM (category IV, dsGUVs, 
Figure 53B). The lower diffusion coefficient is ascribed to SUVs that are in active interaction 
with the droplet periphery and therefore exhibit slower diffusion.263 The higher diffusion 
coefficient, on the other hand, correlates well with literature values for the diffusion of lipids 
within a fluid supported lipid bilayer in 2D.264 This indicates that the SUVs have ruptured and 
a 3D supported lipid bilayer has been successfully formed.  
 
 
Figure 53: FRAP measurements of lipid diffusion in microfluidic droplets. A) 
Representative fluorescence images during FRAP measurements. B) and C) show exemplary 
recovery traces that makes it possible to distinguish between (B) dsGUVs (D= 5 ± 0.4 μm2/s, 
n = 80)/category IV in previous section and (C) multicompartment adhesion (D= 1.1 ± 0.1 μm2/s, 
n = 40)/category II in previous section. Reprinted from with permission from Haller et al . ,  
2018.8 6   
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Additionally, SUV-containing droplets, stabilized by 1.4 wt% PEG-based surfactant and either 
0 mM, 3 mM or 10.5 mM Krytox were freeze-fractured and investigated by high-resolution 
cryo-SEM. As shown in Figure 54, a homogeneous distribution of SUVs, SUV adhesion and 
lipid bilayer formation at the periphery could be observed in presence of 0 mM, 3 mM or 10 
mM Krytox, respectively. This supports the results obtained with confocal imaging and FRAP. 
Note that the fibrous-like connections between the SUVs can be attributed to artifacts related 
to cryo-SEM sample preparation and the following fracturing. 
 
 
Figure 54: Representative cryo-SEM micrographs of freeze-fractured droplets. SUVs were 
encapsulated in droplets stabilized by 1.4 wt% PEG-based fluorosurfactant and 0 mM (A), 
3 mM (B) and 10.5 mM Krytox (C). Arrows are indicating the surfactant shell (1), SUVs 
(2, 3) and lipid bilayer (4). Reprinted from with permission from Haller et al . ,  2018.8 6   
 
In various 2D studies, the formation of supported lipid bilayers, were shown to be influenced 
by the charge of the lipids.262,265 Thus, in the following I will present the influence of lipid charge 
on dsGUV formation.   
 
5.1.3.3. The Effect of Negative Lipid Charge on Compartment 
Formation 
 
The charge density in lipid vesicles was controlled by the addition of negatively charged DOPG 
lipids (from 5% to 30%) to the neutral lipid composition used for SUV formation. Figure 55 
shows representative confocal fluorescence images of negatively charged SUVs (from 5% to 
30%) encapsulated within the droplets stabilized by 1.4 wt% PEG-based fluorosurfactants and 
Krytox at different concentrations (from 0.15 mM to 12 mM).  
As expected, a greater amount of Krytox (3 mM) was needed to attract negatively charged SUVs 
to the droplet interface than if neutral lipids were used (0.75 mM). This might be due to the fact 
that higher attraction forces are needed to overcome the repulsion of the negatively charged 
SUVs.265 Therefore, a higher density of Mg2+ ions was required on the inner droplet interface, 
which in turn corresponds to a higher Krytox concentration in the oil phase. 
Creation of Droplet-Stabilized GUVs (dsGUVs)        
 106 
 
 
Figure 55:  Phase diagram of representative confocal images showing the effect of lipid 
charge and Krytox concentration on the formation of a supported lipid bilayer onto the 
droplets shell.  To evaluate the influence of negatively charged DOPG lipids on dsGUV 
formation, Tris buffer containing both 10 mM Mg2 + and SUVs with different lipid 
compositions (cholesterol 15%, DOPG 5% – 30%, indicated on the left, DOPC x%, POPC 
x%, x=rest) was encapsulated in the droplets stabilized by surfactants which contained 1.4 
wt% PEG-based fluorosurfactants and various Krytox concentrations as indicated above 
the fluorescence images. Based on fluorescence images and diffusion coefficients measured 
by FRAP, lipid-containing droplets were classified into 4 categories: I) a multicompartment 
system II) multicompartment adhesion, III) flocculation or partial fusion of the droplets, 
or IV) the formation of a single compartment per droplet (dsGUV). Scale bar 50  μm. 
Reprinted from with permission from Haller et al . ,  2018.8 6   
 
FRAP measurements, performed on the lipids (30% DOPG) close to the droplet’s periphery, 
revealed diffusion coefficients of 1 ± 0.1 and 4.2 ± 0.3 μm2/s in the droplets stabilized by 
surfactants containing 1.5 and 10.5 mM Krytox, respectively (see Appendix, Table SI 3). These 
values refer to multicompartment adhesion and dsGUV, respectively. Just like in the case of the 
droplets containing neutral lipids, flocculation was observed at Krytox concentrations between 
3 to 7.5 mM. Additionally, droplet coalescence occurred when the encapsulated vesicles 
contained more than 15% DOPG lipids.  
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Emulsion instability due to certain Krytox- to- PFPE–PEG–PFPE surfactant mixtures was 
similarly reported in a study of Matochko and colleagues, where they induced the breakage of 
the emulsion and the release of the content via the addition of Krytox.266  
Further, partial leakage of lipids into the oil phase was observed at Krytox concentrations above 
12 mM (See appendix Figure SI 3). This is in accordance with a work from Gruner et al. where 
they showed that the extraction of an encapsulated fluorophore into the oil phase was based on 
the PFPE–PEG–PFPE surfactant-to-Krytox ratio that was used to stabilize microfluidic water-
in-oil droplets.250 Note that reduced lipid leakage was detected when the lipids contained more 
than 20% DOPG (See appendix Figure SI 5).  
 
For dsGUV formation with neutral and negatively charged SUVs, the presence of salt is 
required to screen the negative charge of Krytox by a cation layer. Thus, effectively, leading to 
positive charges on the surface and the an electrostatic attraction of the neutral – namely 
zwitterionic 261– and negatively charged SUVs.267 How positively charged SUVs behave in that 
system, will be described in the following. 
 
5.1.3.4. The Effect of Positive Lipid Charge on Compartment Formation 
 
A pronounced tendency towards SLB formation of positively charged lipids on negatively 
charged surfaces has been already shown in 2D.267,268 Thus, DOTAP lipids (30%) were mixed 
with the neutral lipids to obtain positively charged lipid vesicles. Figure 56 shows representative 
confocal fluorescence images of 30% positively charged SUVs encapsulated within the droplets 
stabilized by 1.4 wt% PEG-based fluorosurfactant and Krytox at different concentrations 
(between 1.5 mM and 12 mM). Interaction of the lipids with the droplets periphery could be 
observed for Krytox concentrations above 1.5 mM.  
 
 
Figure 56:  Representative confocal images showing the effect of Krytox concentration on 
positively charged SUVs (DOPC 27,25%, POPC 27,25%, cholesterol 15%, DOTAP 30%. 
Atto455 DOPE 0.5%), which were dissolved in Tris buffer and encapsulated in droplets 
stabilized by surfactants which contained 1.4 wt% PEG-based fluorosurfactants and 
various Krytox concentrations as indicated above the fluorescence images. Based on 
fluorescence images and diffusion coefficients measured by FRAP, lipid-containing droplets 
were categorized into II) multicompartment adhesion, III) flocculation or partial fusion of  
the droplets, or IV) the formation of a single compartment per droplet (dsGUV). Scale bar 
50  μm. 
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FRAP measurements performed on the lipids in proximity to the droplet’s periphery revealed 
diffusion coefficients of 4.5 ± 0.3 μm2/s for Krytox concentrations above 6 mM, indicating that 
the positively charged SUVs fused to create a supported lipid bilayer (see Appendix Table SI 
4).263  
Similarly, as for neutral and negatively charged lipids some flocculation and fusion of droplets 
can be observed in Krytox concentrations ranging from 3 to 4.5 mM Krytox due to micellar 
exclusion,182,186 indicating that this effect is probably independent on encapsulated lipid vesicles. 
Note that positively charged SUVs were encapsulated in the absence of MgCl2. Importantly, 
whereas negatively charged or neutral SUVs require the presence of Mg2+ ions, no interaction 
of positively charged SUVs with the periphery could be observed when Mg2+ was present in the 
buffer, independently of the Krytox concentrations. Mg2+ ions screen the negative charge of the 
Krytox and thereby prohibit electrostatic interaction of the positively charged SUVs with the 
surfactant shell.  
 
5.1.3.5. The Creation of Multicompartment dsGUVs 
 
The distinct behavior of positively and negatively charged SUVs in different buffer conditions 
allows to trigger a complementary response of the encapsulated SUVs. For this aim, Atto 488-
labeled negatively (DOPG) and Rhodamine-labeled positively charged (DOTAP) SUVs were 
combined in Tris buffer without MgCl2 and encapsulated into droplets stabilized by 10.5 mM 
Krytox.  
 
 
Figure 57: Sketch and confocal fluorescent image of a multicompartment dsGUV containing 
Atto488-labeled negatively and Rhodamine-labeled positively charged SUVs (of DOPC 
27.25%, POPC 27.25%, cholesterol 15%, plus either DOPG 30% and ATTO 488-labeled 
DOPE 0.5%, or 30% DOTAP and Rhodamine-labeled DOPE 0.5%) in Tris buffer without 
MgCl2, stabilized by 10.5 mM Krytox. Scale bar 10 µm. 
 
While these conditions allowed for an interaction of positively charged SUVs with the interface, 
the interactions of negatively charged SUVs with the surfactants were prohibited (Figure 57). 
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Hence, this method allows for reconstitution of morphological lipid structures, mimicking the 
eukaryotic cell membrane and internal organelles. 
Besides the negatively charged Krytox surfactant, a positively charged amine-terminated 
surfactant can be used to provide charges to the droplets’ interface. In the following, the effect 
of this positively charged surfactant is investigated.  
 
5.1.3.6. The Effect of a Positively Charged Interface on Lipid-
Compartment Systems 
 
To generate a positively charged droplet interface a block copolymer surfactant with a positively 
charged functional group (amine, NH3) was synthesized by Dr. Jan-Willi Janiesch based on a 
previously published protocol (see Section 3.2.4). This surfactant comprises a PFPE 
hydrophobic part connected via the amid group to the hydrophilic amine-terminated PEG 
molecule, thus providing positive charge at the droplet’s inner interface at pH of 7.4. As a first 
step, partitioning experiments were performed to rule out possible presence of Krytox 
molecules in the amine-terminated surfactants (see Appendix, Figure SI 1B). Then 5 mM of this 
surfactant in HFE-7500 oil was used to stabilize droplets containing neutral, negatively (30% 
DOPG) and positively charged (30% DOTAP) SUVs (Figure 58). Leakage of negatively charged 
lipids was observed in the oil phase after few minutes independently on presence or absence of 
MgCl2.  
  
 
Figure 58:  Confocal images showing fluorescence of Atto488-DOPE. Neutral, negatively 
(DOPG) and positively charged (DOTAP) SUVs (DOPC 27.25% or 42.25%, POPC 27.25% 
or 42.25%, cholesterol 15%, DOTAP or DOPG 30% or 0%. Atto488-DOPE 0.5%) dissolved 
in Tris buffer with and without MgCl2 are encapsulated in droplets stabilized by 5 mM 
amine surfactant. Scale bar 50  μm. 
 
This may be attributed to the strong and direct electrostatic attraction force with the surfactant 
molecules. Neutral and positively charged lipids were retained within the droplet. In the case of 
neutral lipids, adhesion of SUVs at the droplets periphery was observed only in the buffer 
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lacking Mg2+ ions. This can be explained by the zwitterionic nature of neutral phospholipids269, 
attracting Mg2+ ions, which prevent the interactions with the positively charged surface. Not 
surprisingly, no interactions with the periphery could be observed in case of positively charged 
SUVs independently on Mg2+ ions.  
 
To improve retention and to tune droplet interface charge density, the interactions between the 
SUVs and the surfactant shell of the droplet, the amine surfactant was mixed with the inert 
PEG-based fluorosurfactant. Figure 59 shows representative fluorescence images of neutral and 
negatively charged lipids encapsulated within droplets stabilized by 1.4 wt% of inert PEG-based 
surfactant and different amounts of amine surfactant (from 3 mM to 10 mM). Note that for 
these experiments a Tris buffer without Mg2+ ions was used. Positively charged lipids are not 
presented here since they stayed unaltered in the multicompartment system independent on 
amine surfactant concentration or the here used buffers.  
 
 
Figure 59:  Confocal images showing the effect of amine surfactant concentration on 
encapsulated SUVs within water-in-oil droplets. SUVs (DOPC 27.25% or 42.25%, POPC 
27.25% or 42.25%, cholesterol 15%, DOPG (negatively charged) 0% or 30%. Atto488-DOPE 
0.5%) were dissolved in Tris buffer and encapsulated in droplets stabilized by surfactants 
which contained 1.4 wt% PEG-based fluorosurfactant and various concentrations of amine 
surfactant as indicated above the fluorescence images. Based on fluorescence images and 
diffusion coefficients measured by FRAP, compartment systems were categorized into II) 
multicompartment adhesion, V) lipid leakage. Scale bar 50  μm. 
 
The encapsulated neutral and negatively charged SUVs were attracted to the periphery of the 
droplets stabilized by surfactants containing 3 mM or more amine-terminated surfactants in 
addition to 1.4 wt% inert PEG-based surfactant. Negatively charged lipids could be retained in 
the aqueous phase of the droplet, stabilized by 5 mM or less amine surfactant. For more than 5 
mM amine surfactant, negatively charged lipids leaked out into the oil phase.  
FRAP measurements performed on lipids close to the periphery, revealed diffusion coefficients 
no larger than 2.2 ± 0.2 µm2/s (0% DOPG, 7 mM amine surfactant) for none of the measured 
samples. This indicates that, probably, no fusion to a lipid bilayer took place.  
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The ultimate proof of the successful formation of dsGUVs is the possibility to subsequently 
release the assembled GUVs from the stabilizing surfactant shell into an aqueous phase. The 
following sections clarifies the influence of lipid and surfactant charge on GUV release.  
 
5.1.4. GUV Release into a Physiological Environment  
The continuous lipid bilayer within the dsGUVs makes the release of the GUVs from the 
surfactant shell and oil phase into a physiological buffer possible.16 Towards this end, a bulk 
release approach (see Methods Section 4.5.5), which allows for the simultaneous generation of 
several hundred thousand free-standing GUVs within a few minutes, was employed (Figure 
60). In this approach, the produced dsGUVs were collected in a micro tube and supplemented 
with an osmolarity-matched aqueous release buffer. Subsequently, a de-emulsifier (perfluoro-
1-octanol) was added in order to destabilize the droplet’s surfactant shell, thereby, allowing for 
the release of GUVs into the aqueous phase.  
 
 
Figure 60: Bulk method to release free-standing GUVs from the stabilizing polymer shell 
and from the oil phase into the aqueous phase. A) Representative fluorescence image and 
sketch of dsGUVs (DOPC 34.75%, POPC 34.75%, cholesterol 15%, DOPG 15% and 0.5% 
ATTO 488-labeled DOPE, 30 mM Tris, 10 mM Mg2 + ions) in the oil phase (containing 
1.4 wt% PEG-based fluorosurfactant and 9 mM Krytox). B) For release, droplets were 
collected inside a micro tube and an osmolarity-matched buffer (30 mM Tris, 10 mM Mg2 + 
ions) was pipetted onto the droplet emulsion. Upon addition of a de-emulsifier (perfluoro-
1-octanol), GUVs were released from the oil phase into the aqueous phase. C) A 
representative fluorescence image and sketch of free-standing GUVs after release. Scale bar 
25  μm. Reprinted from with permission from Haller et al . ,  2018.8 6   
 
The successful release of the GUVs was, however, only possible under certain conditions that 
correlated with the successful fusion of the vesicles to a lipid bilayer (see Section 5.1.3.2 for 
dsGUV investigations) but seemed to be also influenced by the retention of lipids within the 
droplet and the magnitude of electrostatic interactions between surfactants and lipid bilayer. 
These influencing factors will be discussed in more detail in the following sections. 
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5.1.4.1. Influence of Negative Surfactant Charge on GUV Release 
 
In the dsGUVs assembly approach, in which Krytox molecules were used towards the attraction 
of SUVs to the periphery, the release efficiencies of the assembled GUVs reached values of up 
to 9% of the initial amount of produced dsGUVs were obtained. This is significant given the 
kHz production rates of dsGUVs (i.e., 2.5 x 106 dsGUVs are produced within 10 min) that, in 
turn, lead to the overall yield of approximately 2.25 x 105 GUVs within few minutes. 
 A successful release is, however, only possible upon the formation of a continuous bilayer. This, 
in turn, depends on Krytox concentration in the oil phase and on lipid charge (see Figure 61) 
as discussed in previous sections. If the attraction force between SUVs and surfactants are too 
low, SUVs only attach, but not rupture to form a lipid bilayer (multicompartment adhesion). 
On the other side, if the adhesion strength is too high, the lipid bilayer may form, however, lipid 
leakage into the oil phase may appear or GUVs may rupture during release.  
 
 
Figure 61: Efficiency of GUV (only size >20 µm) release from dsGUVs depends on the Krytox 
concentration in the oil phase (HFE-7500 plus 1.4% PEG-based fluorosurfactants) and the 
type and concentration of lipid charge (negatively charged DOPG and positively charged 
DOTAP) in the lipid composition. GUVs < 20 µm were not taken into account. Reprinted 
from with permission from Haller et al . ,  2018.8 6   
 
Efficient GUVs release was observed from the dsGUVs containing more than 10% negatively 
charged lipids and at Krytox concentrations between 6 mM to 13.5 mM. Higher Krytox 
concentrations were necessary when GUVs contained more negatively charged lipids. As 
expected, release was not obtained from droplets stabilized by a surfactant solution containing 
less than 3 mM Krytox, because no continuous supported lipid bilayer could form under these 
conditions (multicompartment adhesion, see Section 5.1.3.2 for dsGUV investigations). 
Unfortunately, release efficiency of GUVs consisting of positively charged and neutral lipids 
was significantly lower (below 0.3%) even though diffusion coefficients correlated with the 
presence of a lipid bilayer. In the case of neutral lipids, this might be attributed to the partial 
leakage of lipids into the oil phase predominantly observed for neutral lipids (See Appendix, 
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Figure SI 5). Whereas lipid leakage and release efficiency of neutral GUVs could be improved 
by replacing the 10 mM MgCl2 with 50 – 100 mM KCl, positively charged lipids could not be 
released in any of the tested buffer conditions (water, KCl (data not shown)). The explanation 
for this could be, in my opinion, the strong and direct interaction with the charged Krytox, 
causing GUV rupture during the release process. However, since the release processes depends 
critically on counter ions present in the buffers, salt and buffer conditions may have to be 
investigated and adjusted further towards successful release of positively charged GUVs.  
 
The release of the GUVs from the surfactant shell and the oil phase into a physiological 
environment paves the way towards future applications in which synthetic cell interactions with 
a physiological environment are crucial. Further the here presented method is a great benefit 
for the scientific community as it describes a simple way to create GUVs in high yield in a variety 
of possible buffers and lipid compositions, that are not allowed in case of standard GUV 
preparation methods as electroformation. 
 
5.1.4.2. Influence of Positive Surfactant Charge on GUV Release 
 
In the context of dsGUVs formation, positively charged amine-terminated surfactants have a 
strong potential and provide flexibility in applications since no addition of ions would be 
necessary (see Section 5.1.3.6, Figure 59). However, no release of GUVs has been achieved with 
a positively charged surfactant. This is in agreement with the relatively low diffusion coefficients 
(see Appendix, Table SI 5) obtained by FRAP measurements. Thus, one can assume that the 
interactions between the surfactants and the SUVs might have been too weak preventing the 
successful formation of continuous bilayers. Note that more experimental conditions should be 
tested in future as a change in buffer conditions may lead to successful formation of dsGUVs.  
 
5.1.4.3. Release of Multicompartment Systems 
 
The multicompartment systems described in Section 5.1.2 (Figure 50A) are solely confined by 
the droplet polymer shell; thus, their observation and analysis are performed directly in the 
oil/surfactant environment.  
In fact, the presented approach also allows for the transfer of a multicompartment system into 
a physiological environment. Therefore, however, the internal aqueous volume requires to be 
additionally enclosed by an outer lipid bilayer (multicompartment dsGUV, see Figure 62A). To 
obtain this, I encapsulated a SUV-based multicompartment system inside a dsGUV using 
experimental conditions similar to those for single-compartment dsGUV formation (described 
in 4.5.1) (Figure 62). However, an excess amount of encapsulated SUVs (greater than that 
required for just the formation of a continuous bilayer) was necessary to obtain a spherical lipid 
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bilayer and additional free-floating SUVs. Due to the continuous lipid bilayer, this lipid 
structure can be released from the surfactant shell and the oil phase into an aqueous buffer.  
 
 
 
Figure 62:  Schematic representation and confocal fluorescent images of multicompartment 
systems enclosed by a dsGUV (left) or a free-standing GUV (right). Lipid composition: 
DOPC 27.25%, POPC 27.25%, DOPG 30%, cholesterol 15%, Atto488-DOPE 0,5% in Tris 
buffer, 10 mM Mg2 + A) An excess of SUVs (53 µM) was encapsulated in a water-in-oil 
droplet stabilized by PEG-based fluorosurfactants with 9 mM Krytox. This led to the 
formation of a lipid bilayer inside the surfactant shell.  Excess SUVs stayed in the droplet 
volume, resulting in a multicompartment dsGUV. The lower inset shows a representative 
confocal fluorescence image of green fluorescence emitted by labeled lipids. B) Released 
GUV-enclosed multicompartment system in an osmolarity-matched aqueous buffer. The 
lower inset shows a representative confocal fluorescence image of green fluorescence emitted 
by labeled lipids. Scale bar 20 µm. Reprinted from with permission from Haller et al . ,  
2018.8 6   
 
Once the multicompartment GUV is released into a physiological buffer, it resembles greatly 
the architecture of a eukaryotic cell that has a similar sized outer lipid bilayer and within this 
cell body organelle structures. When aiming to mimic a living cell, this compartment system 
sets the first morphological step towards the combination of distinct reaction spaces within an 
outer larger confinement. In this regard, a similar system has been seen by Bolinger et al. In this 
study, SUVs were encapsulated inside larger lipid vesicles by hydrating a dried lipid film with 
an SUV mixture. Remarkably, it was possible to perform distinct and successive chemical 
reactions within this multicompartment system through the rupture of encapsulated SUVs 
comprising different phase transition temperatures.136  
In the approach presented in my thesis, this could be feasible as well by picoinjecting a distinct 
SUV mixture into preformed dsGUVs or by selectively recruiting distinct SUVs to the 
periphery based on the different lipid charge (see Section 5.1.3.5). This highlights the great and 
versatile potential of the lipid-based compartment system in oil or in physiological buffers for 
future experiments.  
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5.1.4.4.  Investigation of Released GUVs 
 
In the following, I will characterize the released GUVs in respect to their size distribution, purity 
and unilamellarity. 
 
5.1.4.4.1. Size Distribution of Released GUVs 
 
Using droplet-based microfluidic a very monodisperse production of dsGUV can be achieved 
(size 29.1 ± 0.1 µm, see Figure 63 grey bar). The released GUVs, however, show a wider size 
distribution range, depicted in the histogram of Figure 63. This means that during the bulk 
release fusion and splitting of destabilized dsGUVs may happen. Splitting and fusion can be 
minimized by increasing the emulsion-aqueous phase interface during the release process in 
the micro tube (Figure 60). Alternatively, a microfluidic release device, where GUVs are 
released one by one can be used.16 
 
 
Figure 63: Size distribution of dsGUVs in the oil phase (grey column, n =187) and after the 
release into the water phase (GUVs, white columns, n = 190). The lipid composition 
comprises DOPC 27.25%, POPC 27.25%, ATTO 488-labeled DOPE 0.5%, cholesterol 15% and DOPG 
30%. Note that GUVs smaller than 10 µm were not taken into account. Reprinted from with 
permission from Haller et al . ,  2018.8 6   
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5.1.4.4.2. Purity Investigation of Released GUVs 
 
To check the released GUVs for contaminations of oil or surfactant molecules, FRAP 
measurements and Raman analysis were implemented.  
FRAP measurements performed on released GUVs consisting of 30% negatively charged lipids 
revealed diffusion coefficients of 3.5 ± 1 µm2/s. This diffusion coefficient is in good accordance 
to GUVs created by electroformation,16 suggesting that no contaminations affecting bilayer 
fluidity are present in the samples.  
 
 
Figure 64: Raman spectra performed to investigate the purity of released GUVs. (A) Raman 
spectra collected from the solution of custom-made triblock surfactants in FC40 oil (brown) 
and from the SUVs (green), consisting of 40% DOPC, 40% POPC and 20% cholesterol. (B) 
Raman spectra collected across the water-oil interphase of the single dsGUV (see insert 
bright-field image) show characteristic water and oil peaks. In sake of clarity of 
presentation, the spectra collected from the oil and water phases were brown and blue 
colored, respectively. (C) Representative Raman spectra collected across the water-lipid 
interphase of the released GUV (insert bright-field image). In sake of clarity of 
presentation, the spectra collected from the water phases and the lipid bilayer were blue 
and green colored, respectively. Importantly, no characteristic peaks of the oil/surfactant 
were detected. Reprinted with permission from 1 6.Copyright © 2017, Springer Nature.  
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Furthermore, Raman spectra were collected from the surfactants in the oil, the SUV solution, 
as well as line scans were performed across the boundary layer of dsGUVs and of the released 
GUVs (Figure 64).  
The collected Raman spectra from the SUV and from the surfactant solution showed both 
characteristic footprint structures (Figure 64A): SUV spectrum revealed a carbon- hydrogen 
stretching vibration of lipid tails (between 2800 and 3000 cm-1)270 and the spectrum for the 
surfactants in FC40 oil, revealed similar peaks as published before.271 These spectra were then 
compared to the Raman spectra collected across the interface boundary of the dsGUVs (Figure 
64B) and the released GUVs (Figure 64C). In case of dsGUVs Raman spectra collected from the 
aqueous phase showed a large water peak between 3000 and 3500 cm-1 whereas the oil phase 
showed the characteristic spectrum of the surfactant and oil measured before. Spectra collected 
from the released GUVs show a large water peak and at the interface boundary of the GUV a 
CH-stretching peak referring to the lipid bilayer.270 No peaks of surfactant or oil residues could 
be detected. 
 
5.1.4.4.3. Assessment of Unilamellarity of Released GUVs 
 
Giant vesicles produced by methods as e.g. gentle hydration are mainly found to possess 
multilamellar lipid membranes.272 This can be disadvantageous 126 and can limit their 
application when it comes to e.g. transmembrane proteins in adhesion studies or other 
membrane-dependent functions.  
 
 
Figure 65: Representative confocal fluorescence images of (A) a single and (B) a 
multicompartment system released into the water phase. Images were taken under the same 
acquisition conditions. Fluorescent intensity profiles along the cross section of the GUVs 
are plotted in yellow. Fluorescence signal of 0.5% Alexa 488-labeled DOPE lipids in the 
lipid compositions (DOPC 27.25%, POPC 27.25%, ATTO 488-labeled DOPE 0.5%, 
cholesterol 15% and DOPG 30%). Scale bars, 10  μm. Reprinted from with permission from 
Haller et al . ,  2018.8 6   
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In the approach presented in this thesis, a multilamellarity can be excluded, as the amount of 
encapsulated lipids is calculated and precisely adjusted to cover the inner surface of a 30 µm 
droplet with one bilayer. However, in case of the multicompartment GUVs presented in Section 
5.1.4.3 there is an excess amount of lipids, thus, a multilamellar structure cannot be ruled out 
per se.  
Thus, the lamellarity of the lipid structure was further investigated. In this concern, a time-lapse 
microscopy analysis (2 h) of the multicompartment system was performed. Here no 
accumulation of lipids on the periphery was observed. This indicates that the SUVs remain 
stable within the GUV lumen. Moreover, to exclude possible multilamellar structures the 
fluorescence intensity profiles of free-standing multicompartment- and single -GUVs, which 
were prepared and released the same way, were compared. The measurements revealed similar 
fluorescence intensity profiles at the boundaries of the released multicompartment GUV and 
the single GUVs, indicating unilamellarity also in case of the multicompartment system (Figure 
65). 
 
5.1.4.4.4. Manipulation of Released GUVs by Unbalanced Ionic 
Conditions 
 
Even though, multilamellar structures have been excluded in the previous section, when 
investigating the released GUVs via fluorescence microscopy, it appears that, occasionally, 
released GUVs reveal some localized lipid accumulations. This may be due to lipids from 
ruptured GUVs that stick to the outer leaflet of the lipid bilayer. These excess lipids can be seen 
as agglomerates or as tentacle-like structures at the surface of the GUV. In equilibrated ion 
conditions these GUV structures are rare, however these tubular structures appear more often 
when increasing the mismatch between ionic conditions inside and outside GUVs, e.g. 
decreasing or increasing MgCl2 in the ambient buffer. Figure 66 shows representative 
fluorescent images from released GUVs in hypotonic (A) and hypertonic (B) conditions.  
It appeared that lower MgCl2 concentrations in the external GUV space (pure water as release 
buffer) lead to more prevalent tubular structures at the outer lipid leaflet whereas higher MgCl2 
concentrations (15 mM MgCl2 in release buffer) lead to tubular structures inside the GUVs.  
GUVs with an excess membrane area and non-spherical shapes have already been reported 
earlier, as a result of osmotic deflation26 or based on the depletion effect of encapsulated 
macromolecules (depletion effect is described in respect to actin filament bundling in Section 
1.3.9.1).121,139 Also tubular structures have been reported in GUV morphology studies based on 
the mismatch of the expansions of the two bilayer leaflets. This could be due to asymmetry of 
the lipid composition of the two membrane leaflets,26 local pH changes24 or asymmetric 
insertion of membrane proteins.273 A lateral tension in one of the leaflets was also shown to be 
generated through mismatching buffer conditions between the GUV interior and exterior and 
thus, through a different ion adsorption on the two surfaces.274 In this regard, simulations 
showed that ion binding to phospholipids leads to a tighter packing of the membrane.275,276 
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Moreover, it was estimated that an increase of Ca2+ ions could lead to a decrease in area per lipid 
of 3 – 10%.276  
 
 
 
Figure 66: Representative fluorescence images from released GUVs in unbalanced ionic 
conditions. (A) hypotonic conditions lead to increase in tubular structures at the outer 
bilayer leaflet. (B) hypertonic conditions lead to tubular structures reaching into the 
droplets interior. Scale bar 10 µm.  
 
For GUVs with a size of 20 µm, as presented in this thesis, this theoretically means that when 
there is a decrease in one of the leaflet areas of e.g. 3%, the mismatch would provide an excess 
membrane area of ≈ 37 µm2. This could theoretically form tubular structures of around 235 µm 
in length, assuming a tube diameter of 50 nm (for calculations see Appendix, Figure SI 6).277 
This may be in agreement with the observations shown in Figure 66. 
 
Note that such tubular structures has been also seen as a result of trans-bilayer asymmetry of 
the lipid composition evolving due to negatively charged ITO glasses during electroformation.26 
In case of released GUVs, an asymmetry of the leaflets can neither be excluded, since the 
charged droplet interface may as well lead to a biased arrangement of lipids in the two leaflets 
during dsGUV formation. This may need to be further investigated in future. 
 
The GUVs with tubular structures are an excellent model to resemble eukaryotic organelle 
morphology like the membrane of mitochondria, the Golgi apparatus or of the smooth 
endoplasmic reticulum where the membrane is similarly folded. 
 
  120 
 
 
 
 
 
 
 
Part I: Summary  
In part I of the results I showed the creation of multicompartment and single compartment 
(dsGUV) systems within water-in-oil droplets as well as their subsequent release into a 
physiologically relevant aqueous buffer. 
Further I elucidated the mechanism behind the on-demand production of either 
multicompartment systems or dsGUVs and showed that it is dependent on surfactant charge, 
SUV charge and on the presence of certain ions. The repertoire of inert, negatively and 
positively charged surfactants allowed for a versatile combination of lipids and salt conditions. 
The multi- and single compartment systems could serve as a good cell model system, as they 
resemble the internal eukaryotic organelle structures and the outer cellular membrane. 
Remarkably, production conditions can be adjusted to generate a combination of both, a 
multicompartment system enclosed in the spherical lipid bilayer of a dsGUVs. 
The release of these lipid-based systems into aqueous buffers increases the physiologically 
relevance of the approach and allows for further manipulation of the GUVs. In this concern 
released GUVs were used to study membrane tube formation that could model membrane 
folds as present in e.g. the mitochondria’s inner membrane. 
To sum up, I presented here the capability of this purely lipid-based systems to model the 
eukaryotic architecture. 
______________________________________________________________________ 
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Part II 
 
5.2. Reconstitution of Cytoskeletal Networks towards 
Artificial Motility 
 
Cellular motility governs many fundamental processes including, but not limited to, embryonic 
development, immune response, tissue formation and wound healing. In the context of a living 
cell, the machinery of cellular locomotion is highly complex and not fully understood as it 
involves many cell signaling processes. Towards elucidating cellular motility, it is important to 
first dissect the mechanism into its basic features. Therefore, I present a bottom-up approach 
in which cell motility will be broken down to three steps: a) the generation of a pushing force 
and an extension force at the leading edge; b) the adhesion of the leading edge to the substrate; 
and c) the detachment and the contraction of the cell body at the rear. Key players in these steps 
are 1) actin networks, creating a pushing force against the membrane in the front; 2) myosin 
motors leading to a contractile force at the rear; and 3) integrin transmembrane proteins 
responsible for adhesion and detachment of the cell body on the extracellular substrate. 
 
In the following part I will demonstrate the assembly of these key players within the here 
presented synthetic cell approach. Primarily, however, I will start with the investigation of actin 
networks in 2D and will continue with the reconstitution of actin cytoskeletal networks within 
water-in-oil droplets. In this regard, I created actin-based pushing forces by the reconstitution 
of crosslinked and rigid actin filaments. To reconstitute the corresponding counter force, in a 
next step, the motor protein myosin II was introduced leading to a contractile actomyosin 
network. Similarly, this was investigated first in 2D and then within the synthetic cell approach. 
Moreover, towards the creation of an actomyosin cortex, I linked the actomyosin network to 
the droplet by tuning the electrostatic interaction between the network and the droplet’s 
interface. 
A highlight of this part is the observation of spontaneous motion of cytoskeletal network-
containing droplets. In contrast to motility in a living eukaryotic cell, this spontaneous motion, 
however, was shown to be independent of pushing and contractile forces. In this regard, I will 
characterize multiple aspects of this spontaneous motion and finally raise a hypothesis to 
explain the observed artificial motion.  
Some of the experiments of the following sections have been done in cooperation with Dr. 
Marian Weiss (postdoc, MPI, Department Prof. Spatz).  
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5.2.1. Actin-Generated Pushing Forces  
 
Actin filaments have a plus and a minus end. They disassemble at the minus end or grow at the 
plus end upon exposure of actin monomers below or above a critical concentration, 
respectively.40 Through this actin polymerization a pushing force against the cell membrane can 
be generated.278 In a living cell this so-called treadmilling of actin filaments is besides 
actomyosin contraction one of the key aspects in cell locomotion.11  
In a synthetic cell approach, the actin concentration is supposed to stay the same over time. 
Thus, the creation of treadmilling conditions is challenging.28 Nevertheless, several previous 
studies have described that actin – in a steady state and without motor proteins – can indeed 
exert a force on the confinement.162,163,165 In this regard, by the encapsulation of rigid actin 
filaments (with a persistence length larger than their confinement dimension) a deformation of 
the membrane has been reported. This pushing force is supposed to be mediated by the energy 
costs related to actin filament bending162,163 and can resemble the stretching of the leading edge 
in a migrating cell. Towards this aim, I reached out to implement this pushing force within my 
synthetic cell approach as a key step towards reconstitution of cellular motility. 
 
5.2.1.1. Actin Bundling to Rigid Filaments in 2D 
 
While single actin filaments possess a persistence length of around 12 µm168 and can generate a 
maximal polymerization force per monomer of around 1.5 pN,165 actin can reach much higher 
persistence lengths and forces by the addition of crosslinkers e.g. a persistence length of 150 µm 
and much higher forces for an actin to fascin ratio of 1:2.35,279 
In a synthetic cell actin bundling is mainly achieved by the crosslinker fascin165 or by 
macromolecules,166 as PEG or methylcellulose. Macromolecules bundle actin filaments based 
on the depletion effect that leads to entropy-driven interaction of larger objects (e.g. actin 
filaments).168  
In this thesis, actin was purified from skeletal rabbit muscle by Christine Mollenhauer (see 
Section 3.4.1). To characterize the actin cytoskeleton in vitro, prior to the assembly in water-in-
oil droplets, the activity of actin and its crosslinkers was tested in bulk on PLL-PEG coated glass 
slides. In low salt conditions (G-buffer, see Section 3.5) actin stayed in its globular monomeric 
form. Upon increasing the ionic strength of the buffer by adding the actin polymerization buffer 
monomers assembled to form actin filaments (1% of actin is labeled with Alexa Fluor 568) as 
shown in Figure 67A. Further the crosslinker fascin in a molar ratio of 1:20 or 0.4 wt% 
methylcellulose was added to the polymerization buffer and mixed with the actin monomers in 
bulk. In comparison to actin filaments without crosslinkers actin filaments formed much 
thicker and more rigid bundles in the presence of fascin (Figure 67B) and methylcellulose 
(Figure 67C), whereby the effect of methylcellulose was most prevalent.  
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Figure 67: Representative fluorescence images of actin filaments (1% Alexa Fluor 568 
conjugated actin) in polymerization buffer containing (A) no crosslinker, (B) fascin (molar 
ratio 1:20), or (C) 0.4 wt% methylcellulose. Scale bar 50 µm. 
 
After showing that actin filament rigidity can be tuned in bulk, I included these crosslinked 
actin networks within cell-sized microfluidic water-in-oil droplets. This will be presented in the 
next section. 
 
5.2.1.2. Actin-Generated Pushing Forces within Water-in-Oil Droplets  
 
Geometric constraints alter the cytoskeletal assembly and its dynamics as it provides barriers 
and interfaces to apply forces on.168,280 Therefore, actin networks were reconstituted within 
microfluidic water-in-oil droplets by means of a droplet production device with two aqueous 
inlets (see Section 4.3.1). In order to prevent polymerization prior to the droplets formation one 
aqueous phase contained the actin monomers (1% of actin is fluorescently labeled with Alexa 
fluor 568) and the other aqueous phase the polymerization buffer. A microfluidic zick-zack 
mixing unit ensured the mixing of the two phases following droplet formation. To test the 
influence of actin filament rigidity on the network assembly, actin was encapsulated in the 
presence of fascin (molar ratio 1:20) or in presence of 0.4 wt% methylcellulose into the droplets. 
The actin network crosslinked by fascin (Figure 68A) assembled mainly in the center of the 
droplet without prevalent interactions with the periphery. This crosslinked actin filament 
network is in accordance with other studies showing comparable network arrangements in 
similar-sized confinements.281,282 Distinct to that, highly ordered actin network structures were 
generated when actin filaments were crosslinked by methylcellulose (Figure 68B). The inset on 
the right of Figure 68B shows that the filaments all assembled at the periphery of the droplet 
into a cage-like structure, leaving the droplet’s center empty. Similar actin ring structures have 
been seen in a previous study by Miyazaki et al.166 In that study, the authors demonstrated that 
ring formation is dependent on the diameter of the droplet that need to be equal to or smaller 
than the persistence length of the filaments. This is in accordance with our observations. 
Whereas fascin-crosslinked actin filaments have an persistence length smaller than the 
confinement size,279 thus can stretch out; the filaments in the presence of methylcellulose are 
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much more rigid and thus cannot stretch out completely. To minimize curvature and bending 
energy costs, filaments assemble at the droplet’s equator.166 
 
 
Figure 68: Z-stack projections of actin networks within water-in-oil droplets (1% of actin 
is labeled with Alexa Fluor 568). A) In the presence of the crosslinker fascin (1:20) Scale 
bar 30 µm. B) The presence of 0.4%  methylcellulose leads to a cage-like actin network 
assembly. Insets on the right shows a confocal image of the middle of the droplet revealling 
that all fibers assembled at the periphery of the droplets. Scale bar 10 µm. 
 
Note that in other studies the encapsulation of rigid actin bundles deformed lipid-based 
compartments.162,163 In the here presented system, the water-in-oil droplets comprise a much 
higher membrane rigidity.165,166 Therefore, the force that the actin bundles apply on the droplets 
interface cannot be evidenced by droplet deformation but through the filament arrangement 
tightly aligned against the droplet wall.  
In fact, the pushing force in a living cell are mainly based on actin treadmilling.28 To generate 
such treadmilling conditions in an artificial cell is as mentioned before challenging, since it 
includes many signaling molecules.28 However, in order to investigate and observe the initial 
actin polymerization dynamics, the polymerization process of encapsulated actin monomers to 
actin filaments, was slowed down. This was achieved by keeping the droplets and the buffers on 
ice before the droplets were imaged. Further, the increased viscosity of buffers containing 
methylcellulose additionally slowed down diffusion283 and thus, the polymerization. 
Representative fluorescence images in Figure 69A show that at time point 0 min the 
fluorescence signal was still spread within the droplets, however, first polymerization sites could 
be observed. After 10 min the fluorescence signal was detected mainly from the actin filaments, 
and not from distributed actin monomers, indicating that actin polymerization was mainly 
completed. Anyway, network rearrangement proceeded leading to a further bundling of the 
filaments as presented at time point 20 min and in Figure 68 of the previous section. This 
dynamic arrangement is further shown in Figure 69B. Here the fluorescence intensity was 
converted into a color-code representing the z-position of the confocal stacks. Due to the 
depletion effect, thinner and shorter adjacent filaments got dynamically arranged into thicker 
and longer filaments. These, in turn, assembled at the periphery and created these highly 
ordered structures to decrease bending energy costs. 
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This shows that actin networks in the presence of methylcellulose are not static but are within 
the first 20 min dynamically arranged even though polymerization has been completed.  
 
 
Figure 69: Representative fluorescence images of droplets containing actin in a 
polymerization buffer substituted with 0.4 wt% methylcellulose to different timepoint.(A) 
Observation of actin polymerisation: After around 3 min, fluorescent signal was still  
distributed within the droplets, however, first polmerization events were obvious. After 
10 min fluorescence signal was localized on the polymerized actin network. Scale bar 
50 µm.(B) Dynamical actin filaments arrangent due to depletion effect. Fluorescence of 
actin filaments (10 µM, 1% Alexa Fluor 568-conjugated actin) was converted into a color-
code representing the position in the Z-plane. Arrows indicate movement of fibers. Scale 
bar 10 µm. 
 
Taken together, the here presented results show the reconstitution of actin networks that, in 
presence of methylcellulose, exert a pushing force onto the compartment and a dynamical 
arrangement of the network.  
With this, a key feature of cellular motility could be implemented within my artificial cell 
approach. Another important key feature in cellular motility is the myosin motor-driven 
network contraction. Towards the reconstitution of such contractile networks, actomyosin 
networks were first studied in bulk and then in water-in-oil droplets. This will be described in 
the following section.  
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5.2.2. Actomyosin Networks in Bulk 
After the reconstitution of cytoskeletal pushing forces, I want to address next the associated – 
and not less important – counter force in cellular motility: the myosin motor-based contractile 
force. 
Towards this, the motor protein myosin II was purified from skeletal rabbit muscle by Christine 
Mollenhauer, and combined with actin (1% of actin is fluorescently labeled with Alexa Fluor 
568). To achieve polymerization conditions, actin and myosin (ratio of actin monomers : 
myosin 20:1) were mixed with the actomyosin polymerization buffer containing 1.1 mM ATP, 
resulting in an actomyosin network, whose actin filaments were crosslinked by myosin motor 
bundles (see Introduction Section 1.2.1.1). After around 10 min incubation time, the network 
was observed on a PLL-PEG coated cover slip (Figure 70B). In comparison to the network in 
absence of myosin (Figure 70A), the assembly of actomyosin structures showed a denser 
network and thicker actin bundles. This observation is expected since myosin II crosslinks actin 
filaments and contracts the network upon conversion of ATP to ADP.45  
 
 
 
Figure 70: A and B show representative fluorescence images of polymerized actin (1% Alexa 
Fluor-568 conjugated) and actomyosin (20:1 molar ratio, 1.1 mM ATP) networks, 
respectively, on a PLL-PEG coated cover slide. The images were recorded after 10 min of 
incubation time at RT in actin or actomyosin polymerization buffer, respectively. Scale bar 
50 µm. 
 
The activity of the myosin motor can be seen by the cluster formation of contracted actin 
networks in bulk (Figure 70B). However, to further control and monitor the activity of myosin, 
a ATP sensor, expressed in E.coli and purified by Dr. Amelie Benk, was implemented, as I will 
show next. 
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5.2.2.1. ATP Sensor to Monitor Actomyosin Activity in Bulk 
 
The ATP sensor is based on a fluorescent dye, whose excitation maxima depend on the binding 
of either ATP or ADP (see Section 3.4.6).249 To test the actomyosin activity based on the 
hydrolysis of ATP, the sensor was mixed with ATP and actomyosin-containing buffer. 
Excitation spectra were collected after 25 min, 1h and 1.5 h (Figure 71). In samples containing 
actomyosin a clear decrease in ATP and an increase of ADP could be observed by a change in 
fluorescence intensity at 420 and 500 nm excitation. The change in excitation maxima indicated 
that after 1 h, 0.5 µM myosin had consumed 100 µM ATP, which corresponds to 0.055 ATPs 
per second per myosin. This consumption is significantly lower than previously described for 
myosin II from skeletal muscle.284 
 
 
Figure 71: Analysis of ATP / ADP ratios by means of distinct excitation spectra of a 
ATP/ADP sensitive fluorescent dye. In presence of ADP or ATP, the fluorescent dye has a 
strong fluorescence emission (520nm) when excited with 420 nm or 500 nm, respectively.2 4 9  
Sample composition described on the right (myosin II: 0.5 µM, actin 10 µM, ATP or ADP: 
100 µM ATP). 
 
A reason for the reduced activity could be the fact that actomyosin buffers had to be adjusted 
to be compatible with the ATP sensor (see Section 3.5.2). Supposedly, this did not match the 
conditions for efficient myosin performance. Therefore, the myosin activity was controlled with 
a second method, an actin sliding or so-called motility assay, as presented in the next section.  
 
5.2.2.2. Motility Assay to Monitor Actomyosin Activity in Bulk 
 
A motility assay is a common approach to quantify myosin activity.285 Towards this end, myosin 
was immobilized on nitrocellulose-coated glass slips in a flow chamber (see Section 4.6.1.6). 
Upon introduction of actin filaments into the flow chamber, the filaments bound to the myosin 
heads and upon addition of ATP, a sliding of the filaments could be observed. Figure 72A shows 
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a representative fluorescence image of fluorescently labeled actin filaments bound to the myosin 
that was immobilized on the cover slide of the flow chamber. Actin filament movement was 
recorded and tracked with Image-J (trajectories are shown in Figure 72B). 
 
 
 
Figure 72: Actomyosin motility assay to verify myosin motor activity. (A) Atto 488 
Phalloidin-labeled actin filament fragments on myosin II (bound on the cover slip of a flow 
chamber). (B) Upon introduction of ATP, myosin motors translocated actin filaments 
across the coverslip. Trajectories of filament movement were analyzed with Image-J. Scale 
bar 10 µm. 
 
The calculated velocity (based on the Image-J plugin) of actin filaments of 3.39 ± 0.05 µm/s is 
in good agreement with previously published actin sliding performance164 and confirmed the 
activity of the here used myosin II motors. 
To move one step further, towards reconstitution of cellular motility, I included these 
contractive actomyosin networks within cell-sized microfluidic water-in-oil droplets. 
 
 
5.2.3. Encapsulation of Actomyosin Network into Water-in-Oil 
Droplets 
After proofing the myosin motor activity in bulk, I reached out to encapsulate actomyosin 
networks into the cell-sized water-in-oil droplets by means of a droplet production device with 
two aqueous inlets (see Section 4.3.1).  
Figure 73 shows a merged bright-field and fluorescence z-stack projection of a droplet 
containing an actomyosin network shortly after the production (actin 10 µM, 1% Alexa 568-
labeled actin, myosin 0.5 µM, fascin 0.5 µM). The actomyosin filaments assembled into a dense 
network partly agglomerated due to myosin contraction, similar to what could be observed in 
bulk (Figure 70B). 
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Figure 73: A merged confocal fluorescence and bright-field z-stack projection of 
fluorescently labeled actomyosin network (10 µM actin, 1% Alexa Fluor 568 labeled, 0.5 
µM myosin, 0.5 µM fascin, in actomyosin polymerization buffer) within a water-in-oil 
droplet, stabilized by PEG-based surfactant. Scale bar 20 µm. 
  
To analyze myosin activity in more detail within water-in-oil droplets, the actomyosin network 
contraction was studied in a myosin concentration dependent manner. This will be presented 
in the following section. 
 
5.2.3.1. Analysis of Actomyosin Contraction within Water-in-Oil 
Droplets 
 
In the following, I set out to study actomyosin contraction as a function of myosin motor 
concentration within water-in-oil droplets. In this regard, actomyosin networks with different 
actin-to-myosin ratios were encapsulated into droplets, stabilized by PEG-based surfactant and 
observed by means of confocal fluorescence microscopy (Figure 74). An increased myosin-to-
actin ratio of 1/10 already lead to an enhancement in network contraction, resulting in a 
completely collapsed network when a myosin-actin ratio of 1:5 was used. By introducing the 
myosin-inhinitor blebbistatin to the actomyosin network, a reverse effect could be observed. 
This is an expected behavior of actomyosin activity seen already in many 2D studies.172,286 With 
this I could show the activity of actomyosin networks within the droplets and further, the 
possibility to tune contractile forces in a controlled way within the water-in-oil droplets based 
on the myosin-to-actin ratio. 
 
Note that the process of actomyosin contraction could not be observed in real-time. This 
indicates that the process of actomyosin contraction happened instantly right after actin 
polymerization and droplet formation. 
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Figure 74: Representative merged fluorescence and bright-field images of actomyosin 
networks within water-in-oil droplets, encapsulated into droplets with different actin (1% 
Alexa Fluor 568 labeled actin)-to-myosin ratios. A myosin-to-actin ratio of 1:20 (left) leads 
to the formation of a partly contracted network. A myosin-to-actin ratio of 1:10 
(right)leads to a completely collapsed network. The addition of blebbistatin inhibits myosin 
activity (myosin-actin ratio 1:10). Scale bar 50 µm.  
 
In a living cell, the actomyosin network forms a membrane-connected cortex at the cell 
periphery. This allows to apply contractile force onto the cell body and to move the cell body 
forward during migration over a substrate.41 In this regard, I reached out to implement a similar 
transmission of actomyosin contractile force onto the confinement in an artificial cell. The 
approach to mimic the protein complexes that connect the actin network to transmembrane 
proteins in a living cell is challenging and will be investigated separately in Section 5.3. Here, I 
first will present a more direct link between actin and the periphery: a linkage based on 
electrostatic interactions. Towards this, a negatively charged surfactant, named Krytox, was 
mixed with the PEG-based surfactant to stabilize the actomyosin-containing droplets.  
 
5.2.3.2. Linkage of Actomyosin Networks to the Periphery via 
Electrostatic Interaction 
 
In order to link the actomyosin network to the periphery via an electrostatic attraction force a 
custom-made triblock surfactant was used that contained the negatively charged surfactant 
molecule Krytox. Following droplet production, Krytox molecules assembled at the interface 
and introduced their negatively charged carboxylic group towards the aqueous phase. This 
allows the carboxylic group to attract counter ions from the buffer181 and that in turn, promotes 
attraction of negatively charged actin molecules.  
To check the adsorption of actin to the periphery, fluorescently labeled actomyosin was 
encapsulated into droplets stabilized by this custom-made triblock surfactant containing 
Krytox (see Appendix, Figure SI 1) or by Krytox-free PEG-based surfactant. Figure 75 shows 
fluorescence images of actomyosin networks within droplets and the fluorescence intensity 
profile of their cross section. The fluorescence intensity within the droplets stabilized by 
Krytox-containing surfactants (Figure 75A) was most prevalent at the periphery whereas in 
Krytox-free droplets (Figure 75B) fluorescence was mainly in the droplet’s center. This shows 
that due to the negatively charged droplet interface, actin can be successfully recruited to the 
periphery, leading to an actomyosin cortex.  
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Figure 75: Representative fluorescence images of droplets containing actin (10 µM) in 
polymerization buffer stabilized by custom-made triblock surfactant containing Krytox (A) 
or stabilized by Krytox-free PEG-based surfactant (B). Scale bar 50 µm. Graph in the 
middle shows average fluorescence intensities of droplets cross section (n= 15). green relates 
to A, orange relates to B. 
 
Similar actin cortex formation has been seen in other studies that linked the actin filaments to 
the periphery e.g. via positively charged lipids in the membrane,87,171 via biotin-streptavidin-
interactions174 or via an amphiphilic protein assembled at the oil-water interface.89   
Note that a second approach with custom-made gold-functionalized surfactants (Section 3.2.3) 
was tested to create an actomyosin cortex, leading to a similar but not as prominent effect (see 
Appendix, Figure SI 8), thus, it is not further discussed in this thesis. 
 
As a next step, I wanted to check in what time-scales this cytoskeletal cortex is assembled at the 
interface. This was expected to happen within very short time-scales. Thus, I checked the actin 
adsorption kinetics to the droplets’ interface within the droplet production device. These 
measurements were done in cooperation with Dr. Eli Zamir (Senior Postdoc, MPI, Prof. Spatz 
Department) and will be presented in the following section. 
 
5.2.3.3. Actin Adsorption  
 
To check the adsorption of fluorescently labeled actin to the periphery via electrostatic 
interactions actin-containing droplets were recorded within the microfluidic droplet 
production device. Towards this aim, a droplet production device was mounted on a LSM 880 
confocal microscope and the distribution of encapsulated actin was analyzed by screening the 
fluorescence intensity profile (with an open pinhole) of flowing droplets at different distances 
after production, corresponding to different time points: shortly after production at the droplet-
producing nozzle, before and after the microfluidic zick-zack-mixing unit, and shortly before 
the channel ends at the droplet outlet. In this regard, droplets were screened at each of these 
positions for 10s resulting in around 1200 recorded intensity profiles. 
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Figure 76A shows the droplet production device and color-coded fluorescence intensity profiles 
of the droplets’ cross sections, collected at the indicated spots of the production device.  
 
 
Figure 76: Fluorescence intensity screening of droplets in four positions within the 
production device. (A) Color-coded fluorescence intensity lines of 1200 passing droplets 
and the corresponding plotted means. (B) Counts of intensity peaks in the droplet centers, 
indicating the formation of polymerized actin filaments. 
 
Before the mixing unit the fluorescence intensity of the droplets was located only in one part of 
the droplets. After the mixing unit two sharp intensity peaks indicated a clear localization of 
actin at the periphery of the droplets. Further, this profile shows an actin-depleted zone close 
to the peripheral peaks. This indicates that the recruitment of actin to the surfactant interface 
happened faster than the diffusion of that actin-depleted zone. These diffusion-limited 
adsorption kinetics would be generally not expected in such length scales.203 However, it can be 
explained by the electrostatic attraction forces that seem to be mediating the adsorption process.  
At the outlet, individual droplets showed in the center red spots of high intensities. This may 
indicate the presence of actin filaments. To quantify the polymerization events, based on the 
intensity peaks in the droplets center, the counts of these high intensity values were plotted 
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(Figure 76B). Not surprisingly, most polymerized actin filaments were found after 0.45 s at the 
outlet.  
These results show that actin was instantly recruited to the periphery by electrostatic 
interactions. Moreover, these results indicate that first actin polymerization events happened 
also very fast within less than half a second after production. 
 
Having investigated the time scale of initial adsorption process of actin to the periphery, I 
wanted to investigate next, how this linkage influence actomyosin contraction within longer 
time scales. 
In this regard, previous studies reported that by connecting the actomyosin network to the 
confinement, the contractile force could be transmitted onto the confinement. This was 
observable by means of e.g. membrane oscillation,171 membrane blebbing,175 deformation,89 or 
even by a collapse171 of the compartment membrane.  
Thus, I set out to assess how the linkage between the actomyosin network and the droplets’ 
surfactant shell may impact the actomyosin network contraction in the here presented system. 
Towards this, I will present time-lapse studies in the following section. 
 
5.2.3.4. Influence of Negatively Charged Surfactant on Actomyosin 
Networks within Droplets  
 
To test the actomyosin contraction when the network is electrostatically linked to Krytox 
molecules at the droplets periphery, droplets were observed over a time period of 30 minutes. 
Figure 77 shows representative time-lapse images of actomyosin-containing droplets stabilized 
by Krytox-containing surfactants. Similarly, as seen already in the previous section, an actin 
recruitment based on electrostatic interaction was visible as a bright ring in the confocal plane 
at the periphery of the droplet.  
 
 
Figure 77: Representative fluorescence images of time-lapse analysis and schematic 
representations of actomyosin-containing droplets, stabilized by a custom-made triblock 
surfactant containing Krytox at different time points showing a loss of fluorescence signal 
with the time. Scale bar 50 µm.
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However, it appeared that after few minutes the encapsulated actomyosin network started to 
disintegrate, resulting in a nearly vanished fluorescence signal after 22 min. This indicated that 
the conditions within the droplets were not stable over the time. This could be explained by the 
dynamic nature of the surfactant shell that goes along with a constant desorption and 
adsorption of new surfactant molecules181 what may lead to the extraction of encapsulated 
molecules.250 The interaction of proteins from the aqueous phase as well as the leakage of 
molecules out of the droplets due to Krytox has been reported before.206,250 These effects have 
been explained by the carboxylic acid group of Krytox at the interface (see IFT measurements 
Results part I Section 5.1.1.1) that exchanges a proton by binding a counter ion from the 
aqueous solution. This leads to a decrease in ionic strength and a drop in pH.181 
The decrease in ionic strength and the drop of pH can both explain the depolymerization of 
actin filaments, seen in Figure 77. Moreover, actin may denature when interacting with the 
carboxylic group of Krytox leading to a tight actin-Krytox linkage.287 The subsequent desorption 
of this complex form the interface into the oil phase may then explain the overall loss of 
fluorescence intensity. Note that in some cases fluorescent agglomerates were found in the oil 
phase indicating the transport of material out of the droplet.  
Especially when water-in oil droplets are used as microreactors, the retention of encapsulated 
content is crucial. As shown in this section, this is not always the case. The leakage of 
encapsulated content could be due to direct diffusion into the oil phase in case of amphiphilic 
molecules,258 the formation of surfactant micelles, or the transfer of content from one droplet 
to another across a surfactant bilayer of the two adjacent droplets.288 
 
To compromise between stable biochemical conditions and an actomyosin linkage to the 
interface different Krytox concentrations were tested in a next step. 
 
5.2.3.5. Impact of Charged Surfactants on Actomyosin Networks and 
Droplet Dynamics  
 
To tune the interaction of actomyosin networks with the droplets periphery, a Krytox-free, 
PEG-based surfactant was used and mixed additionally with Krytox. Figure 78 presents 
fluorescence images of droplets containing actomyosin networks stabilized by a purified PEG-
based surfactant with 0, 1 and 2 mM of Krytox. While without the addition of Krytox no 
actomyosin cortex formation was obtained (Figure 78, left image), for 1 mM and 2 mM Krytox 
actomyosin networks were recruited to the periphery. 
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Figure 78: Representative fluorescence images of time-lapse videos and schematic 
representations, demonstrating actomyosin network location and droplet dynamics in the 
absence and presence of Krytox. Actomyosin cortex formation was observable for 1 mM and 
2 mM Krytox. Droplet dynamics, indicating through the circular arrow, were observed for 
1 mM and below. Scale bar 50 µm. 
 
In contrast to previous studies where actomyosin contraction lead to a deformation of the 
compartment or to a cortex detachment from the compartment,89 no such phenomena could 
be observed here. Not less remarkable, however, the time-lapse studies in Figure 78 revealed a 
rotational self-propulsion of some of the droplets. Interestingly, this happened only in droplets 
that were stabilized by PEG-based surfactant with no or only 1 mM Krytox. This indicates that 
an actomyosin cortex may be redundant for droplet rotation or, moreover, may even impair 
droplet motility.  
Creating a controllable and directed movement is indeed an ultimate goal in artificial cell 
motility approaches. Thus, this observed phenomenon of self-propulsion of water-in-oil 
droplets was investigated further in order to elucidate the mechanism behind it. 
Since the addition of higher (> 1mM) amounts of Krytox seemed to have a rather negative effect 
on droplet dynamics, the following experiments have been performed with pure PEG-based 
surfactant. In these cases, no actin-surfactant interactions were visible by confocal fluorescence 
microscopy.  
Note, however, that on a molecular level an interaction of actin with Krytox molecules cannot 
be ruled out, as even the purified surfactant (that was mainly used in this thesis) contained still 
some Krytox traces (1% Krytox, see Section 5.1.1.3). 
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5.2.4. Self-Propulsion of Actomyosin-containing Water-in-Oil Droplets  
 
During the investigation of cytoskeletal networks within water-in-oil droplets, time-lapse 
videos revealed a rotational self-propulsion of some of the droplets. This rotation of water-in-
oil droplets has first been observed in droplets containing actomyosin networks. Figure 79 
presents a representative fluorescence time-lapse analysis of a droplet showing one rotation in 
25 min.  
 
 
Figure 79: Representative time-lapse analysis of a rotating droplets containing actomyosin 
networks. (A) Fluorescence images (1% of actin is fluorescently labeled). Scale bar 20 µm 
(B) Merged fluorescence and bright-field images of a rotating droplet with a hydrophobic 
bead at the outside of the droplet that rotates along with the cytoskeleton, indicated by the 
arrow. Scale bar 10 µm. 
 
To further check if the whole droplet or only the network within the droplet was rotating, 
hydrophobic polystyrene beads were used to break the symmetry of the droplet for observation. 
The arrow in Figure 79B points to the bead that rotates along with the actomyosin network, 
thus providing the evidence that the whole droplet was rotating and not only the network inside 
the droplet.  
 
Moreover, to control if the rotation is governed by an external linearly directional flow 
of the oil phase, rotation speed and the direction of rotation was investigated. By incorporating 
fluorescent beads into the actomyosin networks of water-in-oil droplets and performing time-
lapse z-stack confocal microscopy, droplet rotation could be tracked automatically by means of 
an Image-J plugin. The trajectories of the beads within the droplets are shown in Figure 80.  
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Figure 80: Trajectories of beads encapsulated within actomyosin-containing droplets. By 
means of confocal z-stack time-lapse microscopy, fluorescence of beads was imaged for 8 
min, the fluorescence of beads was tracked and analyzed by Image-J. Scale bar 10 µm. 
  
The color-coding represents the velocity of the beads revealing logically a faster velocity 
the closer the beads were located at the periphery of the droplet. Further, this analysis revealed 
that the rotation of the droplets was independent from each other. Whereas the droplet on the 
very right (droplet 1) performed a quarter turn in the tracked time (8 min), the droplet at the 
bottom (droplet 2) rotated around half a turn. Further, all droplets rotated in a different 
direction. This shows that droplet rotation is probably not accelerated by a large scale external 
oil flow. For future experiments, it will be great to use hydrophobic micrometer-sized beads 
with the density similar to the oil. These beads will be the best solution to track the oil flow. 
 
Next, I wanted to check which kind of internal forces could initiate the observed rotation. 
Towards this, the two major forces of cellular locomotion - pushing and contractile forces that 
are described in Section 5.2.1 and 5.2.3, respectively - were investigated on their influence on 
droplet rotation. This will be discussed critically in the following.  
 
5.2.5. Impact of Cytoskeletal Forces on Self-Propulsion of Water-in-Oil 
Droplets 
 
In Section 5.2.3.5, I could show that no visible connection of the actomyosin network was 
needed to create the observed droplet rotation. Consequently, questions arise on how the 
actomyosin network applies contractile force onto the droplet to initiate rotation, or whether it 
plays a role in rotation at all.  
In this regard, further investigations showed that myosin motor proteins were redundant for 
droplet rotation and that droplets containing pure actin filaments similarly perform droplet 
rotation (see Figure 81). With this, I can conclude that the myosin contractile force is not a 
major mediator in droplet rotation. 
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In order to elucidate the mechanism behind the self-propulsion, I next checked the 
influence on the actin pushing force, discussed already in Section 5.2.1, on droplet rotation. In 
this regard, time-lapse videos were performed of actin filaments encapsulated in water-in-oil 
droplets. Figure 81 shows fluorescence z-stack projections of the actin-containing droplets with 
(C) and without (B) 0.4 wt% methylcellulose to different time points. The fluorescence signal 
was transformed into a color-code (A) representing the z-plane within the droplets. These time-
lapse videos confirmed that droplet rotation happens in absence of myosin, whereby the 
rotation in droplets containing the rigid actin bundles was most prevalent.  
 
 
 
Figure 81: Influence of actin filament rigidity on droplet dynamics. (A) The fluorescence 
signal of the droplets is transformed into a color-code representing z-plane position. (B) 
Droplet containing actin filaments and no methylcellulose shows only minor dynamics. (C) 
Droplet containing actin filaments and 0.4 wt% methylcellulose shows rotational dynamics 
indicated by the arrows. Scale bar 25 µm. 
 
In a previously published study by Miyazaki et al. actin filaments, which were similarly bundled 
by methylcellulose, were encapsulated into water-in-oil droplets. In this study similar ring 
structures of actin filament bundles could be observed,166 however, no rotation of the droplets 
has been reported.  
The only study to my knowledge showing similar rotational movement of cell-sized 
compartments based on encapsulated cytoskeletal networks was done by Suzuki et al.289 In this 
study the rotation was achieved by reconstitution of microtubules and kinesin motors and was 
explained by the pushing force of microtubules against the membrane and by an internal fluid 
flow, generated by a kinesin-driven microtubule dynamics.289 
This study has some similarities with the synthetic cell system presented in my thesis. The 
stiffness of the microtubules for example could be comparable to the stiffness of thick actin 
bundles in the presence of methylcellulose. Also, a pushing force was shown in Section 5.2.1 in 
my system. However, when considering symmetry breaking of forces conflicts arise. In the 
study of Suzuki et al. the kinesin motor was hold responsible for symmetry breaking.289 In the 
rotation observed in my thesis it is not conclusive how the pushing force of rigid actin filaments 
alone could break the symmetry and initiate the rotation.  
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In case of methylcellulose-mediated actin bundling, time-lapse studies revealed that the 
actin network is not static but is dynamically arranged also without motor proteins (see Figure 
69). This dynamic arrangement of actin bundles aligned closely to the periphery can cause 
friction with the surfactant shell and may be an explanation for symmetry breaking and the 
droplet rotation. However, this does not explain the observed rotation in absence of 
methylcellulose. Thus, a further mechanism for droplet rotation need to be identified. 
In this regard, I next raise a hypothesis explaining droplet rotation based on a physico-chemical 
effect. This is the so-called Marangoni effect. In the following section, this effect will be 
explained and further underpinned with additional experiments testing self-propulsion of 
water-in-oil droplets. 
 
5.2.6. The Marangoni Effect as a Driving Force for Self-Propulsion  
 
In the previous sections of this results part I showed the reconstitution of two different 
cytoskeletal forces within water-in-oil droplets. The myosin-dependent contractile force and 
the pushing force of rigid actin bundles. Both are key players in locomotion of a living cell. 
However, in the observed spontaneous droplet propulsion none of these forces seem to be 
decisive.  
Towards artificial and autonomous motion, several groups have studied self-propulsion 
of water-in-oil droplets based on the Marangoni effect.216,290 This effect is governed by local 
inhomogeneities of the interfacial tension (IFT) around a droplet’s interface that creates then a 
net force and due to viscous stresses an Marangoni flow.212 This flow can, in turn, lead to a 
motion of a droplet (for more details see Introduction, Section 1.4.5). 
In the following section, the Marangoni effect will be explained based on an experiment on 
macro scale. 
 
5.2.6.1. Marangoni Effect in a Millifluidic Approach 
 
The Marangoni effect has been investigated intensively in different fluidic systems.212,214 It 
describes the creation of liquid flows at interfaces due to gradients in the IFT as a result of 
heterogeneous surfactant mixtures, local chemical reactions, gradients in temperature or 
surfactant concentrations (see Section 1.4.5 in Introduction).193 In this regard, Thutupalli et al. 
showed a Marangoni-driven self-propulsion of water-in-oil droplets on top of a surfactant 
containing oil phase.216 Here, the effect was mediated by bromine in the aqueous phase that 
reacted with the surfactants at the interface. This reaction lead to a local increase in IFT, what 
resulted in the induction of the Marangoni flow and a propulsion of the droplet. 
To test if a similar effect can be achieved based on the system I studied in my thesis, I 
performed the millifluidic approach as described in Thutupalli et al. by placing water droplets 
containing either actin filaments in actin polymerization buffer (see Section 3.5) or the buffer 
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alone on a petri dish filled with HFE-7500 oil plus 1.4 wt% PEG-based surfactant and 0 mM, 
1.5 mM or 10.5 mM Krytox. Droplet movement was recorded for 2 min and the trajectories 
were tracked with Image-J. Figure 82A presents images of aqueous droplets containing only 
buffer or additional pre-polymerized actin filaments and the trajectories of their movement on 
top of the surfactant-containing oil phase. For sake of clarity aqueous droplets were labeled with 
red ink. Whereas all droplets showed some minor motion the motion at 10.5 mM Krytox was 
more prevalent. Here also a significant difference in velocity could be seen between droplets 
containing actin filaments and droplets containing only buffer.  
 
 
Figure 82: Self-propulsion of millifluidic droplets containing actin polymerization buffer 
with and without actin filaments (10 µM). (A) Images plus trajectory (2 min) of ink-labeled 
droplets swimming in a petri dish filled with HFE-7500 oil plus 1.4 wt% PEG-based 
fluorosurfactant plus 0 mM, 1.5 mM or 10.5 mM Krytox. Scale bar 1 cm. (B) Calculated 
velocities of protein-free (green) and actin-containing (red) droplets on oil phases 
containing different amounts of Krytox as indicated below. 
 
Note that a time period of 2 min recording time was chosen, as the droplets ended up 
eventually at the edge of the petri dish. Thus, based on this experiment no conclusion can be 
drawn on how long the droplets potentially can perform the observed motion. 
 
The here presented results indicate that actin filaments in combination with Krytox have 
an effect on self-propulsion of the aqueous droplets on an oil interface. Sincerely, this effect 
cannot be attributed to pushing forces generated by actin filament polymerization or by actin’s 
bending rigidity, as droplet dimensions are too large to force actin to bend.  
Moreover, in my opinion, the here observed droplet motion fits quite well in the 
theorem of Marangoni. In this concern, actin filaments, located at the droplet’s interface, could 
create local contact points with the interface. Thereby, actin filaments allow for interaction with 
Krytox molecules from the oil phase. The interaction of Krytox with proteins can lead to an 
increase in interfacial tension 206 and thus, to a inhomogeneous IFT of the droplet. This 
inhomogeneity is maintained by the attraction of actin filaments to Krytox and by the constant 
desorption and adsorption of new Krytox molecules to that contact point forming thereby a 
“stagnant cap”. These Krytox patches lead to an inhomogeneous interfacial tension of the 
droplet’s interface, thus, can induce the Marangoni flow and the motion of the droplet. Figure 
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83 shows a schematic representation of the described mechanism. The large arrow at the right 
side indicate the motion of the droplet in the case that there is no friction with the glass and 
only one stagnation point of actin-interface interaction. When there is friction with the glass, 
this motion will be turned into a rotation as observed in case of microfluidic droplets in an 
observation chamber. 
 
 
Figure 83: Schematic representation of self-propulsion of actin-containing water-in-oil 
droplets based on the Marangoni effect. 
 
Clearly, the Marangoni experiment presented here is only in a limited way comparable 
to the rotation observed in the microfluidic droplets. The 10.5 mM Krytox necessary for droplet 
motion in the Marangoni experiment seems at first glance not in accordance with the rotation 
observed in the microfluidic system, where rotation failed by the addition of high amounts of 
Krytox. However, when considering the 1000 x difference in dimensions and the according 
difference in surface-to-volume ratios, it is feasible that for microfluidic droplets Krytox traces 
in the surfactant (1% Krytox) may be enough to generate the above described scenario.  
The drop in ionic strength and pH in the presence of high amounts of Krytox and large surface-
to-volume ratios – as in microfluidic droplets – can lead to a fast depolymerization of the 
filaments (see Section 5.2.3.4). This allows the monomers to interact homogeneously with the 
interface. In this case, a Marangoni effect cannot be expected. 
Further, it can be speculated about why the methylcellulose-driven bundling of actin 
fibers lead to a more prevalent droplet rotation: Through the described depletion effect actin 
filaments are less diffusive and actin filaments are localized within few bundles. Moreover, as 
they assemble at the periphery to minimize the bending energy costs Krytox molecules have 
easy access to interact with the filaments. This may favor the Marangoni effect and thus, droplet 
rotation.  
In a recently published paper within our group, the same microfluidic water-in-oil 
system has been used to create microtubule networks within droplets.291 Here no rotation of the 
filament-containing droplets could be observed. This may be explained by the fact that 
microtubules’ polymerization happens much slower (observable by eye) than the actin 
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polymerization in the here presented approach, which happened already in the channel of the 
production device (see Section 5.2.3.3). Thus, initially the tubulin (microtubule monomers) is 
distributed in the whole droplet and may interact homogenously with the periphery. 
Consequently, no Marangoni effect evolves.  
 
Towards the creation of autonomous motion, I tested the Marangoni flow in microfluidic 
protein-free droplets. In this regard, I encapsulated positively charged CaCO3 beads292 into 
droplets in order to generate a local interaction with the interface. This will be presented in the 
following. 
 
5.2.6.2. Self-Propulsion in Protein-Free Droplets  
 
The here used porous CaCO3 beads shown in Figure 84 were developed by Dr. 
Rongcong Luo (Postdoc, MPI, Prof. Spatz Department) and produced by Dr. Ilia Platzman 
(Group leader, MPI, Prof. Spatz Department) by means of colloidal crystallization and 
encapsulation of FITC-dextran molecules. 
To test the here presented hypothesis that a Marangoni flow can be induced by a local 
interaction of encapsulated content with the Krytox-containing surfactant interface, I 
encapsulated these CaCO3 beads into the water-in-oil droplets stabilized by 1.4 wt% PEG-based 
surfactant with 10.5 mM Krytox through a simple shaking approach (see Section 4.6.2.1).  
Figure 84 shows merged bright-field and fluorescence images of droplets containing a CaCO3 
bead localized at the periphery of the droplet. Note that the green fluorescence comes from the 
release of the FITC-Dextran from the beads.  
 
 
Figure 84: Merged bright-field and fluorescence images of CaCO3 beads containing 
fluorescently labeled dextran (FITC) encapsulated in water-in-oil droplets, stabilized by 
1.4 wt% PEG-based surfactant and 10.5 mM Krytox. (A) Droplet with a CaCO3 bead 
localized at the periphery of the droplet shows rotation indicated by the arrow (1 rotation 
in ≈50 sec) (B) Trajectories of a second CaCO3  bead-containing droplet that performs an 
orbital movement at velocities of 32.2 +/- 0.5 µm/s. Scale bar 50 µm. 
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In accordance to the here presented hypothesis time-lapse analysis revealed a rotation 
of the droplet (around 1 rotation in 50 sec). Even more remarkable was the phenomenon 
observed in another droplet. Here, the bead-containing droplet showed an orbital movement 
with a significant velocity of around 32.2 +/- 0.5 µm/s (trajectories in Figure 84B). These 
observations are in accordance with the above mentioned hypothesis that a local interaction of 
encapsulated content (here a positively charged CaCO3 bead) can lead to self-propulsion of the 
droplets.  
However, importantly, further investigations need to clarify if the observed self-
propulsion in this case is not based on a different effect due to the dissociation of the CaCO3 
beads into Ca2+ and CO2.  
By writing the last sections I raised and discussed critically a hypothesis explaining the 
observed rotational movement in actin-containing as well as in protein-free water-in-oil 
droplets. This hypothesis is based on the Marangoni flow an effect that evolves at interfaces, 
which comprise local heterogeneities in interfacial tension.  
 
The locomotion of a living cell clearly involves contractile and pushing forces of the 
actin network. Both of these forces I could reconstitute in the here presented artificial cell 
approach, but none of these were decisive for the observed self-propulsion.  
Besides the cytoskeleton, the complex machinery of cellular locomotion includes also 
many other factors as signaling molecules and interaction with the extracellular environment. 
Moreover, the cell membrane is supposed to contribute to the migration process, since it needs 
to be enlarged when the cell body is protruded.61 The additional membrane surface is supposed 
to be provided by exocytosis of internal vesicles at the front of the cell body and the according 
endocytosis at the rear of the cell62 resulting in a lateral membrane flow (see Introduction 
Section 1.2.1.3).61 Interestingly, in amoebas it was observed that this membrane flow flows in 
the same velocity as the forward movement of the cell. Thus, it is feasible that it is directly 
involved in the propulsion mechanism of this cell.64 Moreover, a theoretical model showed that 
tangential travelling surface waves could cause a translational movement in spherical micro-
sized objects.293 Anyway, the exact contribution of this membrane flow is not well understood 
and require further investigations.62 In this regard, the presented self-propulsion of the water-
in oil droplets in my thesis could serve as an adequate model system since it mimics similar 
membrane flows as described in living cells.  
The fact that such a phenomenon of membrane flow is still seen in today’s living cells allows for 
the assumption that this mechanism may have also generated cellular motion in early 
evolutionary life.  
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Part II: Summary  
In Part II of the results, I investigated in a bottom-up synthetic cell approach the major forces 
involved in cellular motility: an actin-based pushing and an actomyosin-based contractile 
force. 
In this regard, I reconstituted actin and actomyosin cytoskeleton networks within water-in-oil 
droplets. Pushing forces were generated by tuning the rigidity of the filaments through 
crosslinking them based on the depletion effect. Contractile forces could be generated by 
combining actin cytoskeleton with myosin motor II. 
Moreover, I could show a self-propulsion of the actin filament-containing droplets and I 
presented a hypothesis about the mechanism behind the droplet rotation that is – in contrast 
to motility in today’s eukaryotic cells – mainly independent of pushing and contractile forces, 
but based on the Marangoni flow. 
______________________________________________________________________ 
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Part III 
 
5.3. The Reconstitution of Adhesion-associated Proteins 
within dsGUVs 
 
Besides the cytoskeletal machinery, the other key feature in cell motility is the adhesion of the 
cell body to the extracellular substrate. The adhesion is mainly mediated by transmembrane 
integrin receptors, which balance the applied forces and build together with associated proteins 
a mechanosensitive linkage to the actin cytoskeleton. 
In this regard, I set out to reconstitute adhesion receptors, more specifically the transmembrane 
protein, aIIbb3 integrin, in droplet-stabilized GUVs (dsGUVs). Moreover, after studying the 
actin cytoskeleton within the surfactant shell in the previous section, I want to move towards a 
more physiological compartment interface and reconstitute also the cytoskeletal network with 
dsGUVs. These resemble the eukaryotic cell much better than the surfactant shell itself. After 
assembling the actin network and the integrin transmembrane receptors individually within 
dsGUVs, I combined both functional modules, and thereby created an artificial cell featuring 
the key structures, adhesion receptors and cytoskeleton, of cellular motility combined. 
In a living cell, integrin proteins are connected to the actin cytoskeleton via a dynamically 
interacting and mechanosensitive protein machinery. The reconstitution of the entire adhesion 
machinery in an artificial cell would be far too complex, thus, I reached out to identify a minimal 
set of purified proteins, linking the integrin to the actin cytoskeleton, in order to create a 
minimal adhesion complex. To assess the success, I performed protein binding assays in bulk 
and QCM-D studies. Thereby, I identified a protein fragment of talin, the talin head domain 
(THD) as a potential linker between integrin and actin. 
Importantly, an artificial cell comprising these major building blocks for cellular motility as 
reconstituted in this thesis has never been reported. Therefore, the outcomes of this thesis might 
pave the way towards better understanding of the fundamental function of cellular motility and 
its assembly.  
 
5.3.1. Actin Networks within dsGUVs 
The dsGUVs provide a physiologically more relevant compartment interface than the 
surfactant shell itself. Thus, I reached out to reconstitute an actin cytoskeletal network within 
dsGUVs. Towards this end, two approaches were used. The first approach involved an 
automated microfluidic picoinjection device (see Section 4.3.1) allowing step by step assembly 
of functional modules in water-in-oil droplets. For these experiments the dsGUVs were 
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produced with 1.4 wt% inert PEG-based surfactant and 10.5 mM Krytox and afterwards 
introduced into the picoinjection device (shown in Figure 85 and in Section 4.3.4) and actin 
monomers were injected into these dsGUVs containing as an aqueous phase the actin 
polymerization buffer. 
 
 
Figure 85 Assembly of an actin cytoskeleton within dsGUVs by microfluidic picoinjection. 
Following the formation, dsGUVs (insets upper left) were introduced into a high 
throughput picoinjection device (draft in the middle). Entering dsGUVs are laterally 
separated by an incoming oil stream (inset lower left) before approaching an electric field 
that leads to a poration of the surfactant shell.  This allows the injection of actin monomers 
into the dsGUVs, when passing the injection channel (inset lower right). Insets on upper 
right show dsGUVs containing polymerized actin network. Scale bar 25 µm. 
 
The second approach for the assembly of actin networks within dsGUVs is a one-step approach 
based on the production device with two aqueous inlets (see Section 4.3.1). Figure 86A shows 
two aqueous inlets: the first inlet delivers actin solution and the other provides SUVs for dsGUV 
formation and the actin polymerization buffer. Similarly, to the assembly of actin networks in 
lipid-free droplets, the actin monomers were mixed with the polymerization buffer only upon 
droplet formation. The droplets were stabilized by 1.4 wt% inert PEG-based surfactant and 10.5 
mM Krytox.  
Note that agglomeration of actin networks with the SUVs were observed for neutral and 
positively charged lipids. In these cases, the formation of a continuous lipid bilayer was 
hampered. To prevent these interactions between actin and SUVs, SUVs needed to comprise at 
least 10% negatively charged DOPG lipids. In this regard, the MgCl2 concentration needed to 
be adjusted depending on the concentration of negatively charged lipids as Mg2+ ions interact 
with the lipids and hence are not available for actin polymerization.  
Figure 86B shows fluorescence images of actin-containing dsGUVs produced by a microfluidic 
two-inlet production device. 
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Figure 86: One-step production of dsGUVs containing actin networks by means of a droplet 
production device with two aqueous inlets. (A) Sketch of the production device. One 
aqueous phase with actin monomers (20 µM, 1% actin is Alexa Fluor 568 –labeled) in its 
storage buffer. Other aqueous phase with SUVs (34.75% DOPC, 34.75% POPC, 30% DOPG, 
0.5% Atto488-DOPE) and double concentrated polymerization buffer. (B) Fluorescence 
images of dsGUVs containing actin networks. Scale bars 50 µm. 
 
 
5.3.1.1. Release of Actin-Containing GUVs into an Aqueous Buffer 
 
As shown in Section 5.1.4, protein-free dsGUVs can be released efficiently out of the surfactant 
shell and oil phase into aqueous buffers. The release of actin-containing GUVs could be 
achieved here as well (see Figure 87), however, in a much lower efficiency.  
 
 
Figure 87: Representative fluorescence images of dsGUVs containing actin networks before release 
(A) and the corresponding released actin-containing GUV in aqueous buffer (B). Scale bar 10 µm. 
 
A reason for the low efficiency could be that the negatively charged actin molecules interact 
similarly like the lipids with the charged surfactant shell and thereby interfere with the 
formation of a continuous lipid bilayer. To overcome this condition, the picoinjection, in which 
the actin is introduced into preformed dsGUVs, is advantageous in comparison to the one-step 
assembly. 
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The assembly of actin networks within GUVs has been reported in several studies in the last 
decades.294 The encapsulation of actin into GUVs were mainly based on the method of gentle 
hydration.162,163 This approach has a similar pitfall in yield, however, is less flexible than the here 
presented dsGUV approach, where GUVs can be equipped with further molecules before 
released into the aqueous phase.  
In the next section, I will describe the reconstitution of additional biomolecules into the 
dsGUVs –towards the creation of a membrane-bound actin cortex – and its limitations. 
 
5.3.1.2. Actin-dsGUV Linkage via Biotin-Streptavidin Chemistry 
 
Whereas in a living cell, the actin network is connected to the lipid membrane by a complex of 
anchoring proteins, in synthetic cell approaches, much simpler connections of actin networks 
with the lipid membrane have been reported e.g. via biotin streptavidin interactions.174  
 
 
Figure 88: Streptavidin-biotin-approach to link actin to the lipid membrane of dsGUVs. 
(A) Sketch of SUVs (59.5% DOPC, 20% DOPG, 20% biotinylated DOPE, 0.5% Atto488-
DOPE) in actin polymerization buffer plus 50 µM streptavidin (in yellow) are used to 
produce dsGUVs. Actin monomers (1% biotinylated, 1% Alexa Fluor 568 labeled) were 
subsequently picoinjected. (B) Fluorescence images of the streptavidin-biotin-approach to 
link actin filaments to the lipid membrane of dsGUVs. Biotin-streptavidin interactions lead 
to the destruction of lipid bilayer and agglomeration of lipids within the actin network. 
Scale bar 50 µm. 
 
Streptavidin has four binding sites for biotin.295 Thus biotinylated lipids are supposed to attract 
the streptavidin from the solution, which provide, in turn, thereby binding sites for biotinylated 
actin filaments (see Figure 88A). Towards this end, in my thesis, SUVs containing 20% of 
biotinylated DOPE lipids and a buffer containing 50 µM streptavidin were used for dsGUV 
production. In a second step actin monomers (1% biotinylated, 1% Alexa Fluor 568 labeled) 
were picoinjected into the dsGUVs.  
However, this approach did not succeed as no actin cortex has been formed at the membrane 
as shown in Figure 88B. Moreover, the lipids detached from the surfactant shell and 
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accumulated within the actin network or leaked into oil phase. Note that lipid leakage into the 
oil phase could be attributed to shearing forces within the picoinjection device.  
 
Other studies showed linkage of actin networks to positively charged lipid membranes via 
electrostatic interactions.87,171 However, such an approach lead in the here presented system to 
a similar agglomeration of the lipids within the actin network as seen in the biotin-streptavidin 
approach. 
 Therefore, I focused on the reconstitution of a nature-inspired connection. Towards this end, 
I reached out to connect the actin network to the membrane via the transmembrane protein 
aIIbb3 integrin. This connection is of major importance in cellular motility, since it forms the 
mechanosensitive linkage responsible for the coordinated attachments at the front and the 
breakage of old attachment sites at the rear of the cell and further initiate many signaling 
pathways.296 Before combining both building blocks, I first reconstituted the aIIbb3 integrin 
within the membrane of dsGUVs alone. This approach will be presented in the next section.  
 
5.3.2. Reconstitution of Integrin in dsGUVs  
aIIbb3 integrin. was purified by Christine Mollenhauer from outdated human blood platelets 
(Katharinenhospital Stuttgart) (see Section3.4.3). 
In order to create integrin-reconstituted dsGUVs, aIIbb3 integrin was in a first step reconstituted 
into liposomes composed of 50/50 (n/n)% eggPC and eggPG as previously described (see 
Section 4.7.3). In a second step these proteoliposomes were mixed 1:10 with SUVs (34.75% 
DOPC, 34.75% POPC, 30% DOPG, 0.5% Atto488-DOPE) and were subsequently used for 
dsGUV formation in a droplet production device. Figure 89A shows a merged fluorescence 
image of the successful reconstitution of fluorescently labeled αIIbß3 integrin (Alexa Fluor 568, 
here shown in blue) within the lipid bilayer (labeled with Atto 488, in green) of a dsGUV.  
Remarkably, the release of the integrin-GUVs into an aqueous buffer was successful. Thus, 
integrin-GUVs can be used for adhesion studies in parallel projects in our group.  
The here presented approach of reconstitution of integrins into dsGUVs and releasing such 
GUVs into the aqueous phase was recently published in Weiss and colleagues.16 Only one other 
study reported the reconstitution of integrin receptors into GUVs.297 This indicates that the 
reconstitution of integrins into GUVs by standard methods is quite challenging. 
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Figure 89: Representative fluorescence images of α I I bß3 integrin in the bilayer of dsGUVs 
(A) and in GUVs after their release from the surfactant shell and oil phase into an aqueous 
buffer (B). α I I bß3 integrin is labeled with Alexa Fluor 568 (here in blue) and lipids are 
labeled with Atto488 (here in green). Scale bar 25 µm 
 
Generally, whereas the reconstitution of active membrane proteins into small liposomes is 
straight forward, the reconstitution into GUVs is difficult, due to the GUV’s mechanical 
instabilities and harsh preparation conditions.117 Therefore, I would like to emphasize the great 
advantage of the here presented method to reconstitute integrin proteins into GUVs. Moreover, 
other membrane proteins such as ATPase were shown to be functionally reconstituted by this 
method.16 This success makes this approach universal for reconstitution of transmembrane 
proteins and allows to bypass the difficulties associated with standard preparation protocols. 
 
5.3.3. DsGUVs with Reconstituted Integrins and Actin Networks 
Next, I investigated the addition of actin networks into the integrin-reconstituted dsGUVs. This 
was achieved similarly as described before in Section 5.3.1: actin was either introduced after 
dsGUV formation via picoinjection or the one-step approach with a two-inlet production 
device was used. Here, one of the aqueous channel contained the SUVs (34.75% DOPC, 34.75% 
POPC, 30% DOPG, 0.5% Atto488-DOPE) together with the proteoliposomes and the actin 
polymerization buffer and the other inlet contained the actin monomers (20 µM in actin storage 
buffer). Figure 90 shows the successful reconstitution of αIIbß3 integrin and actin networks 
within a dsGUV. In this experiment, the aIIbb3 integrin was fluorescently labeled with Alexa 
Fluor 568 (shown in blue), 1% of the actin was labeled with Phalloidin Alexa Fluor 647 (shown 
in red) and 0.5% of the lipids were labeled with Atto488 (shown in green). 
The successful reconstitution of integrin and actin network within an artificial cell has never 
been shown before and thus, need to be highlighted as a great achievement of this thesis and an 
important step towards the construction and understanding of fundamental functional 
modules of a living cell.  
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Figure 90: Representative fluorescence images of dsGUVs containing lipids (34.75% DOPC, 
34.75% POPC, 30% DOPG, 0.5% Atto488-DOPE (shown in green)), a I I bb3 integrin (Alexa 
Fluor 568 labeled (shown in blue)) and actin networks (1% of the actin is labeled with 
Phalloidin Alexa Fluor 647 (shown in red). Scale bar 10 µm. 
 
 
 
5.3.4. Assembly of Minimal Adhesion Complexes  
In a living cell the integrin transmembrane receptors bind with their extracellular part to 
proteins of the extracellular matrix and with their intracellular part to the actin cytoskeleton. 
This integrin - actin connection is not direct and involves several anchoring proteins (see 
Section 1.2.1.2 in Introduction).53 In order to reconstitute such a adhesion complex in a 
synthetic cell, the protein complex has to be dissected to its very basic structure and a minimal 
set of purified proteins that connects the integrin to the actin network has to be identified. In 
this regard protein binding studies by means of QCM-D measurements and pull-down binding 
assays have been performed in bulk.  
 
5.3.4.1. Binding Studies to Identify a Linker Between Actin and Integrin  
 
In the following section, I reached out to identify anchoring proteins for the assembly of a 
minimal adhesion complex. In close cooperation with the protein expression and purification 
facility at the Weizmann Institute in Israel relevant actin or integrin binding proteins were 
selected to be expressed and tested for their integrin and actin binding (see Figure 91). These 
included focal adhesion kinase (FAK), integrin linked kinase (ILK), full length talin and talin 
head domain (THD). Other proteins as a-actinin were purchased from cytoskeleton. 
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Figure 91: Sketch of possible protein linkers, to assemble a minimal adhesion complex. 
 
The binding affinities of FAK, full length talin and THD to integrin /actin are investigated in 
the following. 
 
5.3.4.1.1. Integrin - Focal adhesion kinase (FAK) interaction 
 
The adhesion-associated protein FAK is supposed to be closely involved in the connection of 
integrins to the actin network. It comprises binding sites for integrin. as well as for talin, which, 
in turn, binds to the actin network.298 Thus, as a first step the binding of FAK to aIIbb3 integrin 
was tested using QCM-D. Figure 92A shows the sketch of the sequential application of the used 
proteins onto the QCM-D crystal, and Figure 92B the according frequency and dissipation 
change of the QCM-D sensor.  
First, the QCM-D crystal was functionalized with the extracellular matrix protein fibrinogen 
which is a natural binding partner for aIIbb3 integrin51 (for further details see Section 4.8.1). 
Following the functionalization, aIIbb3 integrin was introduced. The binding of fibrinogen and 
integrin could be observed in the QCM-D as an increase in dissipation and a decrease in 
frequency. Upon introduction of FAK, a similar dissipation and frequency change could be 
observed, indicating a FAK-integrin interaction. 
It is worth to mention that further proteins, integrin-linked kinase (ILK) and a-actinin, was 
tested for integrin binding (see Appendix, Figure SI 7E, F). In this case, no affinity for integrin 
could be detected. 
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Figure 92: QCM-D measurements to study the binding of FAK to a I I bb3  integrin. A) and C): 
sketches of the sequential introduction of proteins onto the QCM-D crystal to test FAK 
integrin binding. B) and D): QCM-D data including dissipation and frequency changes 
upon protein binding on the crystal.  
 
To confirm FAK-integrin binding a second approach was applied (Figure 92C and D). Here a 
supported lipid bilayer (SLB) was formed on top of the QCM-D crystal by introducing SUVs 
(eggPC) onto the oxygen plasma treated silica surface (for further details about 2D SLB see 
Introduction Section 1.3.3). SLB formation could be nicely observed in a sharp dissipation peak 
which represents the adhesion of SUVs (high dissipation) on the crystal and the following 
transformation of the SUVs to a thin rigid bilayer (drastic decrease in dissipation). These 
observations are in accordance with SLB formation on QCM-D crystals in other studies.262,299,300 
The SLB comprised 5% NTA-Ni2+ labeled lipids on which FAK via its His-tag could be 
immobilized. Following the introduction of aIIbb3 integrin, the binding of integrin to FAK could 
be observed in an increase in dissipation and a decrease in frequency. (see Appendix for 
estimated adsorbed mass, see Sauerbrey and Voigt model estimations Table SI 6 and for 
controls Figure SI 7A, B). This interaction is also in agreement with other studies that showed 
a FAK-integrin binding in vitro in a pull-down assay.301  
Besides FAK, talin is a major anchoring proteins of actin to integrin.302 While it is 
controversially discussed,298 which of the two proteins is recruited first during the cellular 
adhesion to the substrate, they mainly appear together, suggesting that they have some binding 
affinity to each other.59 However, based on a similar QCM-D approach as depicted in Figure 
92A, no binding of talin to FAK could be observed (see Appendix, Figure SI 7D).  
 However, talin is supposed to comprise also potential binding sites for integrin and further for 
actin.303,304 Thus, talin may link integrin to actin without assistance of other proteins. Therefore, 
next, talin-integrin interactions were tested.  
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5.3.4.1.2. Talin and Talin Head Domain (THD) 
 
Talin protein was extracted and purified from chicken gizzards by Christine Mollenhauer. As a 
first step, talin-integrin binding was investigated by means of QCM-D measurements (Figure 
93). In this regard, aIIbb3 integrin was immobilized on fibrinogen-functionalized QCM-D 
crystals as described before in Section 4.8.1. When talin was applied on top, no significant 
change in dissipation and frequency could be observed, indicating that talin was not binding to 
aIIbb3 integrin.  
This result might be attributed to the fact that talin can exhibit an autoinhibited alternative 
structure, in which the talin tail folds up and blocks the integrin binding site.305 To improve 
talin-integrin binding performance talin was preincubated with PIP2-lipids which should bring 
talin in an active conformation for integrin binding.306 Contrary to this assumption, a strong 
signal of unspecific binding of PIP2 to aIIbb3 integrin could be observed independently on the 
presence of talin (see Appendix, Figure SI 7C). Thus, a recombinant and supposedly active talin 
fragment, the THD, was used for further binding studies. As it is lacking the tail, autoinhibition 
is supposed to be eliminated, what should render the integrin binding site freely accessible.57 To 
test this, the THD was introduced instead of the full length talin on top of the immobilized 
aIIbb3 integrin on a QCM-D crystal (Figure 93C and D). In that case, a significant decrease in 
frequency could be observed, indicating the integrin-THD binding. These results are in 
agreement with previous studies showing the in vitro binding of THD with the intracellular part 
of the b3 integrin subdomain.306,307 
 
 
Figure 93: QCM-D measurements to study the binding of full length talin and THD to a I I bb3  
integrin. A) and C): schematic representation of the sequential introduction of the proteins 
onto the QCM-D crystal. B) and D) show representative experimental QCM-D data of 
dissipation and frequency changes upon protein binding on the crystal.  
 
Further a pull-down assay (see Section 4.8.2) was performed to verify THD-integrin 
interactions. Therefor the recombinant b3 intracellular integrin domain was attached via its His-
tag to NTA-Ni2+ beads. Before the THD peptide was introduced to test its binding to the b3 
domain, all free NTA-Ni2+ binding sites were blocked with His-tagged ubiquitin. After several 
washing steps the bound proteins were eluted by imidazole and used for Western blot analysis 
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(Figure 94). An anti-THD and an anti-His tag antibody were used to detect the THD and the 
His-tagged b3-tail, respectively, in the elution fractions. Even though a small amount of THD 
bound to the beads without b3 integrin tail, the amount of THD was significantly higher on 
beads that were beforehand incubated with b3-integrin. Thus, the binding of THD to aIIbb3 
integrin measured by means of QCM-D could be confirmed.  
 
 
Figure 94: Representative image of a Western blot membrane showing the analysis of THD-
b3  integrin-binding by means of a pull-down assay. 1s t  band: sample in which THD binds 
to beads that were preincubated with b3-integrin tails. 2n d and 3r d band: show control 
samples of beads without the incubation step of b3-tails or THD, respectively. Free binding 
sites were blocked with His-Ubiquitin.  
 
In a next experiment, THD binding to actin filaments was tested by incubating the THD with 
actin filaments in a micro tube. The unbound molecules were then separated from the actin 
filaments by a centrifugation step (pull-down). Fractions of the supernatant and the pellet were 
analyzed by means of SDS-PAGE (Figure 95A) and Western blot analysis (Figure 95B). Besides 
testing the binding affinity of THD to the actin filaments, a positive and a negative control was 
performed using the actin binding protein a-actinin and a non-binding protein BSA, 
respectively. As actin and THD have similar molecular weights and thus, were not 
distinguishable in SDS-PAGE, a Western blot was performed with an anti-THD antibody and 
an anti-actin antibody. The blot revealed that THD was partly present in the actin pellet (Row 
5) and thus, proved THD-binding to actin. 
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Figure 95: Representative images of SDS-PAGE and a Western blot membrane showing the 
analysis of a actin filament pull-down assay. (A) SDS-PAGE of pull-down assay: actin 
incubated with THD (1) and a-actinin and BSA (2). Samples are then centrifuged and 
pellet and supernatant fractions are used separately for SDS-PAGE analysis. (B) Western 
blot analysis of pull-down assay. Actin incubated with THD (1) anti-actin antibody and 
anti-THD antibody (2) showing the presence of these proteins in different pellet 
/supernatant fractions.  
 
Based on these experiments the THD seems to be a promising candidate to connect integrin to 
the actin network. This is in accordance with other in vitro studies testing THD binding to actin 
and integrin.57,308  
To check this further, a combined actin pull-down assay with integrin and THD was performed. 
In this respect, if THD connected the actin to integrin all three proteins would be found 
cosedimented after centrifugation. Contrary to this assumption, neither THD nor integrin was 
found cosemdimented with the actin filaments (see Figure 96).  
 
 
Figure 96: Representative image of SDS-PAGE showing the analysis of a F-actin pull-down 
assay where actin filaments are incubated with/without THD and integrin in actin 
polymerization buffer. Samples are then centrifuged and pellet and supernatant fractions 
are used separately for SDS-PAGE. 
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This means that the THD has probably a stronger binding affinity to integrin than to actin. In 
this regard, binding conditions need to be adjusted in future experiments to improve THD 
binding to actin, which is supposed to be optimal in low ionic strength and at pH of 6.4.304 Thus, 
in future experiments the focus should be especially dedicated to testing a variety of buffers to 
improve the THD binding affinity to actin. 
 
These results show that the more complex an artificial cell gets, the more difficult it is to find 
buffer conditions that meet all the requirements of implicated building blocks.  
Generally, this may even get more difficult when building blocks of different functional 
modules are supposed to be combined. In some of these cases, compartmentalization like the 
presented multicompartment system (Section 5.1.2) can be used for the successful assembly of 
different functional modules in parallel.97 Alternatively, synthetic building blocks e.g. DNA 
nanotechnology98 or protein engineering309 can be used to create more robust and adaptable 
building blocks.97  
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Part III: Summary  
In Part III of the results, I combined the key building blocks of cellular motility within the 
synthetic cell approach.  
First, integrin receptors and actin cytoskeleton were reconstituted within the dsGUVs 
separately. Then both functional modules where combined, thereby creating a synthetic cell 
comprising cytoskeletal and adhesion functional modules within in a physiological lipid 
membrane-based compartment.  
Remarkably, this has never been shown before somewhere else. 
Moreover, to resemble the mechanosensitive protein complex between actin and integrin that 
mediates cellular motility in a living cell, protein binding studies have been performed. 
Thereby a linker has been identified that may be used in this sense in future synthetic cell 
experiments.  
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6. Summary and Outlook 
6.1. Summary 
In this thesis, the concept of bottom-up synthetic biology has been implemented to reconstitute 
structural and functional modules of a eukaryotic cell in an artificial and minimal system. In 
this regard, major achievements have been reached that will pave the way towards the 
understanding of cellular functions such as cytoskeletal forces and network arrangements, 
cytoskeletal interaction with integrin transmembrane receptors, as well as cell motility. The 
concept of minimal cell systems with distinct functionalities and structures allows for the better 
understanding of how the first form of life – probably similarly simple – has evolved on Earth.  
The technological aspect in my thesis needs to be particularly emphasized. I used automated 
microfluidic technology to create cell-sized water-in-oil droplets as a basic model for synthetic 
cells. This microfluidic technology allowed for high throughput production of stable and, 
therefore, manipulatable synthetic cell systems with a well-defined chemical and biophysical 
microenvironment. The enhanced stability of the developed compartments enabled their 
loading with lipids, transmembrane proteins and cytoskeleton actin proteins without 
compromising the functionality of the synthetic cells.  
The stability of the water-in oil droplets is governed by polymer-based surfactants. In my thesis, 
I showed that these surfactants can not only passively stabilize the water-in-oil droplets, but can 
be also used to manipulate the encapsulated droplet content depending on the choice of 
surfactant molecules in the oil. In this vein, I provided a detailed characterization of how the 
physico-chemical properties of the droplet’s interface can be tuned by the use of differently 
charged surfactant molecules. The physico-chemical properties of the interface were then 
shown to govern the assembly of cellular modules within the droplet.  
I then utilized this newly found knowledge of the surfactant’s role in the droplet’s interface for 
the reconstitution of cellular membrane structures that mimic their presentation in a eukaryotic 
cell, namely an outer phospholipid membrane and multiple internal compartments. Towards 
this aim, lipid vesicles were encapsulated into the droplets and, depending on the lipid’s charge, 
interactions between the lipids and the droplet interface could be either permitted or inhibited. 
Successful implementation of this approach allowed for on-demand production of the 
following synthetic cell structures:  
1) Spherically supported lipid bilayers, called droplet-stabilized giant unilamellar 
vesicles (dsGUVs) that resemble the outer lipid membrane of a eukaryotic cell;  
2) Multicompartment systems, in which encapsulated vesicles are randomly distributed 
in the droplet volume, resembling organelles of a living cell; 
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3) A combination of these two membrane structures, thereby creating a synthetic cell 
with an outer lipid membrane as well as internal organelle-like structures.  
The presented approach is extremely versatile in that after the assembly of such 
membrane structures within the water-in-oil droplets, free-standing GUVs can be released out 
of the surfactant shell into a physiological aqueous environment. Hence, this approach 
combines the advantages of both the initial mechanical stability provided by the water-in-oil 
droplet and the physiological relevance of free-standing GUVs.  
The release process of GUVs based on lipid and surfactant charge was analyzed in great detail 
in this thesis. The released GUVs were also characterized based on their size, purity and 
unilamellarity. Furthermore, the released GUVs were shown to be receptive to further 
manipulation, allowing for the generation of vesicles with high surface-to-volume ratio as is 
seen in some eukaryotic organelle structures, e.g. mitochondria.  
 
In the second part of my thesis, I focused on recapitulating cellular motility within water-in-oil 
droplets. Towards this aim, I broke down the complex machinery mediating cellular motility 
into three major elements and reconstituted these elements within water-in-oil droplets: 
1) The elongation of the cell body at the front was implemented by rigid actin filaments 
that, upon minimizing their bending energy, pushed against the droplet wall.  
2) The contraction of the cell rear was achieved by the addition of myosin motors to the 
actin cytoskeleton, thereby creating a contractile cytoskeletal network.  
3) The attachment of the cell body to the substrate was represented by the integration of 
integrin transmembrane receptors within the lipid membrane of the dsGUVs.  
Expanding on the achievement of reconstituting each of these three key elements in a 
synthetic cell separately, I then worked to combine all of these processes in one compartment. 
This resulted in a synthetic cell featuring cytoskeletal as well as adhesion-associated functional 
modules, which has never been accomplished before. 
 
In a living cell, elongation and contraction of the cell body interplays with substrate attachment 
and detachment. This dynamic feedback mechanism is based on many proteins and signaling 
molecules connecting the actin cytoskeleton to integrins in the membrane. The reconstitution 
of such complex machinery in a synthetic cell has, to-date, proven too complex to achieve in 
the laboratory. Thus, in my thesis, I focused on determining a minimal linkage between actin 
and integrins in bulk binding assays. To do this, I implemented the highly sensitive and label-
free QCM-D technique, as well as pull-down assays, SDS-PAGE and Western blot. Based on 
these techniques, I identified the THD protein fragment comprising binding sites for actin and 
integrins, and which could be used in future synthetic cell approaches.  
  
When investigating cellular motility in a synthetic system, the ultimate goal is the generation of 
synthetic motion. In the last part of my thesis, this goal was accomplished. Surprisingly, the 
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most obvious mechanisms in cellular motility, i.e. actomyosin-based, were shown to not be the 
driving force for the motility of the synthetic cells presented here. In contrast, the self-
propulsion was explained by a physico-chemical effect that evolves on an interface with local 
changes in interfacial tension, the so-called Marangoni effect. In the case of actin-containing 
water-in-oil droplets, heterogeneous interfacial tension is caused by the interaction of the 
encapsulated actin filaments with the interface. The mismatch of interfacial tension results in a 
force that creates, due to viscous stresses, a flow along the interface. This flow in turn propels 
the droplet. Interestingly, such flows along the membrane have also been reported in cells, 
however, the precise mechanism has yet to be elucidated. In amoebae, these flows have shown 
to be directly linked to locomotion, thus, a parallel can be drawn between this semi-simple 
system of an amoebae and our simple synthetic cell, thereby leading to the assumption that such 
membrane flows may have been essential in early evolutionary life. 
 
Taken together, the results presented here show that microfluidic water-in-oil droplets provide 
a powerful platform for synthetic biology with wide-ranging possibilities to study functional 
cellular modules.   
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6.2. Outlook 
 
In this section I would like to present my view over the future perspective of the scientific 
achievements developed in this thesis.   
 
Charged-mediated formation of droplet-stabilized biostructures. In the first part of my 
thesis I showed that the physico-chemical properties of polymer-based membranes can be 
precisely controlled. I presented that by a proper selection of charged and inert polymer-based 
surfactant molecules for the water-in-oil droplets production, the encapsulated SUVs with 
different lipid charge can be recruited to the surfactant shell forming droplet-stabilized GUVs. 
This charge-mediated approach might be extended for the recruitment of proteins to the 
periphery, thereby creating droplet-stabilized protein capsules. First experiments in the group 
showed that when the proteins are crosslinked at the periphery of the droplet, the resulting 
protein capsules can be released into a physiological buffer. By an intelligent design cells could 
be potentially encapsulated within the preformed ECM-based protein capsules. In such a way 
cell-containing ECM-based capsules might be generated for various biophysical and biomedical 
applications such as 3D printing of tissues or organoids.  
 
Functional multicompartment systems. In this thesis, I showed that the precisely controlled 
phyico-chemical properties of the droplet’s interface allow for the creation of 
multicompartment systems enclosed in a dsGUV. This was achieved by the selective, charge-
mediated recruitment of encapsulated SUVs with certain lipid charge to the surfactant shell, 
and at the same time leaving SUVs with a different charge unaltered as organelle-like structures 
within the dsGUV lumen. To elevate this approach to a next level, functional modules can be 
included within the encapsulated SUVs. By doing so, multiple isolated reactions might be 
initiated in one artificial cell. Moreover, for sequestered reactions, functionalized 
phospholipids, e.g. pH-sensitive lipids or phospholipids with distinct phase transition 
temperatures could be used to create the internal SUVs. By the subsequent manipulation of the 
compartment systems – changing pH or temperature – encapsulated SUVs can be triggered to 
release their content. Very interesting will be to encapsulate protein expression or PCR 
machinery into the internal SUVs. These internal SUVs could then nicely resemble the 
ribosomes or the nucleus of a living cell.  
 
Reconstitution of an energy module. Based on the multicompartment system, another 
interesting follow-up experiment would be to encapsulate ATP into the SUVs or to reconstitute 
ATP-Synthases and bacteriorhodopsin within the SUVs in order to fuel ATP-dependent 
functional modules in the cell e.g. the actin polymerization or actomyosin contraction (see 
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Figure 97). The reconstitution of ATP Synthases into SUVs was already successfully achieved.310 
Thus, a next obvious and probably not too complicated step would be to combine the functional 
modules of actin cytoskeleton and ATP producing SUVs in water-in-oil droplets.  
 
 
Figure 97: Schematic representation of controlled delivery of ATP into the water-in-oil 
droplets based on multicompartment systems. A) ATP is encapsulated in vesicles 
comprising pH sensitive lipids. Upon a decrease of pH, vesicles lose their integrity and ATP 
can leak out into the droplets continuous aqueous phase. B) ATP Synthase could be 
reconstituted into lipid vesicles and encapsulated into the water-in-oil droplets. Thereby 
having an in-situ production of ATP. C) The released or produced ATP could trigger ATP 
dependent reactions as e.g. actin polymerization. 
 
 
Cell division model. In this thesis, I have shown successful reconstitution and characterization 
of several functional cellular modules in a droplet-based artificial cell. In this regard, my next 
idea addresses the rigid actin filament bundles that are presented in Section 5.2.1.2. These 
bundles align at the equator of the droplet and thus, resemble contractile ring structures (see 
Figure 98). Similar contractile ring structures are seen in the natural cells, shorty before the cell 
is dividing based on myosin-mediated contraction of these ring structures.166 For follow up 
experiments, it would be interesting to figure out, if myosin motors could contract the rigid 
fibers and lead to network dynamics similarly seen in cell division. Next, towards the generation 
of a dividing droplet (Figure 98) the actomyosin network needs to be linked to the periphery. 
This could be for example done by a DNA linker, developed in our group. This DNA linker 
comprises a cholesterol tag, which attaches to the surfactant layer, and a NTA-tag, which could 
bind to His-tagged actin filaments in the contractile ring structures. Thereby the myosin 
contractile force could be applied onto the droplet compartment and a deformation or even a 
droplet splitting may be obtained. 
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Figure 98: Schematic representation of rigid actin bundles that are encapsulated together 
with myosin motor proteins into water-in-oil droplets to mimic cell division dynamics. 
When the actin fibers are linked to the droplets wall, a deformation of the droplet due to 
actomyosin contraction could be obtained.  
 
Adhesion module. Further work has to be done in the reconstitution of an adhesion complex 
within the artificial cell as addressed in Section 5.3.4. I showed a successful assembly of an 
artificial cell, comprising an outer lipid bilayer with reconstituted integrins and an actin 
cytoskeleton. Moreover, I showed that the talin head domain “THD” has binding sites for actin 
and integrin. However, THD did not bind in parallel to integrin and actin. To continue, a more 
robust linker has to be found or – based on further protein binding studies – binding conditions 
for the THD linker has to be optimized. Another solution would be to use an artificial linker. 
In this regard, a parallel project in our group is addressing the construction of so-called 
DARpins.311 These DARpins are genetically engineered antibody mimetics that consist of two 
binding domains connected via a spacer of ankyrin repeats.309 In this regard, DARpins can be 
engineered comprising an integrin and an actin binding domain. This approach provides a 
promising solution to build an adhesion complex within the described artificial cell.  
The adhesion module in a living cell is involved in many signaling pathways in addition to the 
coordination of ECM attachment and detachment during cell locomotion.50 This adhesion 
module is mechanosensitive, that means that intra- and extracellular mechanical cues can 
trigger its assembly and disassembly.60 Thus, to resemble this mechanosensitive module of a 
living cell, it would be especially interesting to include contractile actomyosin networks into 
this adhesion complex model within the synthetic cells.312 However, to test the assembled 
adhesion complex in subsequent binding studies on ECM substrate, the artificial cell has to be 
released out of the surfactant shell and oil phase into a physiological environment. This requires 
another set of experiments. Even though it was possible to release GUVs containing integrin 
alone, the addition of actin makes the release poorly efficient. The reason could be that actin is 
interfering with the assembly of the lipid bilayer when introduced in one step into the droplet. 
The sequential introduction of lipids and actin via picoinjection improves this to some extent, 
however, the applied electrical field creates as well distortion of the lipid bilayer that allows the 
injected actin to disturb the reassembly of a continuous lipid bilayer. An idea to solve this 
problem is by using a new picoinjection device developed in our group. This microfluidic 
picoinjection device is not relied on an electric field but is based on a rapid mechanical 
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deformation of the droplets. This may lead to less distortion of the lipid bilayer and may 
maintain the passivation of the droplet’s periphery through the lipid bilayer in order to prevent 
injected actin molecules to interact with the periphery. 
 
Autonomous motility model. The fascinating field of self-propulsion of artificial systems, 
which was elucidated in my thesis, needs to be investigated a bit further. To study the effect of 
the described liquid flows a protein-free system should be used. Possible candidates are 
positively charged beads. I would not recommend to use CaCO3 beads due to side-effects from 
the dissociation of the beads. Positively charged stable beads will allow higher flexibility with 
the buffer conditions and Krytox concentration in comparison to actin filaments that 
depolymerize in unphysiological pH ranges or in high Krytox concentrations. Besides the 
addition of internal beads, also the external flow around the droplets should be characterized 
by the addition of fluorescent hydrophobic beads with the same density as the surrounding oil 
phase. 
Further it would be interesting to deeply investigate the influence of the friction effect with the 
cover-glass. Therefore, patterned surfaces (Figure 99) could be generated to create droplet 
rotation and droplet translation on surfaces with higher and lower friction, respectively.  
 
 
Figure 99: Schematic representation of an observation chamber containing droplets with 
autonomous motion due to encapsulated beads or actin filaments and the resulting 
Marangoni flow. Depending on the glass-droplet interaction droplets may perform a 
rotational or a translational motion for higher and lower friction, respectively. 
 
The presented approaches will be possible due to the deep understanding and precise control 
of interfacial droplet properties as achieved in this thesis. The presented ideas for further 
projects show that the approach of water-in-oil droplets with tunable interface properties is 
highly versatile in application and paves the way for biomedical studies as well as for 
fundamental understanding of cellular function and life in general. 
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7. Appendix 
 
7.1. Supplementary Figures and Tables 
 
7.1.1. Krytox Concentrations in Custom-Made triblock Surfactants 
 
 
Figure SI 1: Krytox content in custom-made surfactants based on partitioning experiments. 
(A) Molecular ratio of Krytox per triblock surfactant of three different custom-made 
surfactants. Means calculated from Rhodamine6G concentrations in oil and water phase. 
(For more information see Methods) (B) Images of partitioning experiment to test Krytox 
concentration in the amine surfactant. 1 and 0 mM amine surfactant in the oil phase and 
1 mM Rho6G in the aqueous phase on top after 48 h incubation. No extraction into the oil 
phase indicates absence of Krytox. 
 
7.1.2. IFT measurements of surfactant mixtures 
Table SI 1: IFT values of the surfactant mixtures (PEG-based surfactant and Krytox). 
Krytox [mM] 0 1.5 3 4.5 6 7.5 9 10.50 12 13.5 15 
plus 1 mM MgCl2                     
w/o  PEG-based surfactant                   
Mean [mN/m]   9.23 3.30 1.21 1.07 < 1 < 1 < 1 < 1 < 1 < 1 
Std. Dev   0.54 0.23 0.41 0.66 X X X X X X 
with 1.4 wt% PEG-based surfactant                 
Mean [mN/m] 4.4 3.23 6.68 6.859 6.08 4.64 1.55 X 1.38 1.24 X 
Std. Dev 0.21 0.44 0.47 0.72 0.83 0.06 0.46 X 0.44 0.23 X 
                        
Krytox [mM] 0 1.5 3 4.5 6 7.5 9 10.50 12 13.5 15 
pure water                       
w/o PEG-based surfactant                   
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Mean [mN/m] 38.04 25.34 24.77 19.84 19.79 21.61 21.14 20.14 21.84 21.26 20.35 
Std. Dev 0.65 0.41 0.46 0.12 0.48 0.46 0.15 0.40 0.21 0.23 0.44 
with 1.4 wt% PEG-based surfactant                 
Mean [mN/m] 4.95 7.12 11.44 17.78 20.41 18.8 19.59 22.04 23.07 21.34 22.92 
Std. Dev 0.68 0.44 0.32 0.04 0.03 0.09 0.02 0.01 0.02 0.06 0.76 
 
 
Table SI 2: IFT values of the surfactant mixtures (PEG-based surfactant and amine 
surfactant). 
NH3 surfactant [mM] 0 1 3 6 10 pure NH3 
with 1.4 wt% PEG-based surfactant         
plus 1 mM MgCl2             
Mean [mN/m] 4.34 4.17 2.64 1.83 2.37 2.58 
Std. Dev 0.56 0.51 0.13 0.38 1.63 0.67 
pure water       
Mean [mN/m] 4.86 4.19 3.39 2.28 2.11 2.78 
Std. Dev 0.54 0.57 0.76 0.19 0.06 0.88 
 
 
 
7.1.3. Lipids in droplets after 7 days 
 
 
Figure SI 2: Representative images of fluorescence from lipids (0.5% ATTO 488-labeled 
DOPE) in the microfluidic droplets at day 7 after production. To evaluate the influence of 
Krytox on dsGUV formation and stability, different Krytox concentrations, indicated on 
top of the fluorescence images, were mixed with 1.4 wt% PEG-based fluorosurfactants in 
the oil phase. 10mM Mg2 + and SUVs comprised of 42.25% DOPC, 42.25% POPC and 15% 
cholesterol were used as an aqueous phase for droplets formation. Scale bar 50  μm. 
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7.1.4. Compartments stabilized by high Krytox concentrations 
 
 
Figure SI 3: Representative images of fluorescence from lipids (0.5% ATTO 488-labeled 
DOPE) in the microfluidic droplets. To evaluate the influence of Krytox on dsGUV 
formation, different Krytox concentrations, indicated on top of the fluorescence images, 
were mixed with 1.4 wt% PEG-based fluorosurfactants in the oil phase. To evaluate the 
influence of negatively charged lipids on dsGUV formation, the Tris buffer including 10 mM 
Mg2 + and SUVs comprised of different ratios of negatively charged DOPG lipids (DOPC x%, 
POPC x%, DOPG 0% – 30%, cholesterol 15%) was used as an aqueous phase for droplets 
formation. Scale bar 50  μm. 
 
7.1.5. DLS 
 
 
 
Figure SI 4: Size distribution of SUVs measured by DLS. Histogram indicates the mean 
distribution of 6 measurements (mean diameter: 68 ± 15 nm). 
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7.1.6. FRAP 
 
Table SI 3: Diffusion coefficients of neutral and negatively charged lipids within water-
in-oil droplets stabilized by different Krytox-to-PEG-based surfactant ratios 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table SI 4: Diffusion coefficients of positively charged lipids within water-in-oil droplets 
stabilized by different Krytox-to-PEG-based surfactant ratios. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DOPG in% c(Krytox) [mM] Diffusion coefficient 
[µm2/s] 
 
0 1.5 1.1 ± 0.1 n=20 
0 3.0 1.3 ± 0.2 n=20 
0 7.5 4.8 ± 0.4 n=20 
0 10.5 5.1 ± 0.5 n=40 
0 15 5.1 ± 0.3 n=20 
30 1.5 1.0 ± 0.1 n=20 
30 7.5 5.4 ± 0.4 n=20 
30 10.5 4.2 ± 0.3 n=40 
30 15 5.5 ± 0.3 n=20 
DOTAP in% c(Krytox) [mM] Diffusion coefficient 
[µm2/s] 
 
30 1.5 1.5 ± 0.7 n=10 
30 3.0 1.6 ± 0.2 n=10 
30 4.5 3.2 ± 0.5 n=10 
30 6 4.1 ± 0.3 n=10 
30 7.5 4.1 ± 0.2 n=10 
30 9 5.3 ± 1.0 n=10 
30 10.5 4.5 ± 0.3 n=10 
30 12 5.6 ± 0.4 n=10 
30 13 5.2 ± 0.3 n=10 
30 15 5.0 ± 0.3 n=10 
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Table SI 5: Diffusion coefficients of lipids within water-in-oil droplets stabilized by 
different amine surfactant-to-PEG-based surfactant ratios. 
 
 
 
 
 
 
 
 
 
 
 
7.1.7. Lipid leakage depending on lipid charge 
 
 
 
Figure SI 5: Quantification of lipid leakage from the water phase inside the droplet into the 
surrounding oil phase as a function of lipid charge. The fluorescence intensity from the 
lipids (0.5% DOPE-Atto488) in the oil phase was normalized to the intensity in the water 
phase. Less lipid leakage is observed at higher concentrations of negatively charged lipids 
(DOPG) within the lipid mixture. 
DOPG in% c(amine surf) [mM] Diffusion coefficient 
[µm2/s] 
 
0 3 1.9 ± 0.8 n=10 
0 5 1.3 ± 0.2 n=10 
0 7 2.2 ± 0.4 n=10 
0 10 1.7 ± 0.4 n=10 
30 3 1.8 ± 0.3 n=10 
30 5 1.7 ± 0.5 n=10 
30 7 
leakage 30 10 
Plus MgCl2 3 – 10 No interaction with the 
periphery DOTAP 3 – 10 
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7.1.8. Manipulation of Released GUVs 
 
 
Figure SI 6: Calculation of the theoretically possible length of lipid tubes in released GUVs 
due to mismatching of bilayer leaflet areas (3%) in presence of higher MgCl2 concentration 
in the surrounding aqueous phase. 
 
 
7.1.1. Mass estimation of adsorbed protein on QCM-D crystal 
 
Table SI 6: Mass estimation of adsorbed protein on QCM-D crystal based on two models: 
Sauerbrey (only frequency-mass relation) and viscoelastic Voigt model. 
Figure 92A [ng/cm2] fibrinogen Integrin FAK 
  Sauerbrey 1743.3 602 1296.9 
  Voigt 2226.3 707 1412.5 
Figure 92B [ng/cm2] SLB FAK integrin 
  Sauerbrey 335.5 491.7 156.1 
  Voigt 622.7 1164 653.1 
Figure 93A [ng/cm2] fibrinogen Integrin talin 
  Sauerbrey 1417.6 935.1 163.4 
  Voigt 1608.1 676.4 319.7 
Figure 93B [ng/cm2] fibrinogen Integrin THD 
  Sauerbrey 1121.4 584.6 78.1 
  Voigt 1472.2 865.1 XX 
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7.1.2. QCM-D Controls  
 
 
Figure SI 7: Frequency and dissipation shifts of QCM-D control measurements. 
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7.1.3. Linkage of Actomyosin Networks to the Periphery via Gold-linked 
Surfactants  
 
 
 
Figure SI 8: Droplets stabilized by the addition of gold-linked surfactants. A: 
Representative fluorescence image of actomyosin networks (1% of actin labelled with Alexa 
Fluor 568) within droplets stabilized by triblock surfactant and 1.2 µM gold surfactant. 
Scale bar 50 µm. B: cryo-SEM micrograph of the droplet’s inner interface and the chemical 
structure of gold-linked surfactants in the inset. Arrow points to the bright spots, which 
are gold nanoparticles (5-10 nm) at the droplets interface. 
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